katG Resolved · high auto-curated

H37Rv Rv1908c · MTBC0 mtbc0_002023 · 740 aa · 2171999–2174221 MTBC0 (-) · RefSeq NP_216424.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)catalase-peroxidase
MTBC0 PGAP re-annotationcatalase/peroxidase HPI
Revised (this work)Catalase/peroxidase HPI. Pfam: peroxidase (PF00141.29).
Functional category (TubercuList)virulence, detoxification, adaptation

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 1415 publications

1415 TB publications mention this gene. 1415 publications discuss this gene. Queried separately, 1383 records carry a M. tuberculosis context and 75 a non-TB mycobacterial context (species named in the 40-record verified sample: M. smegmatis (27), M. abscessus (4), M. marinum (4), M. leprae (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 1415: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
A diagnostic performance study of multiplex polymerase chain reaction-based targeted next-generation sequencing for the accurate identification of Mycobacterium tuberculosis in bronchoalveolar lavage fluid. doi:10.3389/fcimb.2026.1807848 2026
Machine learning-based analysis of drug resistance mutations in Mycobacterium tuberculosis. doi:10.1371/journal.pone.0352863 2026
Genetic surveillance of first- and second-line drug-resistant isolates of Mycobacterium tuberculosis in Peru. doi:10.1371/journal.pone.0352881 2026
The potential of molecular testing and mutation analysis for detecting isoniazid and rifampicin-resistant Mycobacterium tuberculosis in Thailand. doi:10.1590/S1678-9946202668040 2026
Molecular Evaluation of Rifampicin and Isoniazid Resistance in Pulmonary Tuberculosis Using Cartridge-Based Nucleic Acid Amplification Test and Line Probe Assay. doi:10.7759/cureus.110237 2026
1487 records returned by the alias sweep (a separate sweep from the 1415 above; both are shown, neither is exhaustive)

Searched as: Rv1908c, katG, Mb1943c, MMAR_2914, MSMEG_6384, MAB_2470c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Genomic epidemiology of the Mycobacterium tuberculosis complex in Fiji reveals community transmission and human Mycobacterium bovis infection. doi:10.3389/fmicb.2026.1933597 Front Microbiol 2026
Genomic characterization of drug-resistant Mycobacterium tuberculosis complex in western Kenya reveals predominance of isoniazid resistance and discordance with routine susceptibility testing. doi:10.3389/ftubr.2026.1855780 Front Tuberc 2026
Comparative whole genome analysis of Mycobacterium tuberculosis isolated from BPaLM and individualized regimen treated patients at Dr. Soetomo Hospital, Indonesia. doi:10.1007/s11033-026-12652-7 Mol Biol Rep 2026
Synthesis, computational and in vitro anti-tubercular activity studies of thiadiazole-linked pyridazinone derivatives. doi:10.1016/j.bmcl.2026.130761 Bioorg Med Chem Lett 2026
Molecular Mechanisms Underlying Antimicrobial Resistance in Mycobacteria. doi:10.3390/ijms27156893 Int J Mol Sci 2026
Modulation of NF-κB in tuberculosis - understanding host-pathogen interactions and therapeutic opportunities. doi:10.1016/j.micpath.2026.108766 Microb Pathog 2026
Whole-genome sequencing reveals lineage-associated drug resistance and enables machine learning-based prediction in Mycobacterium tuberculosis clinical isolates. doi:10.3389/fmicb.2026.1828991 Front Microbiol 2026
Genomic diversity and transmission routes of Mycobacterium tuberculosis isolates in Morocco. doi:10.1016/j.meegid.2026.105997 Infect Genet Evol 2026
Rapid Extensively Drug-Resistant (XDR) TB Diagnosis: An In-House DNA Biochip for Drug Resistance Detection and Mutation Profiling of Mycobacterium tuberculosis. doi:10.1155/cjid/5518992 Can J Infect Dis Med Microbiol 2026
Reactive oxygen detoxification contributes to Mycobacterium abscessus antibiotic survival. doi:10.7554/eLife.104944 Elife 2026
Thin-Film-Based Three-Chamber Microfluidic Chip Powered by Pyrococcus furiosus Argonaute for Sample-to-Answer Multiplex Genotyping of Tuberculosis Drug-Resistance Mutations. doi:10.1021/acssensors.6c01347 ACS Sens 2026
A diagnostic performance study of multiplex polymerase chain reaction-based targeted next-generation sequencing for the accurate identification of Mycobacterium tuberculosis in bronchoalveolar lavage fluid. doi:10.3389/fcimb.2026.1807848 Front Cell Infect Microbiol 2026
Machine learning-based analysis of drug resistance mutations in Mycobacterium tuberculosis. doi:10.1371/journal.pone.0352863 PLoS One 2026
Genetic surveillance of first- and second-line drug-resistant isolates of Mycobacterium tuberculosis in Peru. doi:10.1371/journal.pone.0352881 PLoS One 2026
The potential of molecular testing and mutation analysis for detecting isoniazid and rifampicin-resistant Mycobacterium tuberculosis in Thailand. doi:10.1590/S1678-9946202668040 Rev Inst Med Trop Sao Paulo 2026
Molecular Evaluation of Rifampicin and Isoniazid Resistance in Pulmonary Tuberculosis Using Cartridge-Based Nucleic Acid Amplification Test and Line Probe Assay. doi:10.7759/cureus.110237 Cureus 2026
Genotypic Characterization of Drug Resistance-associated Mutations in Mycobacterium tuberculosis Using Line Probe Assays in Central India. doi:10.4103/ijmy.ijmy_85_26 Int J Mycobacteriol 2026
Novel Anti-Microbial Peptides Design and Screening Against the KatG Using Molecular Docking and MD Simulation. doi:10.1007/s12602-026-11086-8 names it Probiotics Antimicrob Proteins 2026
Discovery of novel InhA inhibitors through structural bioinformatics and machine learning-driven QSAR screening of natural products. doi:10.1093/biomethods/bpag015 Biol Methods Protoc 2026
Analysis of Drug Resistance Characteristics and Risk Factors of Cavitary Tuberculosis Based on Whole Genome Sequencing and Machine Learning. doi:10.1093/ofid/ofag328 Open Forum Infect Dis 2026
Influence of Diabetes Mellitus on the Development of Multidrug-Resistant Tuberculosis (MDR-TB) in Relation With Genetic Mutations of M. tuberculosis Isolates in Ethiopia. doi:10.1155/cjid/7830270 Can J Infect Dis Med Microbiol 2026
Discovery and functional characterization of katG mutations mediating Isoniazid resistance in Mycobacterium tuberculosis. doi:10.1016/j.diagmicrobio.2026.117504 names it Diagn Microbiol Infect Dis 2026
Simultaneous molecular detection of Mycobacterium tuberculosis and multidrug resistance using CRISPR-AaCas12b-based nucleic acid assay. doi:10.3389/fcimb.2026.1844184 Front Cell Infect Microbiol 2026
Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis. doi:10.3390/pathogens15050455 Pathogens 2026
Routine Molecular Surveillance of Drug-Resistant Tuberculosis: Translating Mutation Proxies into Clinical Governance Intelligence in Rural Eastern Cape. doi:10.3390/healthcare14101280 Healthcare (Basel) 2026
Association of pyrazinamide resistance in Mycobacterium tuberculosis with mutations in rpoB, katG, and inhA genes. doi:10.1038/s41598-026-53296-8 names it Sci Rep 2026
Identification and drug resistance profiling of Mycobacterium orygis from an African elephant using whole-genome sequencing. doi:10.1128/spectrum.03586-25 Microbiol Spectr 2026
Evaluation of the potential virulence of Mycobacterium avium subspecies paratuberculosis isolates from cattle in Uganda. doi:10.1007/s42770-026-01951-7 Braz J Microbiol 2026
Inhibitory effects of thiophene-2-thiazole hybrids against sensitive strains and resistant clinical isolates of Mycobacterium tuberculosis. doi:10.1016/j.bmcl.2026.130679 Bioorg Med Chem Lett 2026
Predictive Analysis of Drug-Resistant Tuberculosis: Integrating Molecular Markers, Clinical Governance, and Community-Engaged Education in Rural South Africa. doi:10.3390/diseases14040132 Diseases 2026
Association of katG, inhA, and AhpC Mutations with Isoniazid Resistance of Mycobacterium tuberculosis in Pulmonary Tuberculosis Patients from Nanjing, China. doi:10.1177/10766294261446052 names it Microb Drug Resist 2026
First-line drug-resistant tuberculosis among children under 15 years in Ethiopia: insights from phenotypic and whole-genome sequencing approaches. doi:10.1186/s12879-026-13206-9 BMC Infect Dis 2026
A cartridge-based assay for improved detection of multidrug-resistant Mycobacterium tuberculosis directly from sputum. doi:10.1128/jcm.01100-25 J Clin Microbiol 2026
Mutations in oxyR and oxyR-ahpC Interogenic Region in Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Chongqing, China. doi:10.2147/IDR.S562591 Infect Drug Resist 2026
Prevalence and resistance spectrum of ahpC mutations in isoniazid-resistant Mycobacterium tuberculosis isolates. doi:10.1128/spectrum.02496-25 Microbiol Spectr 2026
Predicting isoniazid resistance in Mycobacterium tuberculosis complex in New York State using whole-genome sequencing. doi:10.1128/jcm.01609-25 J Clin Microbiol 2026
Drug-Resistant Pulmonary Tuberculosis among Adolescents and Young Adults in China. doi:10.3967/bes2025.159 Biomed Environ Sci 2026
The role of reactive oxygen species in macrophage-mediated immune response against Mycobacterium tuberculosis. doi:10.1016/j.freeradbiomed.2026.03.027 Free Radic Biol Med 2026
Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan Africa. doi:10.1183/23120541.00427-2025 ERJ Open Res 2026
Simultaneous detection of Mycobacterium tuberculosis complex and rifampin/isoniazid resistance with sanity 2.0 MTBC-MDR: a moderate-complexity automated NAAT. doi:10.1007/s11274-026-04858-5 World J Microbiol Biotechnol 2026
Comparative transcriptomic profiling of pyrazinamide resistance in Mycobacterium tuberculosis. doi:10.1093/jambio/lxag064 J Appl Microbiol 2026
Genetic diversity and drug resistance profiles of Mycobacterium tuberculosis among Ethiopian children as determined by whole-genome sequencing. doi:10.1128/spectrum.02736-25 Microbiol Spectr 2026
Investigation of Gene Regions Responsible for Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis Complex Resistant to at Least Two First-Line Anti-Tuberculosis Drugs. doi:10.3390/pathogens15020222 Pathogens 2026
In Silico Design of gRNA for CRISPR System for Detection of Multidrug Resistant Tuberculosis Using Indian Mycobacterium tuberculosis Genomes: A Computational Study. doi:10.7759/cureus.101851 Cureus 2026
First insight of characteristics and prediction of Mycobacterium tuberculosis drug resistance by whole genome sequencing in Fujian Province, China. doi:10.1038/s41598-026-40398-6 Sci Rep 2026
Comment on "Epidemiology and molecular characterization of multidrug-resistant Mycobacterium tuberculosis among patients with pulmonary symptoms in Kaduna State, Nigeria". doi:10.1016/j.actatropica.2026.108027 Acta Trop 2026
Isoniazid-derived vanillin and Salicylaldehyde Hydrazones: Promising Antimycobacterials with KatG-dependent activation. doi:10.1016/j.bioorg.2026.109644 names it Bioorg Chem 2026
iFIND INH/FQ: a LC-aNAAT assay for rapid simultaneous detection of isoniazid and fluoroquinolone resistance in Mycobacterium tuberculosis. doi:10.1128/spectrum.03743-25 Microbiol Spectr 2026
Characterization of pulmonary tuberculosis in high-altitude region using nanopore targeted sequencing. doi:10.1186/s12866-026-04761-x BMC Microbiol 2026
Mutations related to rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains in Ankara, Turkey. doi:10.1556/030.2026.02818 Acta Microbiol Immunol Hung 2026
Isolation, identification and genomic analysis of Mycobacterium caprae strain SY-1 from Chinese sika deer (Cervus nippon). doi:10.1186/s12864-026-12540-1 BMC Genomics 2026
The genetic diversity of drug resistance in Mycobacterium tuberculosis strains from the Tibetan Plateau. doi:10.1016/j.jiph.2025.103120 J Infect Public Health 2026
Molecular epidemiology of drug resistance and transmission of Mycobacterium tuberculosis in Meigu County, Sichuan Province, China. doi:10.1128/spectrum.02685-25 Microbiol Spectr 2026
Uncovering the structural impact of KatG Ser315 mutations in Mycobacterium tuberculosis via cryo-EM. doi:10.1002/pro.70409 names it Protein Sci 2026
Pharmacogenomics and mutation informatics: correlation of NAT2 mutations and isoniazid acetylation rate. doi:10.1016/j.drudis.2025.104561 Drug Discov Today 2026
Protein-Mediated Virulence in Mycobacterium tuberculosis. doi:10.1007/978-3-031-96883-9_5 Adv Exp Med Biol 2026
Machine learning approaches to predict drug resistance in tuberculosis. doi:10.1016/j.compbiolchem.2025.108705 Comput Biol Chem 2026
Isoniazid. 2026
Artificial intelligence for screening drug resistance in tuberculosis. doi:10.25259/IJMR_1546_2025 Indian J Med Res 2025
Deciphering the population dynamics and drug-resistance characteristics of extrapulmonary tuberculosis: genomic and clinical insights from a Chinese hospital. doi:10.3389/fcimb.2025.1692783 Front Cell Infect Microbiol 2025
Drug resistance profile of Mycobacterium tuberculosis in China: update until 2024. doi:10.3389/fmicb.2025.1697490 Front Microbiol 2025
A novel one-tube nested fluorescence melting curve analysis for rapid detection of drug-resistant Mycobacterium tuberculosis. doi:10.1186/s12866-025-04601-4 BMC Microbiol 2025
Characterization of Drug Resistance Patterns, Mutation Profiles and Prevalence of Mycobacterium tuberculosis in Shaoxing. doi:10.2147/IDR.S570295 Infect Drug Resist 2025
Genomic landscape of Mycobacterium tuberculosis: Identifying mutation hotspots and stable regions for implications for drug development. doi:10.1016/j.nmni.2025.101674 New Microbes New Infect 2025
Evaluation of multiplex allele-specific PCR for rapid detection of isoniazid and fluoroquinolone resistance in Mycobacterium tuberculosis: A cross-sectional study in high-TB-burden settings in India. doi:10.1016/j.ijtb.2025.06.007 Indian J Tuberc 2025
Molecular characterization of rifampicin-resistant Mycobacterium tuberculosis isolates by line probe assay method. A cross-sectional study from a nodal DR-TB centre of Bihar. doi:10.1016/j.ijtb.2025.06.005 Indian J Tuberc 2025
Molecular Epidemiology of Mycobacterium tuberculosis in Mexico. doi:10.3390/microorganisms13112453 Microorganisms 2025
Inactivation of cAMP receptor protein (MSMEG_6189) increases isoniazid susceptibility in Mycobacterium smegmatis via altered oxidative phosphorylation, elevated ROS production, and loss of ahpC expression. doi:10.1128/jb.00429-25 J Bacteriol 2025
Genomic characterization of XDR Mycobacterium tuberculosis isolates in Argentina (2006-2015). doi:10.1186/s12879-025-11913-3 BMC Infect Dis 2025
Investigating cytokine responses in rats: Genetic immunization against tuberculosis using five Mycobacterium tuberculosis-specific genes. doi:10.36721/PJPS.2025.38.6.REG.14594.1 Pak J Pharm Sci 2025
Molecular epidemiology of drug-resistant tuberculosis in Jiangxi Province, China, 2022-2023. doi:10.35772/ghm.2025.01065 Glob Health Med 2025
Challenges and Potential of Antibody-Drug Conjugates as Prospective Tuberculosis Therapeutics. doi:10.3390/microorganisms13102234 Microorganisms 2025
Molecular insights of drug-resistant tuberculosis: genetic mutations and their profile. doi:10.3389/fmicb.2025.1669327 Front Microbiol 2025
Genetic diversity, drug resistance, and transmission patterns of tuberculosis based on whole-genome sequencing in Almaty, Kazakhstan. doi:10.3389/fmicb.2025.1649137 Front Microbiol 2025
Discrepancies in isoniazid susceptibility profiles: Bactec MGIT 960-resistant but GenoType MTBDRplus-susceptible Mycobacterium tuberculosis strains in Hunan, China. doi:10.1128/spectrum.01101-25 Microbiol Spectr 2025
Genetic diversity and antibiotic resistance of Mycobacterium bovis in bovines in the Delta area of Egypt. doi:10.3389/fcimb.2025.1600225 Front Cell Infect Microbiol 2025
Cross-species virulence strategies of Mycobacterium avium subsp. paratuberculosis: Gene expression and infection progression in sheep and guanacos. doi:10.1016/j.actatropica.2025.107853 Acta Trop 2025
Innowave MTB/RIF/INH facilitates timely and accurate diagnosis of multiple-drug resistant tuberculosis as a near POCT technique: a multicenter prospective on-site performance evaluation study. doi:10.1186/s12941-025-00822-7 Ann Clin Microbiol Antimicrob 2025
Characterization of Drug Resistance Mutations in Mycobacterium tuberculosis Isolates from Moroccan Patients Using Deeplex Targeted Next-Generation Sequencing. doi:10.3390/microorganisms13092163 Microorganisms 2025
Isoniazid-Derived Hydrazones Featuring Piperazine/Piperidine Rings: Design, Synthesis, and Investigation of Antitubercular Activity. doi:10.3390/biom15091305 Biomolecules 2025
Comprehensive analysis of mutations associated with rifampicin- and isoniazid-resistant tuberculosis in a high-burden setting. doi:10.1590/0037-8682-0184-2025 Rev Soc Bras Med Trop 2025
Genotypic study of isolated resistance to isoniazid in the Mycobacterium tuberculosis complex in a Moroccan hospital. doi:10.1099/acmi.0.000928.v5 Access Microbiol 2025
Rational Design and Antimycobacterial Evaluation of Aryl Sulfonamide-Linked Isoniazid Hydrazones Against Mycobacterium Tuberculosis. doi:10.1002/cmdc.202500398 ChemMedChem 2025
Rationally Designed InhA Inhibitors: A Comparative Anti-Tubercular Activity Study of Sulfonate Esters of Isoniazid Hydrazones and Their Structurally Flexible Benzyl Analogues. doi:10.1111/cbdd.70171 Chem Biol Drug Des 2025
Isoniazid-rhodanine molecular hybrids: design, synthesis, antimycobacterial activity and computational validation. doi:10.1039/d5ra03641k RSC Adv 2025
Application of engineered CRISPR/Cas12a variants with altered protospacer adjacent motif specificities for the detection of isoniazid resistance mutations in Mycobacterium tuberculosis. doi:10.1128/spectrum.00165-25 Microbiol Spectr 2025
Metabolic rewiring of isoniazid sensitivity in Mycobacterium tuberculosis. doi:10.1073/pnas.2421336122 Proc Natl Acad Sci U S A 2025
Whole-genome sequencing and machine learning reveal key drivers of delayed sputum conversion in rifampicin-resistant tuberculosis. doi:10.3389/fcimb.2025.1641385 Front Cell Infect Microbiol 2025
Surveillance and analysis of drug resistance and drug resistance levels in multidrug resistant tuberculosis on the tropical islands of China. doi:10.1186/s12879-025-11312-8 BMC Infect Dis 2025
Cold Shock Proteins Balance Biofilm-Associated Antibiotic Resistance and Oxidative Vulnerability in Mycobacteria. doi:10.3390/microorganisms13071597 Microorganisms 2025
Promising Antimycobacterial Agents: Salicylidenehydrazines. doi:10.1002/ardp.70065 Arch Pharm (Weinheim) 2025
Sentinel-Site-Based Surveillance of Mycobacterium tuberculosis Drug Resistance and Epidemiology in Sichuan, China. doi:10.3390/antibiotics14070625 Antibiotics (Basel) 2025
Whole-genome sequencing for analyzing the transmission characteristics of drug-resistant Mycobacterium tuberculosis in Ganzhou, China. doi:10.1186/s12879-025-11356-w BMC Infect Dis 2025
Whole genome sequencing reveals novel resistance-conferring mutations and large genome deletions in drug-resistant Mycobacterium tuberculosis isolates from Indonesia. doi:10.1016/j.jgar.2025.07.017 J Glob Antimicrob Resist 2025
A comparative study using Xpert MTB/RIF and culture methods evaluates MassARRAY technology for rapid detection of Mycobacterium tuberculosis and drug resistance. doi:10.3389/fcimb.2025.1539240 Front Cell Infect Microbiol 2025
Epidemiology and molecular characterization of multidrug-resistant Mycobacterium tuberculosis among patients with pulmonary symptoms in Kaduna State, Nigeria. doi:10.1016/j.actatropica.2025.107748 Acta Trop 2025
Lineage identification and mutation profile of Mycobacterium tuberculosis: A study from National Reference Laboratory, India. doi:10.1016/j.ijmmb.2025.100925 Indian J Med Microbiol 2025
Innovo GenMax MTB-RIF/INH: a moderate-complexity automated NAAT for rapid simultaneous detection of Mycobacterium tuberculosis complex and rifampin/isoniazid resistance. doi:10.3389/fcimb.2025.1600170 Front Cell Infect Microbiol 2025
Machine learning-based prediction of antimicrobial resistance and identification of AMR-related SNPs in Mycobacterium tuberculosis. doi:10.1186/s12863-025-01338-x BMC Genom Data 2025
CRISPRi knockdown of mycobacterial tkt gene potentiates the anti-mycobacterial activity of phyto-compounds from selected medicinal plants. doi:10.1186/s12906-025-04987-8 BMC Complement Med Ther 2025
Delayed culture conversion predicts poor outcomes for isoniazid mono-resistant TB in Uganda: a retrospective cross-sectional study from 2017- 2022. doi:10.1186/s12879-025-11218-5 BMC Infect Dis 2025
Nanopore-based targeted sequencing (NTS) for drug-resistant tuberculosis: an integrated tool for personalized treatment strategies and guidance for new drug development. doi:10.1186/s12879-025-11227-4 BMC Infect Dis 2025
In Vitro and In Silico Evaluation of Isatin-Derived Spirooxindoles as Antituberculosis Drug Candidates. doi:10.1111/cbdd.70152 Chem Biol Drug Des 2025
CRISPR-Cas9-based electrochemical biosensor for the detection of katG gene mutations in isoniazid-resistant tuberculosis. doi:10.5599/admet.2766 names it ADMET DMPK 2025
Fitness Effect of the Isoniazid Resistance Mutation S315T of the Catalase-Peroxidase Enzyme KatG of Mycobacterium tuberculosis. doi:10.1093/gbe/evaf120 names it Genome Biol Evol 2025
Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in China. doi:10.3389/fcimb.2025.1586938 Front Cell Infect Microbiol 2025
Human Gut Bacteriophageome: Insights Into Drug Resistance Mechanisms in Tuberculosis. doi:10.1155/ipid/8811027 Interdiscip Perspect Infect Dis 2025
Mutations associated with resistance to rifampicin and isoniazid identified in strains of the Mycobacterium tuberculosis complex by GenoType MTBDRplus in Panama, 2015-2021. doi:10.1128/spectrum.02400-24 Microbiol Spectr 2025
An exploratory study on the application of nanopore sequencing for detecting Mycobacterium tuberculosis drug resistance in respiratory specimens. doi:10.1186/s12890-025-03747-1 BMC Pulm Med 2025
Genotypic analysis of drug-resistant tuberculosis in Ghana: Insights into pre-XDR and XDR-TB. doi:10.1371/journal.pone.0323527 PLoS One 2025
Utility of Rapid Molecular Assays for Detecting Multidrug-Resistant Mycobacterium tuberculosis in Extrapulmonary Samples. doi:10.3390/diagnostics15091113 Diagnostics (Basel) 2025
Genomic characterization of multidrug-resistant tuberculosis in Shanghai, China: antibiotic resistance, virulence and transmission. doi:10.1093/jacamr/dlaf064 JAC Antimicrob Resist 2025
Whole-genome sequencing analysis to identify antimicrobial resistance regions and virulence factors in Mycobacterium tuberculosis isolates from the Amhara Region, Ethiopia. doi:10.1038/s41598-025-01241-6 Sci Rep 2025
Tuberculosis in Malaysia: Disease timeline, epidemiology, control initiatives and outlook. Malays J Pathol 2025
The ahpC c-54t compensatory mutation is not always a valid surrogate for isoniazid resistance in Mycobacterium tuberculosis. doi:10.1128/aac.00265-25 Antimicrob Agents Chemother 2025
Ferromagnetic Resonance Multiplexing of Orthogonal Magnetic Nanoparticle Agglutination for Simultaneous Analysis of Nucleic Acid Mutations and Nonspecific Interactions. doi:10.1002/smll.202502062 Small 2025
Prevalence and Genetic Analysis of Isoniazid-Resistant Tuberculosis in Eastern Uttar Pradesh, India. doi:10.7759/cureus.80243 Cureus 2025
Is Mycobacterial InhA a Suitable Target for Rational Drug Design? doi:10.1002/cmdc.202500079 ChemMedChem 2025
A duplex one-step recombinase aided PCR assay for the rapid and sensitive detection of the isoniazid resistance genes katG and inhA in Mycobacterium tuberculosis. doi:10.3389/fmicb.2025.1548965 names it Front Microbiol 2025
Molecular epidemiology and antibiotic resistance profiles of Mycobacterium and Nocardia species in patients with cancer: Detection of multidrug-resistant and extensively drug-resistant strains. doi:10.1016/j.micpath.2025.107514 Microb Pathog 2025
Genetic and Cheminformatic Characterization of Mycobacterium tuberculosis Inhibitors Discovered in the Molecular Libraries Small Molecule Repository. doi:10.1021/acsinfecdis.4c00936 ACS Infect Dis 2025
Multi-drug resistance and compensatory mutations in Mycobacterium tuberculosis in Vietnam. doi:10.1111/tmi.14104 Trop Med Int Health 2025
Integrating genomic, transcriptomic, and phenotypic information to explore drug resistance in Mycobacterium tuberculosis sub-lineage 4.2.2.2. doi:10.1093/jambio/lxaf063 J Appl Microbiol 2025
Isoniazid-Dihydropyrimidinone Molecular Hybrids: Design, Synthesis, Antitubercular Activity, and Cytotoxicity Investigations with Computational Validation. doi:10.1002/cmdc.202400949 ChemMedChem 2025
Prevalence of katG and inhA mutations associated with isoniazid resistance in Mycobacterium tuberculosis clinical isolates in Cameroon. doi:10.1186/s12866-025-03816-9 names it BMC Microbiol 2025
Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment. doi:10.3201/eid3103.241473 Emerg Infect Dis 2025
Whole genomic analysis uncovers high genetic diversity of rifampicin-resistant Mycobacterium tuberculosis strains in Botswana. doi:10.3389/fmicb.2025.1535160 Front Microbiol 2025
Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China. doi:10.3389/fpubh.2025.1442987 Front Public Health 2025
Xpert MTB/RIF Ultra-resistant and MTBDRplus-susceptible rifampicin results in people with tuberculosis: utility of FluoroType MTBDR and deep sequencing. doi:10.1128/aac.01671-24 Antimicrob Agents Chemother 2025
Whole genome sequence of a Mycobacterium tuberculosis M64 isolate harboring extensive deletions, including the katG-containing region. doi:10.1128/mra.00745-24 names it Microbiol Resour Announc 2025
Reactive Oxygen Detoxification Contributes to Mycobacterium abscessus Antibiotic Survival. doi:10.1101/2024.10.13.618103 bioRxiv 2025
Computational analyses of drug resistance mutations in katG and emb complexes in Mycobacterium tuberculosis. doi:10.1002/prot.26684 names it Proteins 2025
Exploring natural products library to identify potential inhibitors targeting isoniazid-resistant tuberculosis. doi:10.1080/07391102.2023.2283159 J Biomol Struct Dyn 2025
Catalase-peroxidase (KatG): a potential frontier in tuberculosis drug development. doi:10.1080/10409238.2025.2470630 names it Crit Rev Biochem Mol Biol 2024
Catalase activity deficiency sensitizes multidrug-resistant Mycobacterium tuberculosis to the ATP synthase inhibitor bedaquiline. doi:10.1038/s41467-024-53933-8 Nat Commun 2024
Whole genome CRISPRi screening identifies druggable vulnerabilities in an isoniazid resistant strain of Mycobacterium tuberculosis. doi:10.1038/s41467-024-54072-w Nat Commun 2024
Mycobacterium tuberculosis evolution from monoresistance to pre-extensive drug resistance during a prolonged household outbreak. doi:10.1016/j.jctube.2024.100482 J Clin Tuberc Other Mycobact Dis 2024
Genetic diversities and drug resistance in Mycobacterium bovis isolates from zoonotic tuberculosis using whole genome sequencing. doi:10.1186/s12864-024-10909-8 BMC Genomics 2024
Exploring gene mutations and multidrug resistance in Mycobacterium tuberculosis: a study from the Lung Hospital in Vietnam. doi:10.1007/s11033-024-10015-8 Mol Biol Rep 2024
Drug-resistance characteristics, genetic diversity, and transmission dynamics of multidrug-resistant or rifampicin-resistant Mycobacterium tuberculosis from 2019 to 2021 in Sichuan, China. doi:10.1186/s13756-024-01482-6 Antimicrob Resist Infect Control 2024
Contribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosis. doi:10.1128/aac.00357-24 Antimicrob Agents Chemother 2024
Characterization of isoniazid resistance and genetic mutations in isoniazid-resistant and rifampicin-susceptible Mycobacterium tuberculosis in China. doi:10.1016/j.imj.2024.100129 Infect Med (Beijing) 2024
Indole N-Linked Hydroperoxyl Adduct of Protein-Derived Cofactor Modulating Catalase-Peroxidase Functions. doi:10.1002/anie.202407018 Angew Chem Int Ed Engl 2024
The performance of Xpert MTB/RIF and MTBDRplus within a Programmatic setting at TB Laboratory in Rio de Janeiro, Brazil. doi:10.1590/0037-8682-0167-2024 Rev Soc Bras Med Trop 2024
Detection of katG, inhA and ahpC gene mutation in clinical isolates of isoniazid-resistant Mycobacterium tuberculosis in Makassar City, South Sulawesi, Indonesia. doi:10.1016/j.ijtb.2023.03.019 names it Indian J Tuberc 2024
Diagnostic Accuracy of FluoroCycler XT MTBDR Assay for Detection of Rifampicin and Isoniazid-resistant Mycobacteria tuberculosis in Clinical Isolates from Kenya. doi:10.4103/ijmy.ijmy_202_23 Int J Mycobacteriol 2024
Multi-drug resistant gene mutation analysis in Mycobacterium tuberculosis by molecular techniques. doi:10.18502/ijm.v16i4.16304 Iran J Microbiol 2024
Detection of multidrug-resistance in Mycobacterium tuberculosis by phenotype- and molecular-based assays. doi:10.1186/s12941-024-00741-z Ann Clin Microbiol Antimicrob 2024
Evaluation of GeneNAT Real-Time Polymerase Chain Reaction Analyzer and Pre-loaded Chip-Based Mycobacterium tuberculosis and Multidrug-Resistant Tuberculosis Detection in the Diagnosis of Pulmonary Tuberculosis. doi:10.7759/cureus.65067 Cureus 2024
Epidemiology and molecular characterization of Mycobacterium tuberculosis including a drug-resistant strain associated with mortality of Asian elephants in Nepal 2019-2022. doi:10.1016/j.tube.2024.102550 Tuberculosis (Edinb) 2024
Occurrence of multidrug-resistant Mycobacterium tuberculosis in upper Southern Thailand. doi:10.14202/vetworld.2024.1405-1412 Vet World 2024
Isoniazid monoresistant tuberculosis treatment outcomes in Puducherry, South India - A mixed methods study. doi:10.1016/j.ijtb.2024.05.013 Indian J Tuberc 2024
Mutational analysis in drug resistant Mycobacterium tuberculosis in Western Uttar Pradesh. doi:10.1016/j.ijtb.2024.01.009 Indian J Tuberc 2024
Compounds Derived from 5-Fluoropyridine and Benzo[b]thiophene: Killing Mycobacterium tuberculosis and Reducing its Virulence. doi:10.1002/cbdv.202401191 Chem Biodivers 2024
Drug-Resistant Profiles and Genetic Diversity of Mycobacterium Tuberculosis Revealed by Whole-Genome Sequencing in Hinggan League of Inner Mongolia, China. doi:10.2147/IDR.S466197 Infect Drug Resist 2024
Drug susceptibility testing and line probe assay of first-line anti-tuberculosis drugs among presumptive tuberculosis patients attending a secondary care hospital in Bhubaneswar. doi:10.4103/jfmpc.jfmpc_736_23 J Family Med Prim Care 2024
Enhanced detection of rifampicin and isoniazid resistance in mycobacterium tuberculosis using AuNP-qPCR: a rapid and accurate method. doi:10.62347/QTLS9708 Am J Transl Res 2024
L-DNA-Based Melt Analysis Enables Within-Sample Validation of PCR Products. doi:10.1021/acs.analchem.4c01611 Anal Chem 2024
Polymerase Chain Reaction (PCR) Profiling of Extensively Drug-Resistant (XDR) Pathogenic Bacteria in Pulmonary Tuberculosis Patients. doi:10.7759/cureus.61424 Cureus 2024
The Hidden Epidemic of Isoniazid-Resistant Tuberculosis in South Africa. doi:10.1513/AnnalsATS.202312-1076OC Ann Am Thorac Soc 2024
Cu-promoted synthesis of triclosan-Mannich and Glaser adducts: anti-mycobacterial evaluation with in silico validations. doi:10.4155/fmc-2023-0298 Future Med Chem 2024
Design and Synthesis of the Linezolid Bioisosteres to Resolve the Serotonergic Toxicity Associated with Linezolid. doi:10.1021/acsmedchemlett.4c00114 ACS Med Chem Lett 2024
Accurate and affordable detection of rifampicin and isoniazid resistance in Tuberculosis sputum specimens by multiplex PCR-multiple probes melting analysis. doi:10.1007/s15010-024-02295-w Infection 2024
Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Multidrug-Resistant Mycobacterium tuberculosis in Jiangxi, China. doi:10.2147/IDR.S460267 Infect Drug Resist 2024
Advanced integrative molecular platform for high-throughput screening of drug-resistant tuberculosis. doi:10.1016/j.diagmicrobio.2024.116373 Diagn Microbiol Infect Dis 2024
Large-scale statistical analysis of Mycobacterium tuberculosis genome sequences identifies compensatory mutations associated with multi-drug resistance. doi:10.1038/s41598-024-62946-8 Sci Rep 2024
Evaluation of a real-time PCR assay performance to detect Mycobacterium tuberculosis, rifampicin, and isoniazid resistance in sputum specimens: a multicenter study in two major cities of Indonesia. doi:10.3389/fmicb.2024.1372647 Front Microbiol 2024
Acquired bedaquiline and fluoroquinolones resistance during treatment follow-up in Oromia Region, North Shewa, Ethiopia. doi:10.1016/j.idcr.2024.e01988 IDCases 2024
Drug Susceptibility and Mutation Profiles in Mycobacterium tuberculosis Isolates from a Tertiary Care Hospital in Kerala, India. doi:10.4269/ajtmh.24-0042 Am J Trop Med Hyg 2024
Rapid Detection of M. tuberculosis and Its Resistance to Rifampicin and Isoniazid with the mfloDx™ MDR-TB test. doi:10.4103/ijmy.ijmy_21_24 Int J Mycobacteriol 2024
Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study. doi:10.1371/journal.pone.0303460 PLoS One 2024
Crystal structure and Hirshfeld surface analysis of 5-hy-droxy-penta-nehydrazide. doi:10.1107/S2056989024002871 Acta Crystallogr E Crystallogr Commun 2024
Multidrug-resistant tuberculosis. doi:10.1016/j.cca.2024.119701 Clin Chim Acta 2024
Identification of positively selected genes in Mycobacterium tuberculosis from southern Xinjiang Uygur autonomous region of China. doi:10.3389/fmicb.2024.1290227 Front Microbiol 2024
Dual-centre evaluation of the FluoroType MTBDR version 2 assay for detection of Mycobacterium tuberculosis complex and resistance-conferring mutations in pulmonary and extrapulmonary samples from Denmark, Germany and Sierra Leone. doi:10.1016/j.cmi.2024.04.006 Clin Microbiol Infect 2024
Activity against Mycobacterium tuberculosis of a new class of spirooxindolopyrrolidine embedded chromanone hybrid heterocycles. doi:10.1039/d4ra01501k RSC Adv 2024
Comparison of targeted next-generation sequencing and the Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in clinical isolates and sputum specimens. doi:10.1128/spectrum.04098-23 Microbiol Spectr 2024
Patterns and profiles of drug resistance-conferring mutations in Mycobacterium tuberculosis genotypes isolated from tuberculosis-suspected attendees of spiritual holy water sites in Northwest Ethiopia. doi:10.3389/fpubh.2024.1356826 Front Public Health 2024
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial. doi:10.1164/rccm.202311-2004OC names it Am J Respir Crit Care Med 2024
Whole Genome Sequence-Based Analyses of Drug Resistance Characteristics, Genetic Diversity, and Transmission Dynamics of Drug-Resistant Mycobacterium tuberculosis in Urumqi City. doi:10.2147/IDR.S454913 Infect Drug Resist 2024
Multidrug-resistant Mycobacterium tuberculosis transmission in Shandong, China. doi:10.1097/MD.0000000000037617 Medicine (Baltimore) 2024
Rapid detection of multidrug resistance in tuberculosis using nanopore-based targeted next-generation sequencing: a multicenter, double-blind study. doi:10.3389/fmicb.2024.1349715 Front Microbiol 2024
Molecular Detection of Multidrug Resistance and Characterizations of Mutations in Mycobacterium Tuberculosis Using Polycarbonate Track-Etched Membrane Based DNA Bio-Chip. doi:10.1007/s12088-023-01116-2 Indian J Microbiol 2024
Genetic mechanisms of co-emergence of INH-resistant Mycobacterium tuberculosis strains during the standard course of antituberculosis therapy. doi:10.1128/spectrum.02133-23 Microbiol Spectr 2024
Unlocking InhA: Novel approaches to inhibit Mycobacterium tuberculosis. doi:10.1016/j.bioorg.2024.107250 Bioorg Chem 2024
Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis. doi:10.1016/j.ijpharm.2024.123960 Int J Pharm 2024
Mutational Dynamics Related to Antibiotic Resistance in M. tuberculosis Isolates from Serial Samples of Patients with Tuberculosis and Type 2 Diabetes Mellitus. doi:10.3390/microorganisms12020324 Microorganisms 2024
Phenotypic and Genotypic Drug Resistance of Mycobacterium tuberculosis Strains Isolated from HIV-Infected Patients from a Third-Level Public Hospital in Mexico. doi:10.3390/pathogens13020098 Pathogens 2024
Implementation of Whole Genome Sequencing of Tuberculosis Isolates in a Referral Center in Rome: Six Years' Experience in Characterizing Drug-Resistant TB and Disease Transmission. doi:10.3390/antibiotics13020134 Antibiotics (Basel) 2024
Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand. doi:10.1128/spectrum.03462-23 Microbiol Spectr 2024
Characterization of a catalase-peroxidase variant (L333V-KatG) identified in an INH-resistant Mycobacterium tuberculosis clinical isolate. doi:10.1016/j.bbrep.2024.101649 names it Biochem Biophys Rep 2024
19 Schiff bases as antimycobacterial agents: synthesis, molecular docking and a plausible mechanism of action. doi:10.4155/fmc-2023-0305 Future Med Chem 2024
Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug-resistant Mycobacterium tuberculosis. doi:10.1128/mbio.02968-23 mBio 2024
Insights into the in-vitro Susceptibility and Drug-Drug Interaction Profiles Against Drug-Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates in Amhara, Ethiopia. doi:10.2147/IDR.S440947 Infect Drug Resist 2024
Rapid detection of drug-resistant Mycobacterium tuberculosis by Modified MODS assay suitable for resource-poor settings. doi:10.1371/journal.pntd.0011852 PLoS Negl Trop Dis 2024
Exploring the plasticity of the InhA substrate-binding site using new diaryl ether inhibitors. doi:10.1016/j.bioorg.2023.107032 Bioorg Chem 2024
Genomic analysis of lineage-specific transmission of multidrug resistance tuberculosis in China. doi:10.1080/22221751.2023.2294858 Emerg Microbes Infect 2024
High frequency of isoniazid and fluroquinolone resistance among patients with rifampicin sensitive tuberculosis. doi:10.1016/j.diagmicrobio.2023.116159 Diagn Microbiol Infect Dis 2024
Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis. doi:10.1016/S2666-5247(23)00252-5 Lancet Microbe 2024
Whole genome sequencing of drug-resistant Mycobacterium tuberculosis isolates in Victoria, Australia. doi:10.1016/j.ijid.2023.11.010 Int J Infect Dis 2024
A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country. doi:10.1007/s10096-023-04693-8 Eur J Clin Microbiol Infect Dis 2024
Identification of potential inhibitors of Mtb InhA: a pharmacoinformatics approach. doi:10.1080/07391102.2023.2242499 J Biomol Struct Dyn 2024
Prevalence of Beijing Central Asian/Russian Cluster 94-32 among Multidrug-Resistant M. tuberculosis in Kazakhstan. doi:10.3390/antibiotics13010009 Antibiotics (Basel) 2023
Repurposing Azoles to Resolve Serotogenic Toxicity Associated with Linezolid to Combat Multidrug-Resistant Tuberculosis. doi:10.1021/acsmedchemlett.3c00406 ACS Med Chem Lett 2023
A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools. doi:10.1371/journal.pone.0294670 PLoS One 2023
Distribution of common and rare drug resistance patterns in Mycobacterium tuberculosis clinical isolates revealed by GenoType MTBDRplus and MTBDRsl assay. doi:10.21037/jtd-23-138 J Thorac Dis 2023
Molecular characterization of genetic mutations with fitness loss in pulmonary tuberculosis patients associated with HIV co-infection in Northwest Amhara, Ethiopia. doi:10.1177/20503121231208266 SAGE Open Med 2023
Novel Quinoline-Based Thiosemicarbazide Derivatives: Synthesis, DFT Calculations, and Investigation of Antitubercular, Antibacterial, and Antifungal Activities. doi:10.1021/acsomega.3c03018 ACS Omega 2023
Drug resistance and the genotypic characteristics of rpoB and katG in rifampicin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates in central Vietnam. doi:10.24171/j.phrp.2023.0124 names it Osong Public Health Res Perspect 2023
KatG catalase deficiency confers bedaquiline hyper-susceptibility to isoniazid resistant Mycobacterium tuberculosis. doi:10.1101/2023.10.17.562707 names it bioRxiv 2023
Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure. doi:10.1371/journal.pone.0293194 PLoS One 2023
Rv1255c, a dormancy-related transcriptional regulator of TetR family in Mycobacterium tuberculosis, enhances isoniazid tolerance in Mycobacterium smegmatis. doi:10.1038/s41429-023-00661-8 J Antibiot (Tokyo) 2023
Phenotypic and genotypic drug susceptibility patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Central and Southern Ethiopia. doi:10.1371/journal.pone.0285063 PLoS One 2023
Phenotypic Drug Resistance Pattern and Mutation Characteristics of Mycobacterium tuberculosis from Different Body Fluids Among Extra Pulmonary Patients Presented in Selected Hospitals in Addis Ababa, Ethiopia. doi:10.2147/IDR.S415906 Infect Drug Resist 2023
Molecular Analysis of Anti-Tuberculosis Drug Resistance of Mycobacterium tuberculosis Isolated in the Republic of Korea. doi:10.3390/antibiotics12081324 Antibiotics (Basel) 2023
Isoniazid and Rifampicin Resistance-Conferring Mutations in Mycobacterium tuberculosis Isolates from South Africa. doi:10.3390/pathogens12081015 Pathogens 2023
A Retrospective Analysis of Clinico-Demographic and Genetic Characteristics and Treatment Outcomes in Isoniazid Mono-Resistant Tuberculosis Patients: A Single-Center Study. doi:10.7759/cureus.42166 Cureus 2023
Whole genome sequencing of drug resistance Mycobacterium tuberculosis from extra-pulmonary sites. doi:10.26508/lsa.202302076 Life Sci Alliance 2023
Delphi Survey on the Current and Future Korean Guidelines for Isoniazid-Monoresistant Tuberculosis. doi:10.2147/IDR.S420830 Infect Drug Resist 2023
Surveillance of multidrug-resistant tuberculosis in sub-Saharan Africa through wastewater-based epidemiology. doi:10.1016/j.heliyon.2023.e18302 Heliyon 2023
Isoniazid resistance-conferring mutations are associated with highly variable phenotypic resistance. doi:10.1016/j.jctube.2023.100387 J Clin Tuberc Other Mycobact Dis 2023
Whole Genomic Analysis Revealed High Genetic Diversity and Drug-Resistant Characteristics of Mycobacterium tuberculosis in Guangxi, China. doi:10.2147/IDR.S410828 Infect Drug Resist 2023
Drug resistance prediction for Mycobacterium tuberculosis with reference graphs. doi:10.1099/mgen.0.001081 Microb Genom 2023
Deciphering the emerging role of phytocompounds: Implications in the management of drug-resistant tuberculosis and ATDs-induced hepatic damage. doi:10.1016/j.jiph.2023.07.016 J Infect Public Health 2023
A soft-computation hybrid method for search of the antibiotic-resistant gene in Mycobacterium tuberculosis for promising drug target identification and antimycobacterial lead discovery. doi:10.1093/bioadv/vbad090 Bioinform Adv 2023
In vitro modeling of isoniazid resistance mechanisms in Mycobacterium tuberculosis H37Rv. doi:10.3389/fmicb.2023.1171861 Front Microbiol 2023
The Detection of Mutations and Genotyping of Drug-Resistant Mycobacterium tuberculosis Strains Isolated from Patients in the Rural Eastern Cape Province. doi:10.3390/idr15040041 Infect Dis Rep 2023
Discovery of new diaryl ether inhibitors against Mycobacterium tuberculosis targeting the minor portal of InhA. doi:10.1016/j.ejmech.2023.115646 Eur J Med Chem 2023
[Analysis of Mycobacterium tuberculosis Complex Strains Isolated from the Samples of Patients Living in Northern Syria]. doi:10.5578/mb.20239936 Mikrobiyol Bul 2023
Characterization of Genetic Mutations in Multi-Drug-Resistant Isolates of Mycobacterium tuberculosis Bacilli Conferring Resistance to a Second-Line Anti-tuberculosis Drug. doi:10.7759/cureus.40442 Cureus 2023
Using Microfluidic Chip and Allele-Specific PCR to Rapidly Identify Drug Resistance-Associated Mutations of Mycobacterium tuberculosis. doi:10.2147/IDR.S410779 Infect Drug Resist 2023
Prevalence of Mycobacterium tuberculosis mutations associated with isoniazid and rifampicin resistance: A systematic review and meta-analysis. doi:10.1016/j.jctube.2023.100379 J Clin Tuberc Other Mycobact Dis 2023
Synthesis, antimycobacterial evaluation, and molecular docking study of 1,2,4-triazole derivatives. doi:10.1080/14756366.2023.2229070 J Enzyme Inhib Med Chem 2023
Nicotine promotes Mycobacterium tuberculosis H37Rv growth and overexpression of virulence genes. doi:10.1111/1348-0421.13085 Microbiol Immunol 2023
Insight into Population Structure and Drug Resistance of Pediatric Tuberculosis Strains from China and Russia Gained through Whole-Genome Sequencing. doi:10.3390/ijms241210302 Int J Mol Sci 2023
Coevolution of furA-Regulated Hyper-Inflammation and Mycobacterial Resistance to Oxidative Killing through Adaptation to Hydrogen Peroxide. doi:10.1128/spectrum.05367-22 Microbiol Spectr 2023
Pattern of InhA and KatG mutations in isoniazid mono resistant Mycobacterium tuberculosis isolates from Odisha. doi:10.1016/j.ijmmb.2023.100373 names it Indian J Med Microbiol 2023
Insight into pathogenomics and phylogeography of hypervirulent and highly-lethal Mycobacterium tuberculosis strain cluster. doi:10.1186/s12879-023-08413-7 BMC Infect Dis 2023
Whole-genome sequencing reveals genotypic resistance in phenotypically susceptible Mycobacterium tuberculosis clinical isolates. doi:10.4103/ijmy.ijmy_101_23 Int J Mycobacteriol 2023
Transmission and resistome of extremely drug-resistant tuberculosis in Beijing, China: A retrospective population-based epidemiological study. doi:10.1016/j.jiph.2023.05.020 J Infect Public Health 2023
Evaluating the Impact of the Tyr158 pK(a) on the Mechanism and Inhibition of InhA, the Enoyl-ACP Reductase from Mycobacterium tuberculosis. doi:10.1021/acs.biochem.2c00606 Biochemistry 2023
Genetic Characterization Conferred Co-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Isolates from Southern Xinjiang, China. doi:10.2147/IDR.S407525 Infect Drug Resist 2023
Heteroresistance to rifampicin & isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in Central India. doi:10.4103/ijmr.ijmr_607_22 Indian J Med Res 2023
Profile and Frequency of Mutations Conferring Drug-Resistant Tuberculosis in the Central, Southeastern and Eastern Ethiopia. doi:10.2147/IDR.S408567 Infect Drug Resist 2023
Quantification of Isoniazid-Heteroresistant Mycobacterium tuberculosis Using Droplet Digital PCR. doi:10.1128/jcm.01884-22 J Clin Microbiol 2023
Emergence and evolution of drug-resistant Mycobacterium tuberculosis in eastern China: A six-year prospective study. doi:10.1016/j.ygeno.2023.110640 Genomics 2023
Molecular Characterization of katG and inhA Mutations by Genotype MTBDRplus Line Probe Assay To Guide Isoniazid and Ethionamide Use for Drug-Resistant Tuberculosis. doi:10.7759/cureus.37136 names it Cureus 2023
Evolution and epidemic success of Mycobacterium tuberculosis in eastern China: evidence from a prospective study. doi:10.1186/s12864-023-09312-6 BMC Genomics 2023
Facing Antitubercular Resistance: Identification of Potential Direct Inhibitors Targeting InhA Enzyme and Generation of 3D-pharmacophore Model by in silico Approach. doi:10.2147/AABC.S394535 Adv Appl Bioinform Chem 2023
Effectiveness of Xpert MTB/RIF and the Line Probe Assay tests for the rapid detection of drug-resistant tuberculosis in the Central African Republic. doi:10.1371/journal.pgph.0001847 PLOS Glob Public Health 2023
Comprehensive Drug Resistance Characterization of Pulmonary Tuberculosis in Algeria: Insights on Mycobacterium tuberculosis Strains by Whole-Genome Sequencing. doi:10.1089/mdr.2022.0321 Microb Drug Resist 2023
Heteroresistance of Mycobacterium tuberculosis in the Sputum Detected by Droplet Digital PCR. doi:10.3390/biology12040525 Biology (Basel) 2023
Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia. doi:10.1371/journal.pone.0284737 PLoS One 2023
Exploration of the diversity of multi-drug resistant Mycobacterium tuberculosis complex in Lagos, Nigeria using WGS: Distribution of lineages, drug resistance patterns and genetic mutations. doi:10.1016/j.tube.2023.102343 Tuberculosis (Edinb) 2023
Drug Resistance in Tuberculous Lymphadenitis: Molecular Characterization. doi:10.1155/2023/3291538 Tuberc Res Treat 2023
Spatial Distribution of Drug-Resistant Mycobacterium tuberculosis Infections in Rural Eastern Cape Province of South Africa. doi:10.3390/pathogens12030475 Pathogens 2023
Discrepancy in the transmissibility of multidrug-resistant mycobacterium tuberculosis in urban and rural areas in China. doi:10.1080/22221751.2023.2192301 Emerg Microbes Infect 2023
The Evolution and Transmission Dynamics of Multidrug-Resistant Tuberculosis in an Isolated High-Plateau Population of Tibet, China. doi:10.1128/spectrum.03991-22 Microbiol Spectr 2023
A rapid, accurate, and low-cost method for detecting Mycobacterium tuberculosis and its drug-resistant genes in pulmonary tuberculosis: Applications of MassARRAY DNA mass spectrometry. doi:10.3389/fmicb.2023.1093745 Front Microbiol 2023
Endogenous relapse and exogenous reinfection in recurrent pulmonary tuberculosis: A retrospective study revealed by whole genome sequencing. doi:10.3389/fmicb.2023.1115295 Front Microbiol 2023
Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug resistant Mycobacterium tuberculosis. doi:10.1101/2023.02.06.527416 bioRxiv 2023
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort. doi:10.1128/jcm.01478-22 J Clin Microbiol 2023
Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis. doi:10.1038/s41598-023-27516-4 Sci Rep 2023
Antimycobacterial Compound of Cynoglossum lanceolatum Forsk.: Bioassay Guided Isolation, Molecular Docking, Synthesis of Analogs, and a Plausible Mechanism of Action. doi:10.1002/cbdv.202200965 Chem Biodivers 2023
Strain diversity and gene mutations associated with presumptive multidrug-resistant Mycobacterium tuberculosis complex isolates in Northwest Ethiopia. doi:10.1016/j.jgar.2022.11.012 J Glob Antimicrob Resist 2023
Genetic mutations underlying isoniazid-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan. doi:10.1016/j.tube.2022.102286 Tuberculosis (Edinb) 2023
Molecular Characterization of Mutations in Isoniazid- and Rifampicin-Resistant Mycobacterium tuberculosis Isolated in Thailand. doi:10.7883/yoken.JJID.2022.055 Jpn J Infect Dis 2023
The past, present and future of tuberculosis treatment. doi:10.3724/zdxbyxb-2022-0454 Zhejiang Da Xue Xue Bao Yi Xue Ban 2022
Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases. doi:10.3389/fmicb.2022.1069292 Front Microbiol 2022
Comparative genome analysis reveals high-level drug resistance markers in a clinical isolate of Mycobacterium fortuitum subsp. fortuitum MF GZ001. doi:10.3389/fcimb.2022.1056007 Front Cell Infect Microbiol 2022
Evaluation of Five User-Friendly Whole Genome Sequencing Software for Mycobacterium tuberculosis in Clinical Application. doi:10.3346/jkms.2022.37.e328 J Korean Med Sci 2022
Drug Resistance and Molecular Characteristics of Mycobacterium tuberculosis: A Single Center Experience. doi:10.3390/jpm12122088 J Pers Med 2022
Genotypic Distribution and the Epidemiology of Multidrug Resistant Tuberculosis in Upper Northern Thailand. doi:10.3390/antibiotics11121733 Antibiotics (Basel) 2022
The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development. doi:10.1186/s43556-022-00106-y Mol Biomed 2022
Genomic analysis of Mycobacterium tuberculosis variant bovis strains isolated from bovine in the state of Mato Grosso, Brazil. doi:10.3389/fvets.2022.1006090 Front Vet Sci 2022
Redox Cycling Dioxonaphthoimidazoliums Disrupt Iron Homeostasis in Mycobacterium bovis Bacillus Calmette-Guérin. doi:10.1128/spectrum.01970-22 Microbiol Spectr 2022
Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium Tuberculosis by Droplet Digital PCR. doi:10.2147/IDR.S381097 Infect Drug Resist 2022
Combined Bioinformatics and Combinatorial Chemistry Tools to Locate Drug-Able Anti-TB Phytochemicals: A Cost-Effective Platform for Natural Product-Based Drug Discovery. doi:10.1002/cbdv.202200267 Chem Biodivers 2022
Fingerprinting of Mycobacterium tuberculosis isolates by MIRU-VNTR genotyping and detection of isoniazid resistance by real-time PCR. doi:10.1099/jmm.0.001603 J Med Microbiol 2022
Prevalence and genetic basis of first-line drug resistance of Mycobacterium tuberculosis in Ca Mau, Vietnam. doi:10.1183/23120541.00122-2022 ERJ Open Res 2022
Isoniazid Linked to Sulfonate Esters via Hydrazone Functionality: Design, Synthesis, and Evaluation of Antitubercular Activity. doi:10.3390/ph15101301 Pharmaceuticals (Basel) 2022
Comparison on Major Gene Mutations Related to Rifampicin and Isoniazid Resistance between Beijing and Non-Beijing Strains of Mycobacterium tuberculosis: A Systematic Review and Bayesian Meta-Analysis. doi:10.3390/genes13101849 Genes (Basel) 2022
Factors influencing treatment outcomes in patients with isoniazid-resistant pulmonary TB. doi:10.5588/ijtld.21.0701 Int J Tuberc Lung Dis 2022
Detection of Mutations in pncA in Mycobacterium tuberculosis Clinical Isolates from Nepal in Association with Pyrazinamide Resistance. doi:10.3390/cimb44090283 Curr Issues Mol Biol 2022
Efficacy and Mode of Action of a Direct Inhibitor of Mycobacterium abscessus InhA. doi:10.1021/acsinfecdis.2c00314 ACS Infect Dis 2022
Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia. doi:10.1371/journal.pone.0274426 PLoS One 2022
Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia. doi:10.1371/journal.pone.0271508 PLoS One 2022
Isolation of multidrug-resistant (MDR) Mycobacterium bovis from a dog in Korea. doi:10.1292/jvms.21-0347 J Vet Med Sci 2022
Drug resistant Mycobacterium tuberculosis in Oman: resistance-conferring mutations and lineage diversity. doi:10.7717/peerj.13645 PeerJ 2022
The H(2)O(2) inherently released by the mycobacterial minor subpopulation enhances the survival of the major kin subpopulation against rifampicin. doi:10.1016/j.crmicr.2022.100148 Curr Res Microb Sci 2022
Epidemiology-based Analysis of Characteristics of Dual Infection of Tuberculosis /Acquired Immune Deficiency Syndrome (AIDS) and Drug Resistance Mechanism of Related Genes. doi:10.14715/cmb/2022.68.2.16 Cell Mol Biol (Noisy-le-grand) 2022
Detection of Isoniazid and Rifampin Resistance in Mycobacterium tuberculosis Clinical Isolates from Sputum Samples by High-Resolution Melting Analysis. doi:10.1007/s00284-022-02960-z Curr Microbiol 2022
Urea derivatives carrying a thiophenylthiazole moiety: Design, synthesis, and evaluation of antitubercular and InhA inhibitory activities. doi:10.1002/ddr.21958 Drug Dev Res 2022
MGIT sensitivity testing and genotyping of drug resistant Mycobacterium tuberculosis isolates from Mizoram, Northeast India. doi:10.1016/j.ijmmb.2022.06.003 Indian J Med Microbiol 2022
Designing quinoline-isoniazid hybrids as potent anti-tubercular agents inhibiting mycolic acid biosynthesis. doi:10.1016/j.ejmech.2022.114531 Eur J Med Chem 2022
Frequency of rpoB, katG, and inhA Gene Polymorphisms Associated with Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates among Ethiopian TB Patients: A Systematic Review. doi:10.1155/2022/1967675 names it Interdiscip Perspect Infect Dis 2022
Epidemiological and laboratory characteristics of multidrug-resistant tuberculosis patients in Bhutan, 2015-2019. doi:10.1016/j.ijregi.2022.04.012 IJID Reg 2022
Spoligotype-based population structure and isoniazid-resistance gene mutation of Mycobacterium tuberculosis isolates from Thailand. doi:10.1016/j.jgar.2022.06.013 J Glob Antimicrob Resist 2022
High-Throughput Variant Detection Using a Color-Mixing Strategy. doi:10.1016/j.jmoldx.2022.04.015 J Mol Diagn 2022
An effective nano drug delivery and combination therapy for the treatment of Tuberculosis. doi:10.1038/s41598-022-13682-4 Sci Rep 2022
[Exploratory study on detection of drug resistance of Mycobacterium tuberculosis in sputum specimens by next-generation sequencing]. doi:10.3760/cma.j.cn112147-20211104-00775 Zhonghua Jie He He Hu Xi Za Zhi 2022
Utility of line probe assay in detecting drug resistance and the associated mutations in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia. doi:10.1177/20503121221098241 SAGE Open Med 2022
In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis. doi:10.3389/fphar.2022.868545 Front Pharmacol 2022
Comprehensive genomic analysis of Mycobacterium tuberculosis reveals limited impact of high-fitness genotypes on MDR-TB transmission. doi:10.1016/j.jinf.2022.05.012 J Infect 2022
Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients. doi:10.1016/j.tube.2022.102209 Tuberculosis (Edinb) 2022
First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda. doi:10.1186/s13756-022-01101-2 Antimicrob Resist Infect Control 2022
Trends in rifampicin and isoniazid resistance in patients with presumptive TB. doi:10.5588/ijtld.21.0455 Int J Tuberc Lung Dis 2022
Intra-host genetic population diversity: Role in emergence and persistence of drug resistance among Mycobacterium tuberculosis complex minor variants. doi:10.1016/j.meegid.2022.105288 Infect Genet Evol 2022
Deciphering Isoniazid Drug Resistance Mechanisms on Dimeric Mycobacterium tuberculosis KatG via Post-molecular Dynamics Analyses Including Combined Dynamic Residue Network Metrics. doi:10.1021/acsomega.2c01036 names it ACS Omega 2022
Characterization of Fluoroquinolone-Resistant and Multidrug-Resistant Mycobacterium tuberculosis Isolates Using Whole-Genome Sequencing in Tianjin, China. doi:10.2147/IDR.S361635 Infect Drug Resist 2022
Experimental Evolution Reveals Redox State Modulates Mycobacterial Pathogenicity. doi:10.3389/fgene.2022.758304 Front Genet 2022
Detection and characterization of mutations in genes related to isoniazid resistance in Mycobacterium tuberculosis clinical isolates from Iran. doi:10.1007/s11033-022-07404-2 Mol Biol Rep 2022
Quinoline derivatives as potential anti-tubercular agents: Synthesis, molecular docking and mechanism of action. doi:10.1016/j.micpath.2022.105507 Microb Pathog 2022
Establishment and evaluation of an overlap extension polymerase chain reaction technique for rapid and efficient detection of drug-resistance in Mycobacterium tuberculosis. doi:10.1186/s40249-022-00953-5 Infect Dis Poverty 2022
Evaluation of a Molecular Test for Detection of Mycobacterium tuberculosis Isolates Resistant to Rifampicin and Isoniazid. doi:10.7754/Clin.Lab.2021.210614 Clin Lab 2022
Snapshot of Mycobacterium tuberculosis Phylogenetics from an Indian State of Arunachal Pradesh Bordering China. doi:10.3390/genes13020263 Genes (Basel) 2022
Whole genome sequencing of isoniazid monoresistant clinical isolates of Mycobacterium tuberculosis reveals novel genetic polymorphisms. doi:10.1016/j.tube.2022.102173 Tuberculosis (Edinb) 2022
The Regulation of ManLAM-Related Gene Expression in Mycobacterium tuberculosis with Different Drug Resistance Profiles Following Isoniazid Treatment. doi:10.2147/IDR.S346869 Infect Drug Resist 2022
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century. doi:10.1016/j.jctube.2022.100299 J Clin Tuberc Other Mycobact Dis 2022
Application of Amplicon-Based Targeted NGS Technology for Diagnosis of Drug-Resistant Tuberculosis Using FFPE Specimens. doi:10.1128/spectrum.01358-21 Microbiol Spectr 2022
Whole-genome sequencing of Mycobacterium tuberculosis for prediction of drug resistance. doi:10.1017/S095026882100279X Epidemiol Infect 2022
The autophagy-resistant Mycobacterium tuberculosis Beijing strain upregulates KatG to evade starvation-induced autophagic restriction. doi:10.1093/femspd/ftac004 names it Pathog Dis 2022
Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China. doi:10.1128/spectrum.01475-21 Microbiol Spectr 2022
Antituberculosis, antioxidant and cytotoxicity profiles of quercetin: a systematic and cost-effective in silico and in vitro approach. doi:10.1080/14786419.2021.2008387 Nat Prod Res 2022
Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China. doi:10.1016/j.cmi.2021.09.014 Clin Microbiol Infect 2022
Significance of the coexistence of non-codon 315 katG, inhA, and oxyR-ahpC intergenic gene mutations among isoniazid-resistant and multidrug-resistant isolates of Mycobacterium tuberculosis: a report of novel mutations. doi:10.1080/20477724.2021.1928870 names it Pathog Glob Health 2022
Abattoir survey of bovine tuberculosis in tanta, centre of the Nile delta, with in silico analysis of gene mutations and protein-protein interactions of the involved mycobacteria. doi:10.1111/tbed.14001 Transbound Emerg Dis 2022
Structural analyses and classification of novel isoniazid resistance coupled mutational landscapes in Mycobacterium tuberculosis: a combined molecular docking and MD simulation study. doi:10.1080/07391102.2020.1861986 J Biomol Struct Dyn 2022
[Genetic structure of drug-resistant Mycobacterium tuberculosis strains in Peru based on haplotypes obtained from a line probe assay]. doi:10.17843/rpmesp.2021.384.7834 Rev Peru Med Exp Salud Publica 2021
Whole-Genome Sequencing Reveals Recent Transmission of Multidrug-Resistant Mycobacterium tuberculosis CAS1-Kili Strains in Lusaka, Zambia. doi:10.3390/antibiotics11010029 Antibiotics (Basel) 2021
Design and Synthesis of Highly Active Antimycobacterial Mutual Esters of 2-(2-Isonicotinoylhydrazineylidene)propanoic Acid. doi:10.3390/ph14121302 Pharmaceuticals (Basel) 2021
DNA Methyltransferase HsdM Induce Drug Resistance on Mycobacterium tuberculosis via Multiple Effects. doi:10.3390/antibiotics10121544 Antibiotics (Basel) 2021
Whole Genome Sequencing of Drug Resistant and Drug Susceptible Mycobacterium tuberculosis Isolates From Tigray Region, Ethiopia. doi:10.3389/fmicb.2021.743198 Front Microbiol 2021
Integrative utility of long read sequencing-based whole genome analysis and phenotypic assay on differentiating isoniazid-resistant signature of Mycobacterium tuberculosis. doi:10.1186/s12929-021-00783-x J Biomed Sci 2021
Whole genome sequencing reveals large deletions and other loss of function mutations in Mycobacterium tuberculosis drug resistance genes. doi:10.1099/mgen.0.000724 Microb Genom 2021
Putative extensive and pre-extensive drug resistant-tuberculosis associated with unusual genotypes on the Thailand-Myanmar border. doi:10.1590/S1678-9946202163085 Rev Inst Med Trop Sao Paulo 2021
Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China. doi:10.3390/antibiotics10111367 Antibiotics (Basel) 2021
The whole-genome sequencing in predicting Mycobacterium tuberculosis drug susceptibility and resistance in Papua, Indonesia. doi:10.1186/s12864-021-08139-3 BMC Genomics 2021
Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India. doi:10.1016/j.ijtb.2021.02.014 Indian J Tuberc 2021
Designing new antitubercular isoniazid derivatives with improved reactivity and membrane trafficking abilities. doi:10.1016/j.biopha.2021.112362 Biomed Pharmacother 2021
Whole-genome sequencing as a tool for studying the microevolution of drug-resistant serial Mycobacterium tuberculosis isolates. doi:10.1016/j.tube.2021.102137 Tuberculosis (Edinb) 2021
Novel mutations detected from drug resistant Mycobacterium tuberculosis isolated from North East of Thailand. doi:10.1007/s11274-021-03163-7 World J Microbiol Biotechnol 2021
Analysis of the application of a gene chip method for detecting Mycobacterium tuberculosis drug resistance in clinical specimens: a retrospective study. doi:10.1038/s41598-021-97559-y Sci Rep 2021
Evaluation of Multidrug Resistant Loop-mediated Isothermal Amplification Assay for Detecting the Drug Resistance of Mycobacterium tuberculosis. doi:10.3967/bes2021.085 Biomed Environ Sci 2021
Prevalence and Molecular Characteristics Based on Whole Genome Sequencing of Mycobacterium tuberculosis Resistant to Four Anti-Tuberculosis Drugs from Southern Xinjiang, China. doi:10.2147/IDR.S320024 Infect Drug Resist 2021
Determination of variable region sequences from hybridoma immunoglobulins that target Mycobacterium tuberculosis virulence factors. doi:10.1371/journal.pone.0256079 PLoS One 2021
Early detection of MDR Mycobacterium tuberculosis mutations in Pakistan. doi:10.1038/s41598-021-96116-x Sci Rep 2021
Structure-based virtual screening of essential Mycobacterium tuberculosis enzymes AspS and KatG for potential inhibitors. doi:10.6026/97320630017101 names it Bioinformation 2021
Investigation of the Rv3065, Rv2942, Rv1258c, Rv1410c, and Rv2459 efflux pump genes expression among multidrug-resistant Mycobacterium tuberculosis clinical isolates. doi:10.1016/j.heliyon.2021.e07566 Heliyon 2021
Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting. doi:10.1007/s10096-021-04316-0 Eur J Clin Microbiol Infect Dis 2021
Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan. doi:10.1038/s41598-021-93501-4 Sci Rep 2021
Mycobacterium tuberculosis SIT42 Infection in an Abused Dog in Southern Italy. doi:10.3389/fvets.2021.653360 Front Vet Sci 2021
Prevalence of drug resistance-conferring mutations associated with isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Ethiopia: a systematic review and meta-analysis. doi:10.1016/j.jgar.2021.06.009 J Glob Antimicrob Resist 2021
Rapid Molecular Diagnosis of Tuberculosis and Its Resistance to Rifampicin and Isoniazid with Automated MDR/MTB ELITe MGB(®) Assay. doi:10.3390/antibiotics10070797 Antibiotics (Basel) 2021
Phenotypic and genomic hallmarks of a novel, potentially pathogenic rapidly growing Mycobacterium species related to the Mycobacterium fortuitum complex. doi:10.1038/s41598-021-91737-8 Sci Rep 2021
Rapid detection of multidrug-resistant tuberculosis based on allele-specific recombinase polymerase amplification and colorimetric detection. doi:10.1371/journal.pone.0253235 PLoS One 2021
Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis. doi:10.1016/j.csbj.2021.04.034 Comput Struct Biotechnol J 2021
Detection of genomic mutations in katG and rpoB genes among multidrug-resistant Mycobacterium tuberculosis isolates from Tehran, Iran. doi:10.1016/j.nmni.2021.100879 names it New Microbes New Infect 2021
Zinc limitation triggers anticipatory adaptations in Mycobacterium tuberculosis. doi:10.1371/journal.ppat.1009570 PLoS Pathog 2021
Biological and Biochemical Evaluation of Isatin-Isoniazid Hybrids as Bactericidal Candidates against Mycobacterium tuberculosis. doi:10.1128/AAC.00011-21 Antimicrob Agents Chemother 2021
Genomic epidemiology of tuberculosis in eastern Malaysia: insights for strengthening public health responses. doi:10.1099/mgen.0.000573 Microb Genom 2021
New InhA Inhibitors Based on Expanded Triclosan and Di-Triclosan Analogues to Develop a New Treatment for Tuberculosis. doi:10.3390/ph14040361 Pharmaceuticals (Basel) 2021
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness. doi:10.1016/j.ijmm.2021.151506 names it Int J Med Microbiol 2021
Molecular Characteristics and Drug Resistance of Mycobacterium tuberculosis Isolate Circulating in Shaanxi Province, Northwestern China. doi:10.1089/mdr.2020.0496 Microb Drug Resist 2021
Exploratory development of PCR-fluorescent probes in rapid detection of mutations associated with extensively drug-resistant tuberculosis. doi:10.1007/s10096-021-04236-z Eur J Clin Microbiol Infect Dis 2021
Molecular epidemiology of Mycobacterium tuberculosis in adult Filipino TB-HIV co-infected patients. doi:10.5588/ijtld.20.0878 Int J Tuberc Lung Dis 2021
Drug-Resistant Mycobacterium tuberculosis Isolates from New and Previously Treated TB Patients in China, 2017-2019. doi:10.1590/0037-8682-0728-2020 Rev Soc Bras Med Trop 2021
Value of routine whole genome sequencing for Mycobacterium tuberculosis drug resistance detection. doi:10.1016/j.ijid.2021.03.033 Int J Infect Dis 2021
Promiscuous dye binding by a light-up aptamer: application for label-free multi-wavelength biosensing. doi:10.1039/d1cc00594d Chem Commun (Camb) 2021
Comparative Study of the Susceptibility to Oxidative Stress between Two Types of Mycobacterium bovis BCG Tokyo 172. doi:10.1128/mSphere.00111-21 mSphere 2021
Genotyping and Drug Susceptibility Patterns of M. Tuberculosis Isolated from HIV Seropositive Patients in Tehran Iran. doi:10.2174/1570162X19666210226125335 Curr HIV Res 2021
Drug Resistance Conferring Mutation and Genetic Diversity of Mycobacterium tuberculosis Isolates in Tuberculosis Lymphadenitis Patients; Ethiopia. doi:10.2147/IDR.S298683 Infect Drug Resist 2021
Phenotypic and Genotypic Drug Susceptibility Assessment of Mycobacterium bovis Bacillus Calmette-Guérin Clinical Strains. doi:10.2147/IDR.S248096 Infect Drug Resist 2021
The MTB/MDR ELITe MGB(®) Kit: Performance Assessment for Pulmonary, Extra-Pulmonary, and Resistant Tuberculosis Diagnosis, and Integration in the Laboratory Workflow of a French Center. doi:10.3390/pathogens10020176 Pathogens 2021
The Value of the inhA Mutation Detection in Predicting Ethionamide Resistance Using Melting Curve Technology. doi:10.2147/IDR.S268799 Infect Drug Resist 2021
Differential diagnosis of disseminated Mycobacterium avium and Mycobacterium tuberculosis infection in HIV patients using duplex PCR. doi:10.2217/fmb-2020-0091 Future Microbiol 2021
Heterologous Expression of ethA and katG in Mycobacterium marinum Enables the Rapid Identification of New Prodrugs Active against Mycobacterium tuberculosis. doi:10.1128/AAC.01445-20 names it Antimicrob Agents Chemother 2021
Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China. doi:10.1371/journal.pntd.0009068 PLoS Negl Trop Dis 2021
Analysis of drug resistance and mutation profiles in Mycobacterium tuberculosis isolates in a surveillance site in Beijing, China. doi:10.1177/0300060520984932 J Int Med Res 2021
Using cryo-EM to understand antimycobacterial resistance in the catalase-peroxidase (KatG) from Mycobacterium tuberculosis. doi:10.1016/j.str.2020.12.008 names it Structure 2021
Distribution of sigma factors delineates segregation of virulent and avirulent Mycobacterium. doi:10.1007/s00203-020-02172-8 Arch Microbiol 2021
Detection of Mycobacterium tuberculosis complex in pulmonary and extrapulmonary samples with the FluoroType MTBDR assay. doi:10.1016/j.cmi.2020.12.020 Clin Microbiol Infect 2021
Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China. doi:10.1017/S0950268820003131 Epidemiol Infect 2021
Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis. doi:10.1128/AAC.02091-20 Antimicrob Agents Chemother 2021
Drug-resistant Mycobacterium tuberculosis and its genotypes isolated from an outbreak in western Thailand. doi:10.1093/trstmh/traa148 Trans R Soc Trop Med Hyg 2021
Frequency and patterns of first- and second-line drug resistance-conferring mutations in Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients in a cross-sectional study in Tigray Region, Ethiopia. doi:10.1016/j.jgar.2020.11.017 J Glob Antimicrob Resist 2021
Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis. doi:10.1016/j.ijid.2020.11.007 Int J Infect Dis 2021
Rapid and Simple Detection of Isoniazid-Resistant Mycobacterium tuberculosis Utilizing a DNA Chromatography-Based Technique. doi:10.7883/yoken.JJID.2020.754 Jpn J Infect Dis 2021
Role of post-translational modifications in the acquisition of drug resistance in Mycobacterium tuberculosis. doi:10.1111/febs.15582 FEBS J 2021
Discerning novel drug targets for treating Mycobacterium avium ss. paratuberculosis-associated autoimmune disorders: an in silico approach. doi:10.1093/bib/bbaa195 Brief Bioinform 2021
Molecular characterization and antimicrobial resistance profiles of Mycobacterium tuberculosis complex in environmental substrates from three dairy farms in Eastern Cape, South Africa. doi:10.1080/09603123.2019.1642458 Int J Environ Health Res 2021
Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB. doi:10.1371/journal.pone.0244829 PLoS One 2020
Identification of Mutations Conferring Tryptanthrin Resistance to Mycobacterium smegmatis. doi:10.3390/antibiotics10010006 Antibiotics (Basel) 2020
Novel Isoniazid-Carborane Hybrids Active in Vitro Against Mycobacterium tuberculosis. doi:10.3390/ph13120465 Pharmaceuticals (Basel) 2020
Characterization of Mycobacterium tuberculosis heteroresistance by genotyping. doi:10.4103/ijmy.ijmy_132_20 Int J Mycobacteriol 2020
Biological Profiling Enables Rapid Mechanistic Classification of Phenotypic Screening Hits and Identification of KatG Activation-Dependent Pyridine Carboxamide Prodrugs With Activity Against Mycobacterium tuberculosis. doi:10.3389/fcimb.2020.582416 names it Front Cell Infect Microbiol 2020
Mutations in dnaA and a cryptic interaction site increase drug resistance in Mycobacterium tuberculosis. doi:10.1371/journal.ppat.1009063 PLoS Pathog 2020
Characteristics and Treatment Outcomes of Isoniazid Mono-Resistant Tuberculosis: A Retrospective Study. doi:10.3349/ymj.2020.61.12.1034 Yonsei Med J 2020
Acetylation of Isoniazid Is a Novel Mechanism of Isoniazid Resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.00456-20 Antimicrob Agents Chemother 2020
Prevalence and factors associated with multidrug-resistant tuberculosis in South India. doi:10.1038/s41598-020-74432-y Sci Rep 2020
Genotypic Distribution and a Potential Diagnostic Assay of Multidrug-Resistant Tuberculosis in Northern Thailand. doi:10.2147/IDR.S263082 Infect Drug Resist 2020
The Performance of the Abbott Real Time MTB RIF/INH Compared to the MTBDRplus V2 for the Identification of MDR-TB Among Isolates. doi:10.2147/IDR.S247524 Infect Drug Resist 2020
Detection of Beijing strains of MDR M. tuberculosis and their association with drug resistance mutations in katG, rpoB, and embB genes. doi:10.1186/s12879-020-05479-5 names it BMC Infect Dis 2020
Inhibition of Mycobacterium tuberculosis InhA: Design, synthesis and evaluation of new di-triclosan derivatives. doi:10.1016/j.bmc.2020.115744 Bioorg Med Chem 2020
Tuberculosis drug resistance in Canakkale, Turkey. doi:10.21101/cejph.a5284 Cent Eur J Public Health 2020
Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19. doi:10.1371/journal.pone.0239328 PLoS One 2020
Diabetes and multidrug-resistance gene mutation: tuberculosis in Zunyi, Southwest China. doi:10.21037/apm-20-1368 Ann Palliat Med 2020
Synthesis and evaluation of thiophene based small molecules as potent inhibitors of Mycobacterium tuberculosis. doi:10.1016/j.ejmech.2020.112772 Eur J Med Chem 2020
Efficient genome editing in pathogenic mycobacteria using Streptococcus thermophilus CRISPR1-Cas9. doi:10.1016/j.tube.2020.101983 Tuberculosis (Edinb) 2020
Laboratory Evaluation of a Lateral-Flow Cell for Molecular Detection of First-Line and Second-Line Antituberculosis Drug Resistance. doi:10.1128/JCM.01417-20 J Clin Microbiol 2020
Two Novel katG Mutations Conferring Isoniazid Resistance in Mycobacterium tuberculosis. doi:10.3389/fmicb.2020.01644 names it Front Microbiol 2020
Genomic Analysis Identifies Mutations Concerning Drug-Resistance and Beijing Genotype in Multidrug-Resistant Mycobacterium tuberculosis Isolated From China. doi:10.3389/fmicb.2020.01444 Front Microbiol 2020
Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia. doi:10.1371/journal.pone.0236054 PLoS One 2020
A retrospective cohort study of isoniazid-resistant tuberculosis treatment outcomes and isoniazid resistance-associated mutations in eastern China from 2013 to 2018. doi:10.1016/j.jgar.2020.07.012 J Glob Antimicrob Resist 2020
Cascade of deoxyribozymes for the colorimetric analysis of drug resistance in Mycobacterium tuberculosis. doi:10.1016/j.bios.2020.112385 Biosens Bioelectron 2020
Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran. doi:10.1016/j.meegid.2020.104468 Infect Genet Evol 2020
Evaluation of the frequency of resistance to 2 drugs (Isoniazid and Rifampin) by molecular investigation and it's risk factors in new cases of smear positive pulmonary tuberculosis in health centers under the cover of Jundishapur University of Medical Sciences in 2017. doi:10.4103/jfmpc.jfmpc_983_19 J Family Med Prim Care 2020
Spoligotype and Drug Susceptibility Profiles of Mycobacterium tuberculosis Complex Isolates in Golestan Province, North Iran. doi:10.2147/IDR.S255889 Infect Drug Resist 2020
Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens. doi:10.1016/j.cmi.2020.07.004 Clin Microbiol Infect 2020
Characterization of Large Deletion Mutants of Mycobacterium tuberculosis Selected for Isoniazid Resistance. doi:10.1128/AAC.00792-20 Antimicrob Agents Chemother 2020
Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods. doi:10.1016/j.ijantimicag.2020.106068 Int J Antimicrob Agents 2020
Residues of helix ɑ2 are critical for catalytic efficiency of mycobacterial alkylhydroperoxide reductase subunit C. doi:10.1002/1873-3468.13864 FEBS Lett 2020
Survey of drug resistance associated gene mutations in Mycobacterium tuberculosis, ESKAPE and other bacterial species. doi:10.1038/s41598-020-65766-8 Sci Rep 2020
Genomic signatures of drug resistance in highly resistant Mycobacterium tuberculosis strains of the early ancient sublineage of Beijing genotype in Russia. doi:10.1016/j.ijantimicag.2020.106036 Int J Antimicrob Agents 2020
[Analysis on drug resistance-associated mutations of multi-drug resistant Mycobacterium tuberculosis based on whole-genome sequencing in China]. doi:10.3760/cma.j.cn112338-20191111-00800 Zhonghua Liu Xing Bing Xue Za Zhi 2020
A Rapid and Accurate Detection Approach for Multidrug-Resistant Tuberculosis Based on PCR-ELISA Microplate Hybridization Assay. doi:10.1093/labmed/lmaa016 Lab Med 2020
Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil. doi:10.1590/0074-02760200055 Mem Inst Oswaldo Cruz 2020
Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears. doi:10.1371/journal.pone.0232343 PLoS One 2020
Pattern of InhA and KatG mutations in isoniazid monoresistant Mycobacterium tuberculosis isolates. doi:10.4103/lungindia.lungindia_204_19 names it Lung India 2020
Simultaneous detection of Mycobacterium tuberculosis complex and resistance to Rifampicin and Isoniazid by MDR/MTB ELITe MGB® Kit for the diagnosis of tuberculosis. doi:10.1371/journal.pone.0232632 PLoS One 2020
Genetic profiling of Mycobacterium tuberculosis revealed "modern" Beijing strains linked to MDR-TB from Southwestern Colombia. doi:10.1371/journal.pone.0224908 PLoS One 2020
Mutations in Mycobacterium tuberculosis Isolates with Discordant Results for Drug-Susceptibility Testing in Peru. doi:10.1155/2020/8253546 Int J Microbiol 2020
Rapid detection of Mycobacterium tuberculosis DNA and genetic markers for Isoniazid resistance in Ziehl-Neelsen stained slides. doi:10.1590/0074-02760190407 Mem Inst Oswaldo Cruz 2020
KatG as Counterselection Marker for Nontuberculous Mycobacteria. doi:10.1128/AAC.02508-19 names it Antimicrob Agents Chemother 2020
Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia. doi:10.1128/AAC.00537-20 Antimicrob Agents Chemother 2020
Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors. doi:10.1021/acs.jmedchem.0c00007 J Med Chem 2020
Characterization of katG, inhA, rpoB and pncA in Mycobacterium tuberculosis isolates from MDR-TB risk patients in Thailand. doi:10.3855/jidc.11974 names it J Infect Dev Ctries 2020
Artificial Intelligence and Machine learning based prediction of resistant and susceptible mutations in Mycobacterium tuberculosis. doi:10.1038/s41598-020-62368-2 Sci Rep 2020
Detection of a novel mutation in the rpoB gene in a multidrug resistant Mycobacterium tuberculosis isolate using whole genome next generation sequencing. doi:10.1016/j.jgar.2020.03.004 J Glob Antimicrob Resist 2020
Mutations in rpoB and katG genes and the inhA operon in multidrug-resistant Mycobacterium tuberculosis isolates from Zambia. doi:10.1016/j.jgar.2020.02.026 names it J Glob Antimicrob Resist 2020
Using a Heat Diffusion Model to Detect Potential Drug Resistance Genes of Mycobacterium tuberculosis. doi:10.2174/0929866527666200313113157 Protein Pept Lett 2020
Association Between the Phenotype and Genotype of Isoniazid Resistance Among Mycobacterium tuberculosis Isolates in Thailand. doi:10.2147/IDR.S242261 Infect Drug Resist 2020
One-Year Old Dormant, "Non-culturable" Mycobacterium tuberculosis Preserves Significantly Diverse Protein Profile. doi:10.3389/fcimb.2020.00026 Front Cell Infect Microbiol 2020
Molecular characterisation of mutations associated with resistance to first- and second-line drugs among Indonesian patients with tuberculosis. doi:10.1016/j.jtumed.2019.12.003 J Taibah Univ Med Sci 2020
Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements. doi:10.1016/j.rmed.2019.105844 Respir Med 2020
Molecular characterization of pre-extensive drug resistant Mycobacterium tuberculosis in Northeast Brazil. doi:10.1590/S1678-9946202062004 Rev Inst Med Trop Sao Paulo 2020
A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic. doi:10.1186/s12916-019-1487-2 BMC Med 2020
The Analysis of Drug-Resistant Gene Mutations of Mycobacterium tuberculosis by GeneChip in Lianyungang, China. doi:10.7754/Clin.Lab.2019.190526 Clin Lab 2020
Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among Mycobacterium tuberculosis isolates from Iran. doi:10.1080/1120009X.2020.1716479 J Chemother 2020
Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion. doi:10.1093/infdis/jiaa042 J Infect Dis 2020
The molecular patterns of resistance to anti-tuberculosis drugs: an analysis from Istanbul, Turkey. doi:10.1080/1120009X.2020.1716477 J Chemother 2020
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data. doi:10.1371/journal.pmed.1003008 PLoS Med 2020
Distribution of Antibiotic Resistance Genes in Three Different Natural Water Bodies-A Lake, River and Sea. doi:10.3390/ijerph17020552 Int J Environ Res Public Health 2020
Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial. doi:10.1164/rccm.201910-1960OC Am J Respir Crit Care Med 2020
Spoligotyping and drug sensitivity of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients in the Arsi Zone of southeastern Ethiopia. doi:10.1016/j.nmni.2019.100620 New Microbes New Infect 2020
First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil. doi:10.1016/j.meegid.2019.104127 Infect Genet Evol 2020
Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug. doi:10.1128/AAC.01899-19 names it Antimicrob Agents Chemother 2020
Proteomic characterization of Mycobacterium tuberculosis reveals potential targets of bostrycin. doi:10.1016/j.jprot.2019.103576 J Proteomics 2020
Bacillus Calmette-Guérin strains with defined resistance mutations: a new tool for tuberculosis laboratory quality control. doi:10.1016/j.cmi.2019.10.033 Clin Microbiol Infect 2020
Structure elaboration of isoniazid: synthesis, in silico molecular docking and antimycobacterial activity of isoniazid-pyrimidine conjugates. doi:10.1007/s11030-019-10004-1 Mol Divers 2020
Differential Expression of Resistant and Efflux Pump Genes in MDR-TB Isolates. doi:10.2174/1871530319666191009153834 Endocr Metab Immune Disord Drug Targets 2020
Coordinate regulation of virulence and metabolic genes by the transcription factor HbhR in Mycobacterium marinum. doi:10.1111/mmi.14400 Mol Microbiol 2020
Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China. doi:10.1016/j.jgar.2019.08.005 J Glob Antimicrob Resist 2020
[Cross-resistance between isoniazid and ethionamide and its strong association with mutation C-15T in Mycobacterium tuberculosis isolates from Peru]. doi:10.1016/j.ram.2019.03.005 Rev Argent Microbiol 2020
Elucidation of drug resistance mutations in Mycobacterium tuberculosis isolates from North India by whole-genome sequencing. doi:10.1016/j.jgar.2019.05.019 J Glob Antimicrob Resist 2020
Computational approach identifies protein off-targets for Isoniazid-NAD adduct: hypothesizing a possible drug resistance mechanism in Mycobacterium tuberculosis. doi:10.1080/07391102.2019.1615987 J Biomol Struct Dyn 2020
Structural Basis for Inhibition of Enoyl-[Acyl Carrier Protein] Reductase (InhA) from Mycobacterium tuberculosis. doi:10.2174/0929867326666181203125229 Curr Med Chem 2020
Multicenter evaluation of TB-SPRINT 59-Plex Beamedex®: accuracy and cost analysis. doi:10.1186/s12879-019-4646-3 BMC Infect Dis 2019
Efficacy Of Line Probe Assay In Detection Of Drug-Resistant Pulmonary Tuberculosis In Comparison With GeneXpert And Phenotypic Methods In Iran And Genetic Analysis Of Isolates By MIRU-VNTR. doi:10.2147/IDR.S222905 Infect Drug Resist 2019
Phenotypic isoniazid resistance and associated mutations in pediatric tuberculosis. doi:10.1016/j.ijtb.2019.09.004 Indian J Tuberc 2019
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB. doi:10.1186/s40001-019-0397-2 Eur J Med Res 2019
Improved Resistance Prediction in Mycobacterium tuberculosis by Better Handling of Insertions and Deletions, Premature Stop Codons, and Filtering of Non-informative Sites. doi:10.3389/fmicb.2019.02464 Front Microbiol 2019
Whole genome sequencing, analyses of drug resistance-conferring mutations, and correlation with transmission of Mycobacterium tuberculosis carrying katG-S315T in Hanoi, Vietnam. doi:10.1038/s41598-019-51812-7 names it Sci Rep 2019
Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa. doi:10.7196/SAMJ.2019.v109i9.13730 S Afr Med J 2019
Pharmacoinformatics-based identification of anti-bacterial catalase-peroxidase enzyme inhibitors. doi:10.1016/j.compbiolchem.2019.107136 Comput Biol Chem 2019
Antibiotic resistance of Mycobacterium tuberculosis complex in Africa: A systematic review of current reports of molecular epidemiology, mechanisms and diagnostics. doi:10.1016/j.jinf.2019.10.006 J Infect 2019
Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan. doi:10.1038/s41598-019-51562-6 Sci Rep 2019
Comparison of Conventional and Molecular Methods Used for Diagnosis of Mycobacterium Tuberculosis in Clinical Samples. doi:10.7754/Clin.Lab.2019.190145 Clin Lab 2019
Rapid detection of drug-resistant Mycobacterium tuberculosis directly from clinical specimens using allele-specific polymerase chain reaction assay. doi:10.4103/ijmr.IJMR_374_18 Indian J Med Res 2019
Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action. doi:10.1111/bph.14867 Br J Pharmacol 2019
Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China. doi:10.2147/IDR.S209971 Infect Drug Resist 2019
Whole-genome sequencing-based epidemiological analysis of anti-tuberculosis drug resistance genes in Japan in 2007: Application of the Genome Research for Asian Tuberculosis (GReAT) database. doi:10.1038/s41598-019-49219-5 Sci Rep 2019
Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan. doi:10.1371/journal.pone.0221485 PLoS One 2019
Analysis of drug resistance mutations in pulmonary Mycobacterium tuberculosis isolates in the Southern coastal region of Andhra Pradesh, India. doi:10.1016/j.bjid.2019.07.002 Braz J Infect Dis 2019
Change in prevalence and molecular characteristics of isoniazid-resistant tuberculosis over a 10-year period in China. doi:10.1186/s12879-019-4333-4 BMC Infect Dis 2019
Design of hybrid molecules as antimycobacterial compounds: Synthesis of isoniazid-naphthoquinone derivatives and their activity against susceptible and resistant strains of Mycobacterium tuberculosis. doi:10.1016/j.bmc.2019.07.045 Bioorg Med Chem 2019
Molecular characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from a high-burden tuberculosis state in Brazil. doi:10.1017/S0950268819001006 Epidemiol Infect 2019
Retrospective Analysis of Archived Pyrazinamide Resistant Mycobacterium tuberculosis Complex Isolates from Uganda-Evidence of Interspecies Transmission. doi:10.3390/microorganisms7080221 Microorganisms 2019
Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India. doi:10.1038/s41598-019-46756-x Sci Rep 2019
Use of nanotechnology for infectious disease diagnostics: application in drug resistant tuberculosis. doi:10.1186/s12879-019-4259-x BMC Infect Dis 2019
Insight into genetic diversity of Mycobacterium tuberculosis in Kandy, Sri Lanka reveals predominance of the Euro-American lineage. doi:10.1016/j.ijid.2019.07.001 Int J Infect Dis 2019
DFT study on the effect of proximal residues on the Mycobacterium tuberculosis catalase-peroxidase (katG) heme compound I intermediate and its bonding interaction with isoniazid. doi:10.1039/c9cp01465a names it Phys Chem Chem Phys 2019
Whole genome sequencing provides additional insights into recurrent tuberculosis classified as endogenous reactivation by IS6110 DNA fingerprinting. doi:10.1016/j.meegid.2019.103948 Infect Genet Evol 2019
Identification of virulence and antibiotic resistance factors in Arcobacter butzleri isolated from bovine milk by Whole Genome Sequencing. doi:10.4081/ijfs.2019.7840 Ital J Food Saf 2019
Resistance Reversed in KatG Mutants of Mycobacterium tuberculosis. doi:10.1016/j.tim.2019.05.008 names it Trends Microbiol 2019
Isoniazid mono-resistant tuberculosis: Time to take it seriously. doi:10.1016/j.ijtb.2019.04.001 Indian J Tuberc 2019
WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing. doi:10.1093/jac/dkz215 J Antimicrob Chemother 2019
First genetic characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from Algeria. doi:10.1016/j.jgar.2019.05.010 J Glob Antimicrob Resist 2019
Prevalence and molecular characterization of multidrug-resistant M. tuberculosis in Jiangxi province, China. doi:10.1038/s41598-019-43547-2 Sci Rep 2019
Capacity of Abbott RealTime MTB RIF/INH to detect rifampicin- and isoniazid-resistant tuberculosis. doi:10.5588/ijtld.18.0615 Int J Tuberc Lung Dis 2019
Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis. doi:10.1073/pnas.1818009116 Proc Natl Acad Sci U S A 2019
Cross-talk between the three furA orthologs in Mycobacterium smegmatis and the contribution to isoniazid resistance. doi:10.1093/jb/mvz030 J Biochem 2019
Rapid screening mutations of first-line-drug-resistant genes in Mycobacterium tuberculosis strains by allele-specific real-time quantitative PCR. doi:10.7717/peerj.6696 PeerJ 2019
Characterisation of drug resistance-associated mutations among clinical multidrug-resistant Mycobacterium tuberculosis isolates from Hebei Province, China. doi:10.1016/j.jgar.2019.03.012 J Glob Antimicrob Resist 2019
Eosinophil peroxidase oxidizes isoniazid to form the active metabolite against M. tuberculosis, isoniazid-NAD(). doi:10.1016/j.cbi.2019.03.019 Chem Biol Interact 2019
Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya. doi:10.1186/s12879-019-3911-9 BMC Infect Dis 2019
A new oligonucleotide array for the detection of multidrug and extensively drug-resistance tuberculosis. doi:10.1038/s41598-019-39339-3 Sci Rep 2019
Detection of multidrug resistant Mycobacterium tuberculosis in Tabuk, Saudi Arabia, using Genotype MTBDRplus. doi:10.4103/ijmy.ijmy_29_19 Int J Mycobacteriol 2019
Molecular epidemiology and whole genome sequencing analysis of clinical Mycobacterium bovis from Ghana. doi:10.1371/journal.pone.0209395 PLoS One 2019
Genetic diversity and drug resistance of Mycobacterium tuberculosis in Ecuador. doi:10.5588/ijtld.18.0095 Int J Tuberc Lung Dis 2019
The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis. doi:10.1016/j.jmb.2019.02.016 J Mol Biol 2019
Molecular Evidence of Drug-Resistant Tuberculosis in the Balimo Region of Papua New Guinea. doi:10.3390/tropicalmed4010033 Trop Med Infect Dis 2019
Structural basis for isoniazid resistance in KatG double mutants of Mycobacterium tuberculosis. doi:10.1016/j.micpath.2019.02.003 names it Microb Pathog 2019
Theoretical insights on the binding of isoniazid to the active site residues of Mycobacterium tuberculosis catalase-peroxidase. doi:10.1016/j.tube.2018.11.005 Tuberculosis (Edinb) 2019
Conventional and molecular determination of drug resistance in Mycobacterium tuberculosis and Mycobacterium bovis isolates in cattle. doi:10.1016/j.tube.2018.12.005 Tuberculosis (Edinb) 2019
Computational Approaches as Rational Decision Support Systems for Discovering Next-Generation Antitubercular Agents: Mini-Review. doi:10.2174/1573409915666190130153214 Curr Comput Aided Drug Des 2019
Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates. doi:10.1016/j.jgar.2019.01.003 J Glob Antimicrob Resist 2019
Modulatory effects of verapamil in rifampicin activity against Mycobacterium tuberculosis. doi:10.2217/fmb-2018-0277 Future Microbiol 2019
Spoligotyping, phenotypic and genotypic characterization of katG, rpoB gene of M. tuberculosis isolates from Sahariya tribe of Madhya Pradesh India. doi:10.1016/j.jiph.2018.12.009 names it J Infect Public Health 2019
Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation. doi:10.1186/s12941-018-0300-y Ann Clin Microbiol Antimicrob 2019
Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis. doi:10.1186/s12879-018-3638-z BMC Infect Dis 2019
Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates. doi:10.1016/j.cmi.2018.12.008 Clin Microbiol Infect 2019
A First Insight into the katG and rpoB Gene Mutations of Multidrug-Resistant Mycobacterium tuberculosis Strains from Ecuador. doi:10.1089/mdr.2018.0203 names it Microb Drug Resist 2019
rpoB, katG and inhA mutations in multi-drug resistant strains of Mycobacterium tuberculosis clinical isolates from southeast Mexico. doi:10.1016/j.eimc.2018.09.002 names it Enferm Infecc Microbiol Clin (Engl Ed) 2019
Correlation between GenoType MTBDRplus Assay and Phenotypic Susceptibility Test for Prothionamide in Patients with Genotypic Isoniazid Resistance. doi:10.4046/trd.2018.0027 Tuberc Respir Dis (Seoul) 2019
Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia. doi:10.1016/j.jgar.2018.08.018 J Glob Antimicrob Resist 2019
Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13. doi:10.1080/07391102.2018.1462734 J Biomol Struct Dyn 2019
Rapid detection of multidrug resistant tuberculosis in respiratory specimens at a tertiary care centre in south coastal Karnataka using Genotype MTBDR plus assay. Iran J Microbiol 2018
Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India. doi:10.4103/ijmy.ijmy_98_18 Int J Mycobacteriol 2018
[Molecular diagnosis of multidrug-resistant tuberculosis in sputum samples by melting curve analysis]. doi:10.17843/rpmesp.2018.353.3402. Rev Peru Med Exp Salud Publica 2018
Validation of the FluoroType(®) MTBDR assay using respiratory and lymph node samples. doi:10.1016/j.tube.2018.09.004 Tuberculosis (Edinb) 2018
Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA. doi:10.26508/lsa.201800025 Life Sci Alliance 2018
The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China. doi:10.1038/s41426-018-0184-0 names it Emerg Microbes Infect 2018
Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis. doi:10.2147/IDR.S178831 Infect Drug Resist 2018
New epidemic cluster of pre-extensively drug resistant isolates of Mycobacterium tuberculosis Ural family emerging in Eastern Europe. doi:10.1186/s12864-018-5162-3 BMC Genomics 2018
Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis. doi:10.1038/s41598-018-33370-6 Sci Rep 2018
Evaluation of Genotype MTBDRplus and MTBDRsl Assays for Rapid Detection of Drug Resistance in Extensively Drug-Resistant Mycobacterium tuberculosis Isolates in Pakistan. doi:10.3389/fmicb.2018.02265 Front Microbiol 2018
Evaluation of the GenoType MTBDRplus and MTBDRsl for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Beijing, China. doi:10.2147/IDR.S176609 Infect Drug Resist 2018
Phenotypic and genotypic drug sensitivity of Mycobacterium tuberculosis complex isolated from South Omo Zone, Southern Ethiopia. doi:10.2147/IDR.S165088 Infect Drug Resist 2018
A rapid identification technique for drug-resistant Mycobacterium tuberculosis isolates using mismatch specific cleavage enzyme. doi:10.6026/97320630014404 Bioinformation 2018
Mycobacterium caprae Infection in Captive Borneo Elephant, Japan. doi:10.3201/eid2410.180018 Emerg Infect Dis 2018
A katG S315T or an ahpC promoter mutation mediate Mycobacterium tuberculosis resistance to 2-thiophen carboxylic acid hydrazide, an inhibitor resembling the anti-tubercular drugs Isoniazid and Ethionamide. doi:10.1016/j.tube.2018.08.001 names it Tuberculosis (Edinb) 2018
Effective pragmatic approach of diagnosis of multidrug-resistant tuberculosis by high-resolution melt curve assay. doi:10.4103/ijmy.ijmy_100_18 Int J Mycobacteriol 2018
Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne's model of dormancy. doi:10.1038/s41429-018-0098-z J Antibiot (Tokyo) 2018
Tuberculosis in post-contact Native Americans of Brazil: Paleopathological and paleogenetic evidence from the Tenetehara-Guajajara. doi:10.1371/journal.pone.0202394 PLoS One 2018
Molecular Analysis of katG Encoding Catalase-Peroxidase from Clinical Isolate of Isoniazid-Resistant Mycobacterium tuberculosis. names it J Med Life 2018
Whole-genome sequencing and single nucleotide polymorphisms in multidrug-resistant clinical isolates of Mycobacterium tuberculosis from the Philippines. doi:10.1016/j.jgar.2018.08.009 J Glob Antimicrob Resist 2018
Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis. doi:10.1371/journal.pone.0202568 PLoS One 2018
Mixed Mycobacterium tuberculosis-Strain Infections Are Associated With Poor Treatment Outcomes Among Patients With Newly Diagnosed Tuberculosis, Independent of Pretreatment Heteroresistance. doi:10.1093/infdis/jiy480 J Infect Dis 2018
Comparative Genome Analysis of 2 Mycobacterium Tuberculosis Strains from Pakistan: Insights Globally Into Drug Resistance, Virulence, and Niche Adaptation. doi:10.1177/1176934318790252 Evol Bioinform Online 2018
Validation of Novel Mycobacterium tuberculosis Isoniazid Resistance Mutations Not Detectable by Common Molecular Tests. doi:10.1128/AAC.00974-18 Antimicrob Agents Chemother 2018
Significance of catalase-peroxidase (KatG) mutations in mediating isoniazid resistance in clinical strains of Mycobacterium tuberculosis. doi:10.1016/j.jgar.2018.07.001 names it J Glob Antimicrob Resist 2018
Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis. doi:10.1128/JCM.00531-18 J Clin Microbiol 2018
Genotypicdiversity of drug-resistant Mycobacterium tuberculosis isolates from Hebei, China. Int J Clin Exp Pathol 2018
Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania. doi:10.1038/s41598-018-27962-5 Sci Rep 2018
Insight into multidrug-resistant Beijing genotype Mycobacterium tuberculosis isolates in Myanmar. doi:10.1016/j.ijid.2018.06.009 Int J Infect Dis 2018
The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in Mycobacterium tuberculosis isolates from untreated pulmonary Tuberculosis cases in urban Blantyre, Malawi. doi:10.4314/mmj.v30i1.1 Malawi Med J 2018
Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda. doi:10.1371/journal.pone.0198091 PLoS One 2018
Biochemical Characterization of Isoniazid-resistant Mycobacterium tuberculosis: Can the Analysis of Clonal Strains Reveal Novel Targetable Pathways? doi:10.1074/mcp.RA118.000821 Mol Cell Proteomics 2018
Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy. doi:10.1128/mBio.00938-18 mBio 2018
GeneChip analysis of resistant Mycobacterium tuberculosis with previously treated tuberculosis in Changchun. doi:10.1186/s12879-018-3131-8 BMC Infect Dis 2018
Evaluation of pyrosequencing for extensive drug resistance-defining anti-tuberculosis drugs for use in public healthcare. doi:10.1016/j.tube.2018.03.006 Tuberculosis (Edinb) 2018
Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil. doi:10.1016/j.tube.2018.02.009 Tuberculosis (Edinb) 2018
Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis? doi:10.3389/fmicb.2018.00880 Front Microbiol 2018
KatG-Mediated Oxidation Leading to Reduced Susceptibility of Bacteria to Kanamycin. doi:10.1021/acsomega.8b00356 names it ACS Omega 2018
Significance of Coexisting Mutations on Determination of the Degree of Isoniazid Resistance in Mycobacterium tuberculosis Strains. doi:10.1089/mdr.2017.0330 Microb Drug Resist 2018
Genotyping and molecular detection of multidrug-resistant Mycobacterium tuberculosis among tuberculosis lymphadenitis cases in Addis Ababa, Ethiopia. doi:10.1016/j.nmni.2017.10.009 New Microbes New Infect 2018
Mechanism of irreversible inhibition of Mycobacterium tuberculosis shikimate kinase by ilimaquinone. doi:10.1016/j.bbapap.2018.04.007 Biochim Biophys Acta Proteins Proteom 2018
Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates. doi:10.3343/alm.2018.38.4.316 Ann Lab Med 2018
Prevalence of mutations in genes associated with isoniazid resistance in Mycobacterium tuberculosis isolates from re-treated smear-positive pulmonary tuberculosis patients: A meta-analysis. doi:10.1016/j.jgar.2018.02.009 J Glob Antimicrob Resist 2018
Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates. doi:10.1128/JCM.00072-18 J Clin Microbiol 2018
Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study. doi:10.1016/S1473-3099(18)30073-2 Lancet Infect Dis 2018
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic. doi:10.1186/s12866-018-1168-x names it BMC Microbiol 2018
Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania. doi:10.1016/j.tube.2018.02.004 Tuberculosis (Edinb) 2018
Modeling the structural origins of drug resistance to isoniazid via key mutations in Mycobacterium tuberculosis catalase-peroxidase, KatG. doi:10.1016/j.tube.2017.11.007 names it Tuberculosis (Edinb) 2018
Multi- and Extensively Drug Resistant Mycobacterium tuberculosis in South Africa: a Molecular Analysis of Historical Isolates. doi:10.1128/JCM.01214-17 J Clin Microbiol 2018
TnSeq of Mycobacterium tuberculosis clinical isolates reveals strain-specific antibiotic liabilities. doi:10.1371/journal.ppat.1006939 PLoS Pathog 2018
Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco. doi:10.1186/s12879-018-3009-9 BMC Infect Dis 2018
Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations. doi:10.1038/s41598-018-21378-x Sci Rep 2018
Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii. doi:10.1128/AAC.01788-17 Antimicrob Agents Chemother 2018
Differences in rpoB, katG and inhA mutations between new and previously treated tuberculosis cases using the GenoType MTBDRplus assay. doi:10.1016/j.meegid.2018.01.022 names it Infect Genet Evol 2018
An overview on crystal structures of InhA protein: Apo-form, in complex with its natural ligands and inhibitors. doi:10.1016/j.ejmech.2018.01.047 Eur J Med Chem 2018
Roles of the three Mycobacterium smegmatis katG genes for peroxide detoxification and isoniazid susceptibility. doi:10.1111/1348-0421.12574 names it Microbiol Immunol 2018
Complete Genome Sequences of Two Multidrug-Resistant Mycobacterium tuberculosis Strains Isolated in Guiyang, China. doi:10.1128/genomeA.01257-17 Genome Announc 2018
Diagnostic Opportunities for Optimizing Management of Multidrug-Resistant Tuberculosis (MDR-TB) in Tanzania. doi:10.24248/EAHRJ-D-16-00357 East Afr Health Res J 2018
Molecular drug resistance profiles of Mycobacterium tuberculosis from sputum specimens using ion semiconductor sequencing. doi:10.1016/j.mimet.2017.12.003 J Microbiol Methods 2018
Rapid Microarray-Based Detection of Rifampin, Isoniazid, and Fluoroquinolone Resistance in Mycobacterium tuberculosis by Use of a Single Cartridge. doi:10.1128/JCM.01249-17 J Clin Microbiol 2018
Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy. doi:10.1016/j.jinorgbio.2017.11.013 J Inorg Biochem 2018
Revisiting Activation of and Mechanism of Resistance to Compound IQG-607 in Mycobacterium tuberculosis. doi:10.1128/AAC.02222-17 Antimicrob Agents Chemother 2018
Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium tuberculosis by DeepMelt Assay. doi:10.1128/JCM.01239-17 J Clin Microbiol 2018
Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context. doi:10.1093/jac/dkx372 J Antimicrob Chemother 2018
Wild-type catalase peroxidase vs G279D mutant type: Molecular basis of Isoniazid drug resistance in Mycobacterium tuberculosis. doi:10.1016/j.gene.2017.10.047 Gene 2018
MTBDRplus for the rapid diagnosis of ocular tuberculosis and screening of drug resistance. doi:10.1038/eye.2017.214 Eye (Lond) 2018
Molecular epidemiology of multi- and extensively-drug-resistant Mycobacterium tuberculosis in Ireland, 2001-2014. doi:10.1016/j.jinf.2017.10.002 J Infect 2018
Analysis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis isolates in Morocco using GenoType(®) MTBDRplus assay. doi:10.1016/j.jgar.2017.09.017 J Glob Antimicrob Resist 2018
Performance of GenoType(®) MTBDRplus assay in the diagnosis of drug-resistant tuberculosis in Tangier, Morocco. doi:10.1016/j.jgar.2017.09.002 J Glob Antimicrob Resist 2018
Detection of First-Line Drug Resistance Mutations and Drug-Protein Interaction Dynamics from Tuberculosis Patients in South India. doi:10.1089/mdr.2017.0048 Microb Drug Resist 2018
Performance of MTBDRplus assay in detecting multidrug resistant tuberculosis at hospital level. doi:10.1186/s13104-017-2989-7 BMC Res Notes 2017
[Defining of gene mutations and minimal inhibitory concentrations in isoniazid resistant Mycobacterium tuberculosis isolates]. doi:10.5578/mb.57614 Mikrobiyol Bul 2017
Effect of efflux pump inhibitors on the susceptibility of Mycobacterium tuberculosis to isoniazid. doi:10.4103/0970-2113.217567 Lung India 2017
Insights on the Mechanism of Action of INH-C(10) as an Antitubercular Prodrug. doi:10.1021/acs.molpharmaceut.7b00719 Mol Pharm 2017
Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India. doi:10.1016/j.tube.2017.07.014 names it Tuberculosis (Edinb) 2017
Lack of evidence of isoniazid efficacy for the treatment of MDR/XDR-TB in the presence of the katG 315T mutation. doi:10.1183/13993003.01752-2017 names it Eur Respir J 2017
A katG 315 mutation alone should not lead to exclusion of isoniazid in treatment of multidrug-resistant tuberculosis. doi:10.1183/13993003.01696-2017 names it Eur Respir J 2017
Mutual synergy between catalase and peroxidase activities of the bifunctional enzyme KatG is facilitated by electron hole-hopping within the enzyme. doi:10.1074/jbc.M117.791202 names it J Biol Chem 2017
Update of Antitubercular Prodrugs from a Molecular Perspective: Mechanisms of Action, Bioactivation Pathways, and Associated Resistance. doi:10.1002/cmdc.201700424 ChemMedChem 2017
Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods. doi:10.11604/pamj.2017.27.145.10883 names it Pan Afr Med J 2017
Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis. doi:10.1056/NEJMoa1614915 N Engl J Med 2017
[The Spectrum of Mutations in Genes Associated with Resistance to Rifampicin, Isoniazid, and Fluoroquinolones in the Clinical Strains of M. tuberculosis Reflects the Transmissibility of Mutant Clones]. doi:10.7868/S0026898417030041 Mol Biol (Mosk) 2017
Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant Tuberculosis in Nepal. doi:10.1155/2017/1635780 Int Sch Res Notices 2017
An application of competitive reporter monitored amplification (CMA) for rapid detection of single nucleotide polymorphisms (SNPs). doi:10.1371/journal.pone.0183561 PLoS One 2017
Molecular characterisation of isoniazid resistant clinical isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan. J Pak Med Assoc 2017
Real-time PCR followed by high-resolution melting curve analysis: A rapid and pragmatic approach for screening of multidrug-resistant extrapulmonary tuberculosis. doi:10.1016/j.tube.2017.07.002 Tuberculosis (Edinb) 2017
GenoType MTBDRplus assay for screening and characterization of isoniazid and rifampicin resistance-associated mutations in multidrug-resistant Mycobacterium tuberculosis from India. doi:10.1111/lam.12787 Lett Appl Microbiol 2017
Genetic diversity of Mycobacterium tuberculosis and transmission associated with first-line drug resistance: a first analysis in Jalisco, Mexico. doi:10.1016/j.jgar.2017.07.004 J Glob Antimicrob Resist 2017
Mycobacterial DNA-binding protein 1 is critical for long term survival of Mycobacterium smegmatis and simultaneously coordinates cellular functions. doi:10.1038/s41598-017-06480-w Sci Rep 2017
In Silico Prediction of Antibiotic Resistance in Mycobacterium ulcerans Agy99 through Whole Genome Sequence Analysis. doi:10.4269/ajtmh.16-0478 Am J Trop Med Hyg 2017
Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid. doi:10.1016/j.jgar.2017.06.014 names it J Glob Antimicrob Resist 2017
Drug resistance and Mycobacterium tuberculosis strain diversity in TB/HIV co-infected patients in Ho Chi Minh city, Vietnam. doi:10.1016/j.jgar.2017.07.003 J Glob Antimicrob Resist 2017
Molecular Characterization of Mycobacterium tuberculosis Strains with TB-SPRINT. doi:10.4269/ajtmh.16-0782 Am J Trop Med Hyg 2017
A comparative study of phenotypic and genotypic first- and second-line drug resistance testing of Mycobacterium tuberculosis. doi:10.1016/j.biologicals.2017.07.003 Biologicals 2017
Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand. doi:10.2147/IDR.S130203 Infect Drug Resist 2017
Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan. doi:10.1016/j.micpath.2017.07.005 Microb Pathog 2017
Diagnostic Performance of the GenoType MTBDRplus and MTBDRsl Assays to Identify Tuberculosis Drug Resistance in Eastern China. doi:10.4103/0366-6999.208248 Chin Med J (Engl) 2017
Multidrug-resistant tuberculosis detection and characterization of mutations in mycobacterium tuberculosis by genotype MTBDRplus. doi:10.4103/IJPM.IJPM_53_16 Indian J Pathol Microbiol 2017
Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates. doi:10.1016/j.jctube.2017.06.001 J Clin Tuberc Other Mycobact Dis 2017
Screening mutations in drug-resistant Mycobacterium tuberculosis strains in Yunnan, China. doi:10.1016/j.jiph.2017.04.008 J Infect Public Health 2017
A novel automatic molecular test for detection of multidrug resistance tuberculosis in sputum specimen: A case control study. doi:10.1016/j.tube.2017.03.008 Tuberculosis (Edinb) 2017
Molecular investigation of active binding site of isoniazid (INH) and insight into resistance mechanism of S315T-MtKatG in Mycobacterium tuberculosis. doi:10.1016/j.tube.2017.04.002 Tuberculosis (Edinb) 2017
Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplus. doi:10.1590/0074-02760160376 Mem Inst Oswaldo Cruz 2017
Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study. doi:10.1186/s12879-017-2489-3 BMC Infect Dis 2017
Use of DNA microarray chips for the rapid detection of Mycobacterium tuberculosis resistance to rifampicin and isoniazid. doi:10.3892/etm.2017.4250 Exp Ther Med 2017
Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of Mycobacterium tuberculosis. doi:10.4103/ijmy.ijmy_26_17 Int J Mycobacteriol 2017
[Description of Mycobacterium tuberculosis mutations conferring resistance to rifampicin and isoniazid detected by GenoType® MTBDRplus V.2 in Colombia]. doi:10.7705/biomedica.v37i1.3174 Biomedica 2017
Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis. doi:10.5588/ijtld.16.0510 Int J Tuberc Lung Dis 2017
Diagnostic performance of Anyplex II MTB/MDR/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis. doi:10.1016/j.mimet.2017.05.006 J Microbiol Methods 2017
Performance of TaqMan array card to detect TB drug resistance on direct specimens. doi:10.1371/journal.pone.0177167 PLoS One 2017
Positive epistasis of major low-cost drug resistance mutations rpoB531-TTG and katG315-ACC depends on the phylogenetic background of Mycobacterium tuberculosis strains. doi:10.1016/j.ijantimicag.2017.02.009 Int J Antimicrob Agents 2017
Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing. doi:10.1186/s12879-017-2409-6 BMC Infect Dis 2017
Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda. doi:10.5588/ijtld.16.0544 Int J Tuberc Lung Dis 2017
The Influence of HIV on the Evolution of Mycobacterium tuberculosis. doi:10.1093/molbev/msx107 Mol Biol Evol 2017
Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia. doi:10.2147/IDR.S127903 Infect Drug Resist 2017
Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis. doi:10.1128/JCM.02104-16 J Clin Microbiol 2017
Prevalence and genetic determinant of drug-resistant tuberculosis among patients completing intensive phase of treatment in a Tertiary Referral Center in Nigeria. doi:10.4103/2212-5531.201883 Int J Mycobacteriol 2017
Mutations in catalase-peroxidase KatG from isoniazid resistant Mycobacterium tuberculosis clinical isolates: insights from molecular dynamics simulations. doi:10.1007/s00894-017-3290-3 names it J Mol Model 2017
Molecular modelling and docking analysis of katG and rpoB gene in MDR-TB isolates from North Central Indian population. doi:10.1016/j.jiph.2017.01.005 names it J Infect Public Health 2017
Antituberculosis Drug Resistance in Pulmonary Isolates of Mycobacterium tuberculosis, Cuba 2012-2014. doi:10.37757/MR2017.V19.N1.3 MEDICC Rev 2017
Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment. doi:10.7554/eLife.20420 Elife 2017
Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes? doi:10.1016/j.meegid.2017.02.012 Infect Genet Evol 2017
Multidrug-resistant TB in Eastern region of the EU: is the shorter regimen an exception or a rule? doi:10.1136/thoraxjnl-2016-209841 Thorax 2017
Phenotypic and Genotypic Analysis of Multidrug-Resistant Mycobacterium tuberculosis Isolates from Sudanese Patients. doi:10.1155/2017/8340746 Tuberc Res Treat 2017
The role of pattern recognition receptors in lung sarcoidosis. doi:10.1016/j.ejphar.2017.01.020 Eur J Pharmacol 2017
FIND Tuberculosis Strain Bank: a Resource for Researchers and Developers Working on Tests To Detect Mycobacterium tuberculosis and Related Drug Resistance. doi:10.1128/JCM.01662-16 J Clin Microbiol 2017
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance. doi:10.1038/ng.3767 Nat Genet 2017
Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China. doi:10.1371/journal.pone.0169413 PLoS One 2017
Analysis of discrepant results between the Genotype(®) MTBDRplus assay and an antimicrobial drug susceptibility test for isoniazid-resistant tuberculosis. doi:10.1016/j.rmed.2016.11.016 Respir Med 2017
Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use. doi:10.1128/JCM.01771-16 J Clin Microbiol 2017
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico. doi:10.1016/j.meegid.2016.09.012 Infect Genet Evol 2017
Frequency of mutations in rifampicin and isoniazid resistant isolates of M. tuberculosis: an analysis from Central India. doi:10.11599/germs.2016.1096 Germs 2016
Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa. doi:10.1016/j.ijmyco.2016.11.020 Int J Mycobacteriol 2016
Molecular drug susceptibility testing against the first-line (rifampin and isoniazid) and second-line (ciprofloxacin-amikacin and kanamycin) treatment in different subtypes of Mycobacterium simiae. doi:10.1016/j.ijmyco.2016.11.006 Int J Mycobacteriol 2016
Molecular characterization of Mycobacterium tuberculosis strains resistant to isoniazid. doi:10.1016/j.ijmyco.2016.09.070 Int J Mycobacteriol 2016
Evaluation of genotype MTBDRplus assay for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis clinical isolates from Pakistan. doi:10.1016/j.ijmyco.2016.11.010 Int J Mycobacteriol 2016
Genotypic analysis of multidrug-resistant tuberculosis isolates from extra pulmonary tuberculosis cases in tertiary care centers in Northern India. doi:10.1016/j.ijmyco.2016.09.027 Int J Mycobacteriol 2016
Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis sensitive and resistant Beijing type from a patient with pulmonary tuberculosis. doi:10.1016/j.ijmyco.2016.10.028 Int J Mycobacteriol 2016
Rapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using Real-Time PCR. doi:10.5812/jjm.29147 Jundishapur J Microbiol 2016
Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia. doi:10.1016/j.ijmyco.2016.06.005 Int J Mycobacteriol 2016
A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia. doi:10.1371/journal.pone.0167093 PLoS One 2016
Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC. doi:10.1371/journal.pone.0166807 names it PLoS One 2016
The in vitro mechanisms of isoniazid and ethionamide resistance poorly reflect those in vivo in Mycobacterium tuberculosis. doi:10.1016/j.tube.2016.09.028 Tuberculosis (Edinb) 2016
Role of real-time PCR for detection of tuberculosis and drug resistance directly from clinical samples. doi:10.1016/j.ijtb.2016.08.002 Indian J Tuberc 2016
Discovery of cofactor-specific, bactericidal Mycobacterium tuberculosis InhA inhibitors using DNA-encoded library technology. doi:10.1073/pnas.1610978113 Proc Natl Acad Sci U S A 2016
Drug-resistant tuberculosis among previously treated patients in Yangon, Myanmar. doi:10.1016/j.ijmyco.2016.06.004 Int J Mycobacteriol 2016
Performance of the GenoType MTBDRplus assay (v2.0) and a new extended GenoType MTBDRsl assay (v2.0) for the molecular detection of multi- and extensively drug-resistant Mycobacterium tuberculosis on isolates primarily from Lithuania. doi:10.1016/j.diagmicrobio.2016.08.026 Diagn Microbiol Infect Dis 2016
Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis. doi:10.1002/ardp.201600186 Arch Pharm (Weinheim) 2016
Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. doi:10.1186/s12879-016-1906-3 BMC Infect Dis 2016
Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. doi:10.1016/j.meegid.2016.09.004 Infect Genet Evol 2016
The genotypic study of Mycobacterium tuberculosis complex resistant to isoniazid: Galicia, Spain (2008-2013). doi:10.1007/s10096-016-2730-9 Eur J Clin Microbiol Infect Dis 2016
Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activation. doi:10.15407/ubj88.05.071 names it Ukr Biochem J 2016
Corrigendum to "katG Ser315 and rpoB 81-bp hotspot region substitutions: Reliability for detection of drug-resistant strains of Mycobacterium tuberculosis" [J. Global Antimicrob. Resist. 5 (2016) 92-93]. doi:10.1016/j.jgar.2016.06.001 names it J Glob Antimicrob Resist 2016
Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. doi:10.1016/j.tube.2016.06.002 names it Tuberculosis (Edinb) 2016
Genotypic Detection of rpoB and katG Gene Mutations Associated with Rifampicin and Isoniazid Resistance in Mycobacterium Tuberculosis Isolates: A Local Scenario (Kelantan). names it Malays J Med Sci 2016
Evaluation of MTBDRplus and MTBDRsl in Detecting Drug-Resistant Tuberculosis in a Chinese Population. doi:10.1155/2016/2064765 Dis Markers 2016
Isoniazid minimal inhibitory concentrations of tuberculosis strains with katG mutation. doi:10.5588/ijtld.16.0148 names it Int J Tuberc Lung Dis 2016
Genotypic characterization of drug resistant Mycobacterium tuberculosis in Quebec, 2002-2012. doi:10.1186/s12866-016-0786-4 BMC Microbiol 2016
Detection and characterization of drug-resistant conferring genes in Mycobacterium tuberculosis complex strains: A prospective study in two distant regions of Ghana. doi:10.1016/j.tube.2016.05.014 Tuberculosis (Edinb) 2016
Rapid Screening of MDR-TB in Cases of Extra Pulmonary Tuberculosis Using Geno Type MTBDRplus. doi:10.1371/journal.pone.0159651 PLoS One 2016
First Evaluation of GenoType MTBDRplus 2.0 Performed Directly on Respiratory Specimens in Central America. doi:10.1128/JCM.01196-16 J Clin Microbiol 2016
katG Ser315 and rpoB 81-bp hotspot region substitutions: Reliability for detection of drug-resistant strains of Mycobacterium tuberculosis. doi:10.1016/j.jgar.2015.12.001 names it J Glob Antimicrob Resist 2016
Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor. doi:10.1016/j.ebiom.2016.05.006 EBioMedicine 2016
Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis. doi:10.5588/ijtld.15.0864 names it Int J Tuberc Lung Dis 2016
σ(E) -dependent activation of RbpA controls transcription of the furA-katG operon in response to oxidative stress in mycobacteria. doi:10.1111/mmi.13449 names it Mol Microbiol 2016
Early detection of multidrug resistant (MDR) Mycobacterium tuberculosis in a single tube with in-house designed fluorescence resonance energy transfer (FRET) probes using real-time PCR. Indian J Exp Biol 2016
Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India. doi:10.5588/ijtld.15.0874 Int J Tuberc Lung Dis 2016
High-resolution melting analysis for molecular detection of multidrug resistance tuberculosis in Peruvian isolates. doi:10.1186/s12879-016-1615-y BMC Infect Dis 2016
Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia. doi:10.1016/j.ijmyco.2016.02.009 Int J Mycobacteriol 2016
Isoniazid-induced control of Mycobacterium tuberculosis by primary human cells requires interleukin-1 receptor and tumor necrosis factor. doi:10.1002/eji.201646349 Eur J Immunol 2016
Multi-Fluorescence Real-Time PCR Assay for Detection of RIF and INH Resistance of M. tuberculosis. doi:10.3389/fmicb.2016.00618 Front Microbiol 2016
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012. doi:10.1186/s12866-016-0699-2 BMC Microbiol 2016
Clinical Features and Drug-Resistance Profile of Urinary Tuberculosis in South-Western China: A Cross-sectional Study. doi:10.1097/MD.0000000000003537 Medicine (Baltimore) 2016
Rapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis using TaqMan Allelic Discrimination. doi:10.1016/j.phrp.2016.01.003 Osong Public Health Res Perspect 2016
Longitudinal whole genome analysis of pre and post drug treatment Mycobacterium tuberculosis isolates reveals progressive steps to drug resistance. doi:10.1016/j.tube.2016.02.004 Tuberculosis (Edinb) 2016
High rate of drug resistance among tuberculous meningitis cases in Shaanxi province, China. doi:10.1038/srep25251 Sci Rep 2016
Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape. doi:10.1128/AAC.00222-16 Antimicrob Agents Chemother 2016
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance. doi:10.1186/s12916-016-0575-9 BMC Med 2016
Proficient Detection of Multi-Drug-Resistant Mycobacterium tuberculosis by Padlock Probes and Lateral Flow Nucleic Acid Biosensors. doi:10.1021/acs.analchem.5b04312 Anal Chem 2016
N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity. doi:10.1002/cmdc.201600020 ChemMedChem 2016
Simultaneous drug resistance detection and genotyping of Mycobacterium tuberculosis using a low-density hydrogel microarray. doi:10.1093/jac/dkw015 J Antimicrob Chemother 2016
Comparing isogenic strains of Beijing genotype Mycobacterium tuberculosis after acquisition of Isoniazid resistance: A proteomics approach. doi:10.1002/pmic.201500403 Proteomics 2016
Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda. doi:10.1016/j.meegid.2016.02.019 Infect Genet Evol 2016
Detection of multidrug-resistant Mycobacterium tuberculosis strains isolated in Brazil using a multimarker genetic assay for katG and rpoB genes. doi:10.1016/j.bjid.2015.12.008 names it Braz J Infect Dis 2016
Metabolism of isoniazid by neutrophil myeloperoxidase leads to isoniazid-NAD(+) adduct formation: A comparison of the reactivity of isoniazid with its known human metabolites. doi:10.1016/j.bcp.2016.02.003 Biochem Pharmacol 2016
Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis. doi:10.1128/JCM.03341-15 J Clin Microbiol 2016
Whole genome analysis of an MDR Beijing/W strain of Mycobacterium tuberculosis with large genomic deletions associated with resistance to isoniazid. doi:10.1016/j.gene.2016.02.003 Gene 2016
A molecular platform for the diagnosis of multidrug-resistant and pre-extensively drug-resistant tuberculosis based on single nucleotide polymorphism mutations present in Colombian isolates of Mycobacterium tuberculosis. doi:10.1590/0074-02760150306 Mem Inst Oswaldo Cruz 2016
A Snapshot of Drug-Resistant M. tuberculosis Strains in Croatia. doi:10.1007/5584_2015_5019 Adv Exp Med Biol 2016
Genotypic characterization of multi-drug-resistant Mycobacterium tuberculosis isolates in Myanmar. doi:10.1016/j.jiac.2015.12.009 J Infect Chemother 2016
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement. doi:10.5588/ijtld.15.0221 Int J Tuberc Lung Dis 2016
Outbreak of isoniazid-resistant tuberculosis in an immigrant community in Spain. doi:10.1016/j.arbres.2015.07.014 Arch Bronconeumol 2016
Genotypic assessment of drug-resistant tuberculosis in Baghdad and other Iraqi provinces using low-cost and low-density DNA microarrays. doi:10.1099/jmm.0.000203 J Med Microbiol 2016
Prevalence of mutations conferring resistance among multi- and extensively drug-resistant Mycobacterium tuberculosis isolates in China. doi:10.1038/ja.2015.106 J Antibiot (Tokyo) 2016
Fitness Costs of Drug Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis: A Household-Based Case-Control Study. doi:10.1093/infdis/jiv347 J Infect Dis 2016
Pyrosequencing for rapid detection of tuberculosis resistance to Rifampicin and Isoniazid in Syrian and Lebanese clinical isolates. doi:10.1016/j.ijmyco.2015.05.007 Int J Mycobacteriol 2015
The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae. doi:10.1016/j.ijmyco.2015.05.001 Int J Mycobacteriol 2015
[GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis]. doi:10.7705/biomedica.v35i4.2813 Biomedica 2015
Genome sequence comparisons of serial multi-drug-resistant Mycobacterium tuberculosis isolates over 21 years of infection in a single patient. doi:10.1099/mgen.0.000037 Microb Genom 2015
The concordance between phenotypic and genotypic M. tuberculosis drug susceptibility tests results: observational study. Pneumologia 2015
Detecting mutation pattern of drug-resistant Mycobacterium tuberculosis isolates in Himachal Pradesh using GenoType(®) MTBDRplus assay. doi:10.4103/0255-0857.167336 Indian J Med Microbiol 2015
Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal. doi:10.1371/journal.pmed.1001880 PLoS Med 2015
Multidrug-Resistant Mycobacterium tuberculosis of the Latin American Mediterranean Lineage, Wrongly Identified as Mycobacterium pinnipedii (Spoligotype International Type 863 [SIT863]), Causing Active Tuberculosis in South Brazil. doi:10.1128/JCM.02012-15 J Clin Microbiol 2015
Mycobacterium tuberculosis Is Resistant to Isoniazid at a Slow Growth Rate by Single Nucleotide Polymorphisms in katG Codon Ser315. doi:10.1371/journal.pone.0138253 names it PLoS One 2015
Functional Characterization of Sirtuin-like Protein in Mycobacterium smegmatis. doi:10.1021/acs.jproteome.5b00359 J Proteome Res 2015
Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates. doi:10.1128/AAC.01028-15 Antimicrob Agents Chemother 2015
Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay. doi:10.1371/journal.pone.0137791 PLoS One 2015
High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. doi:10.1371/journal.pone.0135003 PLoS One 2015
Evaluation of efflux pump gene expression among drug susceptible and drug resistant strains of Mycobacterium tuberculosis from Iran. doi:10.1016/j.meegid.2015.08.036 Infect Genet Evol 2015
Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates. doi:10.1093/jac/dkv253 J Antimicrob Chemother 2015
Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates. doi:10.1038/emi.2015.42 names it Emerg Microbes Infect 2015
Distinct Responses of Mycobacterium smegmatis to Exposure to Low and High Levels of Hydrogen Peroxide. doi:10.1371/journal.pone.0134595 PLoS One 2015
Phenotypic and genotypic analysis of anti-tuberculosis drug resistance in Mycobacterium tuberculosis isolates in Myanmar. doi:10.3343/alm.2015.35.5.494 Ann Lab Med 2015
Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City. doi:10.1128/AAC.00764-15 Antimicrob Agents Chemother 2015
Prevalence and risk factors of drug-resistant tuberculosis in border provinces of Iran. doi:10.1080/00325481.2015.1069168 Postgrad Med 2015
Evaluation of GenoType MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana. doi:10.5588/ijtld.14.0864 Int J Tuberc Lung Dis 2015
Characterization of a Clone of Mycobacterium tuberculosis Clinical Isolates with Mutations in KatG (A110V), EthA (Q269STOP), and the inhA Promoter (-15C→T). doi:10.1128/JCM.01537-15 names it J Clin Microbiol 2015
Discrepancies in Drug Susceptibility Test for Tuberculosis Patients Resulted from the Mixed Infection and the Testing System. doi:10.1155/2015/651980 Biomed Res Int 2015
Sequence Analysis of lip R: A Good Method for Molecular Epidemiology of Clinical Isolates of Mycobacterium tuberculosis. doi:10.1007/s00284-015-0856-0 Curr Microbiol 2015
Molecular drug susceptibility testing in the Netherlands: performance of the MTBDRplus and MTBDRsl assays. doi:10.5588/ijtld.15.0043 Int J Tuberc Lung Dis 2015
Density Functional Theory Insights into the Role of the Methionine-Tyrosine-Tryptophan Adduct Radical in the KatG Catalase Reaction: O2 Release from the Oxyheme Intermediate. doi:10.1021/jp511358p names it J Phys Chem A 2015
Development of a Mycobacterium smegmatis transposon mutant array for characterising the mechanism of action of tuberculosis drugs: Findings with isoniazid and its structural analogues. doi:10.1016/j.tube.2015.03.012 Tuberculosis (Edinb) 2015
Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant. doi:10.4103/0971-5916.154492 Indian J Med Res 2015
Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid Among Clinical Mycobacteria Isolates in Ilorin, Nigeria. doi:10.2174/1570162x13666150407143147 Curr HIV Res 2015
Genetic diversity of the Mycobacterium tuberculosis Beijing family in Brazil and Mozambique and relation with infectivity and induction of necrosis in THP-1 cells. doi:10.1016/j.tube.2015.02.025 Tuberculosis (Edinb) 2015
Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations. doi:10.1016/j.diagmicrobio.2015.01.009 Diagn Microbiol Infect Dis 2015
Detection of novel and reported mutations in the rpoB, katG and inhA genes in multidrug-resistant tuberculosis isolates: A hospital-based study. doi:10.1016/j.jgar.2014.10.002 names it J Glob Antimicrob Resist 2015
Prognostic significance of novel katG mutations in Mycobacterium tuberculosis. doi:10.1016/j.ijmyco.2014.11.043 names it Int J Mycobacteriol 2015
Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan. doi:10.1371/journal.pone.0117771 PLoS One 2015
Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes. doi:10.1128/mBio.02273-14 mBio 2015
Investigation of Ser315 substitutions within katG gene in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from south India. doi:10.1155/2015/257983 names it Biomed Res Int 2015
Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates. doi:10.1371/journal.pone.0119013 PLoS One 2015
Quantitative proteomics reveals novel insights into isoniazid susceptibility in mycobacteria mediated by a universal stress protein. doi:10.1021/pr5011058 J Proteome Res 2015
Early detection of multi-drug resistance and common mutations in Mycobacterium tuberculosis isolates from Delhi using GenoType MTBDRplus assay. doi:10.4103/0255-0857.150879 Indian J Med Microbiol 2015
A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA. doi:10.1021/ci500672v J Chem Inf Model 2015
Molecular details of INH-C10 binding to wt KatG and Its S315T mutant. doi:10.1021/mp500736n names it Mol Pharm 2015
Evaluation of point mutation detection in Mycobacterium tuberculosis with isoniazid resistance using real-time PCR and TaqMan probe assay. doi:10.1007/s12010-014-1442-9 Appl Biochem Biotechnol 2015
Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China. doi:10.1016/j.jinf.2014.11.008 J Infect 2015
Crystal structure of the catalase-peroxidase KatG W78F mutant from Synechococcus elongatus PCC7942 in complex with the antitubercular pro-drug isoniazid. doi:10.1016/j.febslet.2014.11.037 names it FEBS Lett 2015
Molecular characterisation of extensively drug-resistant Mycobacterium tuberculosis isolates in China. doi:10.1016/j.ijantimicag.2014.09.018 Int J Antimicrob Agents 2015
Evolution and transmission patterns of extensively drug-resistant tuberculosis in China. doi:10.1128/AAC.03504-14 Antimicrob Agents Chemother 2015
Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries. doi:10.1128/AAC.03614-14 Antimicrob Agents Chemother 2015
Automated liquid culture system misses isoniazid heteroresistance in Mycobacterium tuberculosis isolates with mutations in the promoter region of the inhA gene. doi:10.1007/s10096-014-2262-0 Eur J Clin Microbiol Infect Dis 2015
The crystal structure of isoniazid-bound KatG catalase-peroxidase from Synechococcus elongatus PCC7942. doi:10.1111/febs.13102 names it FEBS J 2015
A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland. doi:10.1007/s10096-014-2202-z Eur J Clin Microbiol Infect Dis 2015
Characterization of phenotypic and genotypic drug resistance patterns of Mycobacterium tuberculosis isolates from a city in Mexico. doi:10.1016/j.eimc.2014.04.005 Enferm Infecc Microbiol Clin 2015
Comparison of three molecular assays for the detection of rifampin resistance in Mycobacterium tuberculosis. doi:10.1002/jcla.21742 J Clin Lab Anal 2015
The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan. doi:10.1016/j.jmii.2013.08.018 names it J Microbiol Immunol Infect 2015
Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug. doi:10.1016/j.ijmyco.2014.08.003 Int J Mycobacteriol 2014
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities. doi:10.1128/microbiolspec.MGM2-0014-2013 Microbiol Spectr 2014
[Analysis of genetic determinants of multidrug and extensively drug-resistant Mycobacterium tuberculosis using oligonucleotide microchip]. Mol Biol (Mosk) 2014
Application of Deletion- Targeted Multiplex PCR technique for detection of Mycobacterium tuberculosis Beijing strains in samples from tuberculosis patients. Iran J Microbiol 2014
Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from North- Eastern States of India using GenoType MTBDRplus assay. Indian J Med Res 2014
[Conventional and molecular diagnosis in a group of patients with drug-resistant tuberculosis]. Pneumologia 2014
Isoniazid in autoimmunity: a trigger for multiple sclerosis? doi:10.1177/1756285614540361 Ther Adv Neurol Disord 2014
Rapid screening of rpoB and katG mutations in Mycobacterium tuberculosis isolates by high-resolution melting curve analysis. doi:10.4103/0255-0857.142245 names it Indian J Med Microbiol 2014
Impact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosis. doi:10.1016/j.tube.2014.08.011 Tuberculosis (Edinb) 2014
Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test. doi:10.1038/ncomms5989 Nat Commun 2014
Assessment of the genotype MTBDRplus assay for rifampin and isoniazid resistance detection on sputum samples in Cote d'Ivoire. doi:10.1556/EUJMI-D-14-00014 Eur J Microbiol Immunol (Bp) 2014
Isoniazid and rifampicin resistance mutations and their effect on second-line anti-tuberculosis treatment. doi:10.5588/ijtld.13.0926 Int J Tuberc Lung Dis 2014
[Fe(CN)5(isoniazid)](3-): an iron isoniazid complex with redox behavior implicated in tuberculosis therapy. doi:10.1016/j.jinorgbio.2014.08.002 J Inorg Biochem 2014
Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia. doi:10.1186/1471-2334-14-478 BMC Infect Dis 2014
Rapid detection of MDR-Mycobacterium tuberculosis using modified PCR-SSCP from clinical Specimens. doi:10.12980/APJTB.4.2014C1186 Asian Pac J Trop Biomed 2014
Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis. doi:10.4103/0377-4929.138738 Indian J Pathol Microbiol 2014
Multidrug resistant Mycobacterium tuberculosis: a retrospective katG and rpoB mutation profile analysis in isolates from a reference center in Brazil. doi:10.1371/journal.pone.0104100 names it PLoS One 2014
An upstream truncation of the furA-katG operon confers high-level isoniazid resistance in a Mycobacterium tuberculosis clinical isolate with no known resistance-associated mutations. doi:10.1128/AAC.03277-14 names it Antimicrob Agents Chemother 2014
Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS. doi:10.1371/journal.pone.0103811 PLoS One 2014
Specific amplification of gene encoding N-terminal region of catalase-peroxidase protein (KatG-N) for diagnosis of disseminated MAC disease in HIV patients. doi:10.1016/j.diagmicrobio.2014.06.014 names it Diagn Microbiol Infect Dis 2014
Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China. doi:10.1111/tmi.12359 Trop Med Int Health 2014
Detecting novel genetic variants associated with isoniazid-resistant Mycobacterium tuberculosis. doi:10.1371/journal.pone.0102383 PLoS One 2014
Occurrence of diverse mutations in isoniazid- and rifampicin-resistant Mycobacterium tuberculosis isolates from autochthonous and immigrant populations of Saudi Arabia. doi:10.1089/mdr.2014.0065 Microb Drug Resist 2014
Association of MDR-TB isolates with clinical characteristics of patients from Northern region of India. doi:10.4103/0255-0857.136561 Indian J Med Microbiol 2014
Exquisite allele discrimination by toehold hairpin primers. doi:10.1093/nar/gku558 Nucleic Acids Res 2014
Higher levels of interleukin IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Löfgren's syndrome. doi:10.1111/cei.12403 Clin Exp Immunol 2014
Molecular approaches for detection of the multi-drug resistant tuberculosis (MDR-TB) in Bangladesh. doi:10.1371/journal.pone.0099810 PLoS One 2014
Sequence analysis for detection of drug resistance in Mycobacterium tuberculosis complex isolates from the Central Region of Cameroon. doi:10.1186/1471-2180-14-113 BMC Microbiol 2014
Detection of mutations in the katG gene among isoniazid-resistant Mycobacterium tuberculosis isolates from Lebanon and Syria. doi:10.1016/j.jgar.2014.01.001 names it J Glob Antimicrob Resist 2014
Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates. doi:10.1093/jac/dku161 J Antimicrob Chemother 2014
Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity. doi:10.1016/j.ejmech.2014.04.077 Eur J Med Chem 2014
In house reverse membrane hybridisation assay versus GenoType MTBDRplus and their performance to detect mutations in the genes rpoB, katG and inhA. doi:10.1590/0074-0276130469 names it Mem Inst Oswaldo Cruz 2014
Usefulness of Genotype MTBDRplus assay in acid-fast bacilli positive smear specimens in Almeria, Spain. doi:10.1016/j.eimc.2014.02.017 Enferm Infecc Microbiol Clin 2014
First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA. doi:10.1371/journal.pone.0095083 PLoS One 2014
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China. doi:10.1128/AAC.02426-14 Antimicrob Agents Chemother 2014
MUBII-TB-DB: a database of mutations associated with antibiotic resistance in Mycobacterium tuberculosis. doi:10.1186/1471-2105-15-107 BMC Bioinformatics 2014
Pyrosequencing for rapid detection of tuberculosis resistance in clinical isolates and sputum samples from re-treatment pulmonary tuberculosis patients. doi:10.1186/1471-2334-14-200 BMC Infect Dis 2014
Simplified microarray system for simultaneously detecting rifampin, isoniazid, ethambutol, and streptomycin resistance markers in Mycobacterium tuberculosis. doi:10.1128/JCM.00238-14 J Clin Microbiol 2014
Analysis of mutational characteristics of the drug-resistant gene katG in multi-drug resistant Mycobacterium tuberculosis L-form among patients with pneumoconiosis complicated with tuberculosis. doi:10.3892/mmr.2014.2045 names it Mol Med Rep 2014
Rapid detection of isoniazid resistance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis. doi:10.1128/JCM.03395-13 J Clin Microbiol 2014
Use of rapid molecular test for multidrug-resistant tuberculosis detection among relapse cases in Cote d'Ivoire. doi:10.1016/j.ijmyco.2013.11.003 Int J Mycobacteriol 2014
Deciphering the sequential events during in vivo acquisition of drug resistance in Mycobacterium tuberculosis. doi:10.1016/j.ijmyco.2013.10.006 Int J Mycobacteriol 2014
Evidence of Clonal Expansion in the Genome of a Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolate from Peru. doi:10.1128/genomeA.00089-14 Genome Announc 2014
Single nucleotide polymorphism (SNP) analysis used for the phylogeny of the Mycobacterium tuberculosis complex based on a pyrosequencing assay. doi:10.1186/1471-2180-14-21 BMC Microbiol 2014
An altered Mycobacterium tuberculosis metabolome induced by katG mutations resulting in isoniazid resistance. doi:10.1128/AAC.02344-13 names it Antimicrob Agents Chemother 2014
Gold nanoprobes for multi loci assessment of multi-drug resistant tuberculosis. doi:10.1016/j.tube.2013.12.009 Tuberculosis (Edinb) 2014
Encoded library technology as a source of hits for the discovery and lead optimization of a potent and selective class of bactericidal direct inhibitors of Mycobacterium tuberculosis InhA. doi:10.1021/jm401326j J Med Chem 2014
A rapid fluorescence polarization-based method for genotypic detection of drug resistance in Mycobacterium tuberculosis. doi:10.1007/s00253-013-5356-1 Appl Microbiol Biotechnol 2014
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China. doi:10.1128/AAC.01792-13 Antimicrob Agents Chemother 2014
Molecular assessment, drug-resistant profile, and spacer oligonucleotide typing (spoligotyping) of Mycobacterium tuberculosis strains from Tamaulipas, México. doi:10.1002/jcla.21650 J Clin Lab Anal 2014
Rapid Detection of Rifampicin and Isoniazid Resistant Mycobacterium tuberculosis Using Genotype MTBDRplus Assay in Nepal. doi:10.1155/2014/648294 Int Sch Res Notices 2014
Rapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array. doi:10.1111/1469-0691.12517 Clin Microbiol Infect 2014
A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis. doi:10.1111/mmi.12476 Mol Microbiol 2014
Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations. doi:10.1128/JCM.02701-13 J Clin Microbiol 2014
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China. doi:10.1038/ja.2013.133 J Antibiot (Tokyo) 2014
Molecular characteristics of MDR Mycobacterium tuberculosis strains isolated in Fujian, China. doi:10.1016/j.tube.2013.03.004 Tuberculosis (Edinb) 2014
Catalase in peroxidase clothing: Interdependent cooperation of two cofactors in the catalytic versatility of KatG. doi:10.1016/j.abb.2013.11.007 names it Arch Biochem Biophys 2014
QSAR based design of new antitubercular compounds: improved isoniazid derivatives against multidrug-resistant TB. doi:10.2174/1381612819666131118164434 Curr Pharm Des 2014
Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. doi:10.2174/1381612819666131118203915 Curr Pharm Des 2014
High degree of multi-drug resistance and hetero-resistance in pulmonary TB patients from Punjab state of India. doi:10.1016/j.tube.2013.10.001 Tuberculosis (Edinb) 2014
Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis. doi:10.1111/1469-0691.12415 Clin Microbiol Infect 2014
Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis. doi:10.1093/jac/dkt358 J Antimicrob Chemother 2014
The thioredoxin antioxidant system. doi:10.1016/j.freeradbiomed.2013.07.036 Free Radic Biol Med 2014
Geographical differences associated with single-nucleotide polymorphisms (SNPs) in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis. doi:10.1128/JCM.00857-13 J Clin Microbiol 2014
Molecular patterns of multidrug resistance of Mycobacterium tuberculosis in Georgia. doi:10.1016/j.ijmyco.2013.02.002 Int J Mycobacteriol 2013
Direct sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in Morocco. doi:10.2147/IDR.S47724 Infect Drug Resist 2013
[Molecular genetic analysis of the isoniazid-resistant strains of M. tuberculosis circulating over the Saratov region]. Mol Gen Mikrobiol Virusol 2013
Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam. doi:10.1186/1756-0500-6-444 BMC Res Notes 2013
Access channel residues Ser315 and Asp137 in Mycobacterium tuberculosis catalase-peroxidase (KatG) control peroxidatic activation of the pro-drug isoniazid. doi:10.1039/c3cc47022a names it Chem Commun (Camb) 2013
Evaluation of rezasurin microtiter assay and high resolution melting curve analysis for detection of rifampicin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates. doi:10.7754/clin.lab.2012.120618 Clin Lab 2013
Mutation in katG315 is, possibly, a good prognostic marker for treatment with second-line drugs in multi-drug resistant tuberculosis: a preliminary study. doi:10.4103/0255-0857.118899 Indian J Med Microbiol 2013
Evaluation of GenoType® MTBDRplus assay for rapid detection of drug susceptibility testing of multi-drug resistance tuberculosis in Northern India. doi:10.4103/0377-4929.118681 Indian J Pathol Microbiol 2013
Primary multidrug-resistant Mycobacterium tuberculosis in 2 regions, Eastern Siberia, Russian Federation. doi:10.3201/eid1910.121108 Emerg Infect Dis 2013
Magnitude of gene mutations conferring drug resistance in mycobacterium tuberculosis isolates from lymph node aspirates in ethiopia. doi:10.7150/ijms.6806 Int J Med Sci 2013
Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India. doi:10.1371/journal.pone.0072036 PLoS One 2013
Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania. doi:10.1186/1471-2334-13-432 BMC Infect Dis 2013
A simple, rapid and economic method for detecting multidrug-resistant tuberculosis. doi:10.1016/j.bjid.2013.04.008 Braz J Infect Dis 2013
Exploration of freely available web-interfaces for comparative homology modelling of microbial proteins. doi:10.6026/97320630009796 Bioinformation 2013
Tuberculosis-spoligo-rifampin-isoniazid typing: an all-in-one assay technique for surveillance and control of multidrug-resistant tuberculosis on Luminex devices. doi:10.1128/JCM.01523-13 J Clin Microbiol 2013
Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N. doi:10.1371/journal.pone.0069762 PLoS One 2013
Multidrug-resistant tuberculosis in panama is driven by clonal expansion of a multidrug-resistant Mycobacterium tuberculosis strain related to the KZN extensively drug-resistant M. tuberculosis strain from South Africa. doi:10.1128/JCM.01122-13 J Clin Microbiol 2013
Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India. doi:10.4103/0255-0857.115625 Indian J Med Microbiol 2013
Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs. doi:10.5588/ijtld.12.0949 Int J Tuberc Lung Dis 2013
[Comparing performance of "TB-BIOCHIP", "Xpert MTB/RIF" and "genotype MTBDRplus" assays for fast identification of mutations in the Mycobacterium tuberculosis complex in sputum from TB patients]. doi:10.7868/s0026898413010102 Mol Biol (Mosk) 2013
High resolution melting curve assay for rapid detection of drug-resistant Mycobacterium tuberculosis. doi:10.1007/s10156-013-0636-3 J Infect Chemother 2013
Drug-resistant tuberculous meningitis. doi:10.1586/eri.13.39 Expert Rev Anti Infect Ther 2013
Identification and analysis of mutations in the katG gene in multidrug-resistant Mycobacterium tuberculosis clinical isolates. names it Pneumonol Alergol Pol 2013
Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes. doi:10.1128/AAC.00077-13 Antimicrob Agents Chemother 2013
Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia. doi:10.1128/JCM.00429-13 J Clin Microbiol 2013
Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. doi:10.3201//EID1903.120246 Emerg Infect Dis 2013
Fitness of acquired drug resistant Mycobacterium tuberculosis isolates from DOTS compliant patients. doi:10.1016/j.tube.2013.03.006 Tuberculosis (Edinb) 2013
Isoniazid: Radical-induced oxidation and reduction chemistry. doi:10.1016/j.bmcl.2013.03.006 Bioorg Med Chem Lett 2013
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. doi:10.1016/j.diagmicrobio.2013.02.035 Diagn Microbiol Infect Dis 2013
High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations. doi:10.1093/jac/dkt090 J Antimicrob Chemother 2013
Digital PCR to detect and quantify heteroresistance in drug resistant Mycobacterium tuberculosis. doi:10.1371/journal.pone.0057238 PLoS One 2013
Performance of the GenoType MTBDRplus assay directly on sputum specimens from Brazilian patients with tuberculosis treatment failure or relapse. doi:10.1128/JCM.00364-13 J Clin Microbiol 2013
Can mycobacterial katG genetic changes in isoniazid-resistant tuberculosis influence human disease features? doi:10.5588/ijtld.12.0380 names it Int J Tuberc Lung Dis 2013
Evidence for diversifying selection in a set of Mycobacterium tuberculosis genes in response to antibiotic- and nonantibiotic-related pressure. doi:10.1093/molbev/mst038 Mol Biol Evol 2013
Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis? doi:10.1128/JCM.00472-13 J Clin Microbiol 2013
Rapid genotypic detection of rpoB and katG gene mutations in Mycobacterium tuberculosis clinical isolates from Northern India as determined by MAS-PCR. doi:10.1002/jcla.21558 names it J Clin Lab Anal 2013
Molecular characterisation of drug resistance in Mycobacterium tuberculosis isolates from North India. doi:10.5588/ijtld.12.0319 Int J Tuberc Lung Dis 2013
Dynamic persistence of antibiotic-stressed mycobacteria. doi:10.1126/science.1229858 Science 2013
Biological cost in Mycobacterium tuberculosis with mutations in the rpsL, rrs, rpoB, and katG genes. doi:10.1016/j.tube.2012.11.004 names it Tuberculosis (Edinb) 2013
Metabolic adaptation of Mycobacterium avium subsp. paratuberculosis to the gut environment. doi:10.1099/mic.0.062737-0 Microbiology (Reading) 2013
Characterization of extensively drug-resistant Mycobacterium tuberculosis in Nepal. doi:10.1016/j.tube.2012.10.007 Tuberculosis (Edinb) 2013
Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan. J Pak Med Assoc 2012
[Detection of S315T mutation in the katg gene as a strategy for identification of isoniazid-resistant Mycobacterium tuberculosis in a reference laboratory]. doi:10.4067/S0716-10182012000700004 names it Rev Chilena Infectol 2012
Phenotypic and genotypic characteristics of drug resistance in Mycobacterium tuberculosis isolates from pediatric population of Chennai, India. doi:10.4103/0255-0857.103761 Indian J Med Microbiol 2012
Fast test for assessing the susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by real-time PCR. doi:10.1590/s0074-02762012000700011 Mem Inst Oswaldo Cruz 2012
Detection of multidrug-resistant Mycobacterium tuberculosis directly from sputum samples of patients from Jakarta, Indonesia by radioisotope-based PCR-dot blot hybridization. Southeast Asian J Trop Med Public Health 2012
Heterogeneity of Mycobacterium tuberculosis strains in Makassar, Indonesia. doi:10.5588/ijtld.12.0055 Int J Tuberc Lung Dis 2012
Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains. doi:10.1128/JCM.01893-12 J Clin Microbiol 2012
Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea. doi:10.1186/1471-2180-12-191 BMC Microbiol 2012
Drug resistance-related mutations in multidrug-resistant Mycobacterium tuberculosis isolates from diverse geographical regions. doi:10.1016/j.ijmyco.2012.08.001 Int J Mycobacteriol 2012
Specific function of the Met-Tyr-Trp adduct radical and residues Arg-418 and Asp-137 in the atypical catalase reaction of catalase-peroxidase KatG. doi:10.1074/jbc.M112.401208 names it J Biol Chem 2012
Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh. doi:10.1016/j.tube.2012.07.005 Tuberculosis (Edinb) 2012
Molecular detection and drug resistance of Mycobacterium tuberculosis complex from cattle at a dairy farm in the Nkonkobe region of South Africa: a pilot study. doi:10.3390/ijerph9062045 Int J Environ Res Public Health 2012
Use of multiplex allele-specific polymerase chain reaction (MAS-PCR) to detect multidrug-resistant tuberculosis in Panama. doi:10.1371/journal.pone.0040456 PLoS One 2012
Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations. doi:10.1039/c2ob25602a Org Biomol Chem 2012
Rapid detection of rifampicin, isoniazid and streptomycin resistance in Mycobacterium tuberculosis clinical isolates by high-resolution melting curve analysis. doi:10.1111/j.1365-2672.2012.05379.x J Appl Microbiol 2012
Rare case of multi-drug resistant endometrial tuberculosis unveiled by DNA signature studies of the rpoB, katG and inhA genes. doi:10.1016/j.ejogrb.2012.05.009 names it Eur J Obstet Gynecol Reprod Biol 2012
[Characterization of oligonucleotides with LNA-monomers for PCR detection of point mutations in mycobacteria tuberculosis genome]. doi:10.18097/pbmc20125802199 Biomed Khim 2012
Characterization of mutations causing rifampicin and isoniazid resistance of Mycobacterium tuberculosis in Syria. Pol J Microbiol 2012
Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis. doi:10.1371/journal.pone.0037956 PLoS One 2012
A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria. doi:10.1074/jbc.M111.333385 J Biol Chem 2012
Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting. doi:10.1186/1471-2180-12-90 BMC Microbiol 2012
Redox biology of tuberculosis pathogenesis. doi:10.1016/B978-0-12-398264-3.00004-8 Adv Microb Physiol 2012
Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China. doi:10.1128/JCM.06860-11 J Clin Microbiol 2012
[DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico]. doi:10.1590/s0036-36342012000200013 Salud Publica Mex 2012
Low rates of synonymous mutations in sequences of Mycobacterium tuberculosis GyrA and KatG genes. doi:10.1016/j.tube.2012.03.004 names it Tuberculosis (Edinb) 2012
The GenoType® MTBDRplus assay for detection of drug resistance in Mycobacterium tuberculosis in Sweden. doi:10.1111/j.1600-0463.2011.02845.x APMIS 2012
Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates in Uruguay. doi:10.5588/ijtld.11.0559 Int J Tuberc Lung Dis 2012
Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis. doi:10.1371/journal.pone.0034538 PLoS One 2012
Estimating fitness by competition assays between drug susceptible and resistant Mycobacterium tuberculosis of predominant lineages in Mumbai, India. doi:10.1371/journal.pone.0033507 PLoS One 2012
Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.06460-11 Antimicrob Agents Chemother 2012
Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing. doi:10.1128/JCM.06664-11 J Clin Microbiol 2012
Sequencing-based detection of drug-resistant Mycobacterium tuberculosis in patients with spinal tuberculosis. doi:10.1007/s00402-012-1506-7 Arch Orthop Trauma Surg 2012
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal. doi:10.1128/AAC.06418-11 Antimicrob Agents Chemother 2012
Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis. doi:10.1038/ncomms1724 Nat Commun 2012
Ferric haem forms of Mycobacterium tuberculosis catalase-peroxidase probed by EPR spectroscopy: Their stability and interplay with pH. doi:10.1016/j.biochi.2012.02.021 Biochimie 2012
Drug resistance of Mycobacterium tuberculosis strains in southern Brazil. doi:10.1590/s0037-86822012000100018 Rev Soc Bras Med Trop 2012
Detection of genomic mutations in katG, inhA and rpoB genes of Mycobacterium tuberculosis isolates using polymerase chain reaction and multiplex allele-specific polymerase chain reaction. doi:10.1016/s1413-8670(12)70275-1 names it Braz J Infect Dis 2012
Assessing the utility of three TaqMan probes for the diagnosis of tuberculosis and resistance to rifampin and isoniazid in Veracruz, México. doi:10.1139/w11-127 Can J Microbiol 2012
Peripheral blood responses to specific antigens and CD28 in sarcoidosis. doi:10.1016/j.rmed.2012.01.012 Respir Med 2012
Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis. doi:10.1371/journal.pone.0031563 PLoS One 2012
New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia. doi:10.1016/j.meegid.2012.01.024 Infect Genet Evol 2012
Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia. doi:10.1186/1471-2334-12-37 BMC Infect Dis 2012
Evaluation of the GenoType® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection. doi:10.5588/ijtld.11.0269 Int J Tuberc Lung Dis 2012
A riboswitch-based inducible gene expression system for mycobacteria. doi:10.1371/journal.pone.0029266 PLoS One 2012
The mycobacterial LysR-type regulator OxyS responds to oxidative stress and negatively regulates expression of the catalase-peroxidase gene. doi:10.1371/journal.pone.0030186 PLoS One 2012
Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India. doi:10.1186/1471-2334-12-9 BMC Infect Dis 2012
Preliminary remarks on assembly whole genome sequencing of MDR M. tuberculosis isolated in Vietnam. doi:10.3855/jidc.2457 J Infect Dev Ctries 2012
The TDR Tuberculosis Strain Bank: a resource for basic science, tool development and diagnostic services. doi:10.5588/ijtld.11.0223 Int J Tuberc Lung Dis 2012
In vitro anti-mycobacterial activity of (E)-N'-(monosubstituted-benzylidene) isonicotinohydrazide derivatives against isoniazid-resistant strains. doi:10.4081/idr.2012.e13 Infect Dis Rep 2012
Molecular characteristics of rifampin- and isoniazid-resistant mycobacterium tuberculosis strains isolated in Vietnam. doi:10.1128/JCM.05171-11 J Clin Microbiol 2012
Molecular characterization of drug-resistant and -susceptible Mycobacterium tuberculosis isolated from patients with tuberculosis in Korea. doi:10.1016/j.diagmicrobio.2011.09.010 Diagn Microbiol Infect Dis 2012
A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD+ adduct. doi:10.1128/AAC.05486-11 Antimicrob Agents Chemother 2012
Characteristics of multidrug-resistant Mycobacterium tuberculosis in southern Brazil. doi:10.1016/j.tube.2011.09.008 Tuberculosis (Edinb) 2012
Isoniazid metal complex reactivity and insights for a novel anti-tuberculosis drug design. doi:10.1007/s00775-011-0848-x J Biol Inorg Chem 2012
Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex: a molecular dynamics simulation study. doi:10.1007/s00894-011-1200-7 J Mol Model 2012
Study of rifampicin and isoniazid resistance mutation genes of M. tuberculosis isolates in Nepal. Nepal Med Coll J 2011
[Rapid detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis using real-time PCR and melting curve analysis]. Zhonghua Jie He He Hu Xi Za Zhi 2011
[Molecular technologies in detecting sensitive and isoniazid-resistant Mycobacterium tuberculosis]. Tsitol Genet 2011
[Characteristics of Mycobacterium tuberculosis strains circulating in Pskov region]. Zh Mikrobiol Epidemiol Immunobiol 2011
Isoniazid MIC and KatG Gene Mutations among Mycobacterium tuberculosis Isolates in Northwest of Iran. names it Iran J Basic Med Sci 2011
Molecular profile of drug resistance in tuberculous meningitis from southwest china. doi:10.1093/cid/cir663 Clin Infect Dis 2011
Mycobacterium smegmatis RNase J is a 5'-3' exo-/endoribonuclease and both RNase J and RNase E are involved in ribosomal RNA maturation. doi:10.1111/j.1365-2958.2011.07888.x Mol Microbiol 2011
Clinical data and molecular analysis of Mycobacterium tuberculosis isolates from drug-resistant tuberculosis patients in Goiás, Brazil. doi:10.1590/s0074-02762011000600003 Mem Inst Oswaldo Cruz 2011
[Evaluation of GenoType MTBDRplus for the detection of multi-drug-resistant Mycobacterium tuberculosis strains]. Kekkaku 2011
Characterization of mutations conferring extensive drug resistance to Mycobacterium tuberculosis isolates in Pakistan. doi:10.1128/AAC.05101-11 Antimicrob Agents Chemother 2011
[Detection of genes associated with drug resistance in Mycobacterium tuberculosis strains isolated in Chile]. Rev Med Chil 2011
Expression of Mycobacterium tuberculosis ferric uptake regulator A gene in Escherichia coli and generation of monoclonal antibodies to FurA. doi:10.1089/hyb.2011.0017 Hybridoma (Larchmt) 2011
Rapid detection of isoniazid, rifampin, and ofloxacin resistance in Mycobacterium tuberculosis clinical isolates using high-resolution melting analysis. doi:10.1128/JCM.01068-11 J Clin Microbiol 2011
Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa. doi:10.1093/cid/cir406 Clin Infect Dis 2011
Impaired fitness of Mycobacterium tuberculosis resistant isolates in a cell culture model of murine macrophages. doi:10.1093/jac/dkr288 J Antimicrob Chemother 2011
[The cluster and drug-resistant characteristics of Beijing genotype Mycobacterium tuberculosis in eastern rural China]. Zhonghua Jie He He Hu Xi Za Zhi 2011
Multidrug-resistant tuberculosis presenting as a solitary splenic mass in an immunocompetent patient. doi:10.1016/j.diagmicrobio.2011.03.013 Diagn Microbiol Infect Dis 2011
Study of Genetic Evolution in Mycobacterium tuberculosis Isolates from Patients with Active Pulmonary Tuberculosis in the Iran and Belarus. doi:10.2174/1874285801105010032 Open Microbiol J 2011
Rapid Detection of Isoniazid Resistance in Mycobacterium tuberculosis by a Single Multiplex Allele-specific Polymerase Chain Reaction Assay. Cell J 2011
Genotypic and phenotypic characteristics of tunisian isoniazid-resistant Mycobacterium tuberculosis strains. doi:10.1007/s12275-011-0268-1 J Microbiol 2011
Survival of civilian and prisoner drug-sensitive, multi- and extensive drug- resistant tuberculosis cohorts prospectively followed in Russia. doi:10.1371/journal.pone.0020531 PLoS One 2011
Novel inhibitors of InhA efficiently kill Mycobacterium tuberculosis under aerobic and anaerobic conditions. doi:10.1128/AAC.00266-11 Antimicrob Agents Chemother 2011
Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan. Jpn J Infect Dis 2011
[GenoType MTBDRplus assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis in Sichuan]. Nan Fang Yi Ke Da Xue Xue Bao 2011
Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR. doi:10.1099/jmm.0.032292-0 J Med Microbiol 2011
Multiplex allele-specific polymerase chain reaction for detection of isoniazid resistance in Mycobacterium tuberculosis. doi:10.5588/ijtld.10.0599 Int J Tuberc Lung Dis 2011
Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates. doi:10.1111/j.1574-695X.2011.00814.x FEMS Immunol Med Microbiol 2011
High level isoniazid resistance correlates with multiple mutation in the katG encoding catalase proxidase of pulmonary tuberculosis isolates from the frontier localities of Iran. doi:10.5578/tt.761 names it Tuberk Toraks 2011
[Design and realization of a microarray data analysis platform]. Nan Fang Yi Ke Da Xue Xue Bao 2011
Sequence and structural characterization of tbnat gene in isoniazid-resistant Mycobacterium tuberculosis: identification of new mutations. doi:10.1016/j.mrfmmm.2011.03.017 Mutat Res 2011
First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait. doi:10.1186/1756-0500-4-123 BMC Res Notes 2011
Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South-Western Uganda. doi:10.1186/1471-2334-11-81 BMC Infect Dis 2011
Prevalence of mutations at codon 463 of katG gene in MDR and XDR clinical isolates of Mycobacterium tuberculosis in Belarus and application of the method in rapid diagnosis. doi:10.1556/AMicr.58.2011.1.6 names it Acta Microbiol Immunol Hung 2011
GenoType® MTBDRplus compared with conventional drug-susceptibility testing of Mycobacterium tuberculosis in a low-resistance locale. doi:10.2217/fmb.11.8 Future Microbiol 2011
Genetic variation of Mycobacterium tuberculosis circulating in Kharkiv Oblast, Ukraine. doi:10.1186/1471-2334-11-77 BMC Infect Dis 2011
Highest prevalence of the Mycobacterium tuberculosis Beijing genotype isolates in patients newly diagnosed with tuberculosis in the Novosibirsk oblast, Russian Federation. doi:10.1099/jmm.0.027995-0 J Med Microbiol 2011
Rapid detection of multidrug-resistant Mycobacterium tuberculosis by multiplex allele-specific polymerase chain reaction. doi:10.5588/ijtld.10.0397 Int J Tuberc Lung Dis 2011
Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China. doi:10.1089/mdr.2010.0135 Microb Drug Resist 2011
inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa? Int J Tuberc Lung Dis 2011
Detection of novel coupled mutations in the katG gene (His276Met, Gln295His and Ser315Thr) in a multidrug-resistant Mycobacterium tuberculosis strain from Chennai, India, and insight into the molecular mechanism of isoniazid resistance using structural bioinformatics approaches. doi:10.1016/j.ijantimicag.2010.11.023 names it Int J Antimicrob Agents 2011
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. doi:10.1128/AAC.01550-10 Antimicrob Agents Chemother 2011
Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India. doi:10.1128/JCM.00113-11 J Clin Microbiol 2011
Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains. Int J Tuberc Lung Dis 2011
Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis. doi:10.1111/j.1365-2958.2011.07547.x names it Mol Microbiol 2011
katG (SER 315 THR) gene mutation in isoniazid resistant Mycobacterium tuberculosis. doi:10.3126/kumj.v9i1.6256 names it Kathmandu Univ Med J (KUMJ) 2011
Toxicogenomic response of Mycobacterium bovis BCG to peracetic acid and a comparative analysis of the M. bovis BCG response to three oxidative disinfectants. doi:10.1007/s00253-010-2931-6 Appl Microbiol Biotechnol 2011
Direct detection of isoniazid-resistant Mycobacterium tuberculosis in respiratory specimens by multiplex allele-specific polymerase chain reaction. doi:10.1016/j.diagmicrobio.2010.08.021 Diagn Microbiol Infect Dis 2011
Molecular typing of Mycobacterium tuberculosis circulated in Moscow, Russian Federation. doi:10.1007/s10096-010-1067-z Eur J Clin Microbiol Infect Dis 2011
A major subgroup of Beijing family Mycobacterium tuberculosis is associated with multidrug resistance and increased transmissibility. doi:10.1017/S0950268810000890 Epidemiol Infect 2011
Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis. doi:10.1186/1465-9921-11-161 Respir Res 2010
Correction to: M. tuberculosis Central Asian Strain 1 MDR isolates have more mutations in rpoB and katG genes compared with other genotypes. doi:10.3109/00365548.2010.525822 names it Scand J Infect Dis 2010
The management of tuberculosis: epidemiology, resistance and monitoring. Dan Med Bull 2010
[The effects of gene mutation related to drug resistance and drug efflux pump in extensively drug-resistant tuberculosis clinical isolates]. Zhonghua Jie He He Hu Xi Za Zhi 2010
Rifampin-isoniazid oligonucleotide typing: an alternative format for rapid detection of multidrug-resistant Mycobacterium tuberculosis. doi:10.1128/JCM.00448-10 J Clin Microbiol 2010
[Detection of wild type isolates and point mutations in genome of isoniazid-resistant Mycobacteria tuberculosis]. Mol Biol (Mosk) 2010
High-resolution melting curve analysis for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates. doi:10.1128/JCM.00396-10 J Clin Microbiol 2010
Rapid detection of multidrug-resistant Mycobacterium tuberculosis by use of real-time PCR and high-resolution melt analysis. doi:10.1128/JCM.00812-10 J Clin Microbiol 2010
Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007. doi:10.3201/eid1609.100253 Emerg Infect Dis 2010
[Molecular genetic tools for etiologic diagnostics of disseminated lung tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol 2010
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India. doi:10.1128/AAC.00661-10 Antimicrob Agents Chemother 2010
Molecular characterization of drug-resistant Beijing family isolates of Mycobacterium tuberculosis from Tianjin, China. doi:10.1016/S0895-3988(10)60051-7 Biomed Environ Sci 2010
Use of the GenoType(R) MTBDRplus assay to assess drug resistance of Mycobacterium tuberculosis isolates from patients in rural Uganda. doi:10.1186/1472-6890-10-5 BMC Clin Pathol 2010
One-tube loop-mediated isothermal amplification combined with restriction endonuclease digestion and ELISA for colorimetric detection of resistance to isoniazid, ethambutol and streptomycin in Mycobacterium tuberculosis isolates. doi:10.1016/j.mimet.2010.07.018 J Microbiol Methods 2010
[Molecular characterization of drug-resistant and extensive-drug resistant isolates of Mycobacterium tuberculosis in Shenzhen of China]. Zhonghua Jie He He Hu Xi Za Zhi 2010
KatG protein: a novel marker for differential diagnosis of Mycobacterium avium complex infection. doi:10.4103/0255-0857.66478 names it Indian J Med Microbiol 2010
Detection of Mycobacterium tuberculosis resistance mutations to rifampin and isoniazid by real-time PCR. doi:10.4103/0255-0857.66474 Indian J Med Microbiol 2010
A high prevalence of resistance in new tuberculosis cases of midwestern Brazil. doi:10.1016/j.meegid.2010.06.018 Infect Genet Evol 2010
Comparison of antibody responses to seventeen antigens from Mycobacterium tuberculosis. doi:10.1016/j.cca.2010.06.014 Clin Chim Acta 2010
Mycobacterium tuberculosis dihydrofolate reductase is not a target relevant to the antitubercular activity of isoniazid. doi:10.1128/AAC.00453-10 Antimicrob Agents Chemother 2010
Isonicotinic acid hydrazide conversion to Isonicotinyl-NAD by catalase-peroxidases. doi:10.1074/jbc.M110.139428 J Biol Chem 2010
M. tuberculosis intramembrane protease Rip1 controls transcription through three anti-sigma factor substrates. doi:10.1111/j.1365-2958.2010.07232.x Mol Microbiol 2010
Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana. doi:10.1016/j.ijmm.2010.04.019 Int J Med Microbiol 2010
Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden. doi:10.1371/journal.pone.0010893 PLoS One 2010
A radical on the Met-Tyr-Trp modification required for catalase activity in catalase-peroxidase is established by isotopic labeling and site-directed mutagenesis. doi:10.1021/ja103311e J Am Chem Soc 2010
Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray. doi:10.1111/j.1469-0691.2010.03267.x names it Clin Microbiol Infect 2010
Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic. Int J Tuberc Lung Dis 2010
Recent progress in the identification and development of InhA direct inhibitors of Mycobacterium tuberculosis. doi:10.2174/138955710791185064 Mini Rev Med Chem 2010
Isoniazid-resistant tuberculosis in Denmark: mutations, transmission and treatment outcome. doi:10.1016/j.jinf.2010.03.017 J Infect 2010
KatG from Salmonella typhimurium is a peroxynitritase. doi:10.1016/j.febslet.2010.03.029 names it FEBS Lett 2010
First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistance. doi:10.1186/1471-2180-10-82 BMC Microbiol 2010
Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.01691-09 names it Antimicrob Agents Chemother 2010
A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis. doi:10.1074/jbc.M109.090373 J Biol Chem 2010
Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study. doi:10.1186/1471-2334-10-43 BMC Infect Dis 2010
Evaluation of cost-effective total nucleic acids extraction protocols for cultured Mycobacterium tuberculosis; a comparison by PCR amplification of genes associated with drug resistance. doi:10.1186/1756-0500-3-48 BMC Res Notes 2010
Rapid detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis by high-resolution melting analysis. doi:10.1128/JCM.02036-09 J Clin Microbiol 2010
Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007. doi:10.3109/00365540903456282 Scand J Infect Dis 2010
Genetic characterisation of drug-resistant Mycobacterium tuberculosis in rural China: a population-based study. Int J Tuberc Lung Dis 2010
Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities. doi:10.1002/pro.324 names it Protein Sci 2010
[THE SENSITIVITY AND SPECIFICITY OF THE MOLECULAR GENOTYPE MTBDRPL US ASSAY (HAIN LIFESCIENCE GMBH, GERMANY) FOR RAPID DIAGNOSIS OF DRUG SUSCEPTIBILITY IN MYCOBACTERIUM TUBERCULOSIS ON SPUTUM SPECIMENS]. Tuberk Biolezni Legkih 2010
Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China. doi:10.1128/AAC.00964-09 Antimicrob Agents Chemother 2010
Mycobacterium tuberculosis spoligotypes in Monterrey, Mexico. doi:10.1128/JCM.01894-09 J Clin Microbiol 2010
Cloning, expression and characterization of the catalase-peroxidase (KatG) gene from a fast-growing Mycobacterium sp. strain JC1 DSM 3803. doi:10.1093/jb/mvp197 names it J Biochem 2010
Clinical efficacy of direct DNA sequencing analysis on sputum specimens for early detection of drug-resistant Mycobacterium tuberculosis in a clinical setting. doi:10.1378/chest.09-0150 Chest 2010
Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101. doi:10.1007/s10875-009-9311-y names it J Clin Immunol 2010
Genotypic analysis of genes associated with isoniazid and ethionamide resistance in MDR-TB isolates from Thailand. doi:10.1111/j.1469-0691.2009.02838.x Clin Microbiol Infect 2010
[Population-based molecular epidemiologic study of rifampicin-resistant tuberculosis in rural area of eastern China]. Zhonghua Liu Xing Bing Xue Za Zhi 2009
High level association of mutation in KatG315 with MDR and XDR clinical isolates of Mycobacterium tuberculosis in Belarus. doi:10.1556/AMicr.56.2009.4.2 Acta Microbiol Immunol Hung 2009
Characterization of Molecular Evolution in Multi-Drug Resistant of Mycobacterium tuberculosis by rpoB Gene in Patient with Active Pulmonary Tuberculosis from Iranian Isolates. Int J Biomed Sci 2009
Microarray analysis of Mycobacterium bovis BCG revealed induction of iron acquisition related genes in response to hydrogen peroxide. doi:10.1021/es902255q Environ Sci Technol 2009
Detection of isoniazid and rifampicin resistance by sequencing of katG, inhA, and rpoB genes in Korea. doi:10.3343/kjlm.2009.29.5.455 names it Korean J Lab Med 2009
[Molecular genetic and bacteriological methods for the diagnosis of multidrug resistant M. tuberculosis]. Tuberk Biolezni Legkih 2009
Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis. Int J Tuberc Lung Dis 2009
First documentation of isoniazid reversion in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009
Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones. doi:10.1128/JCM.01229-09 J Clin Microbiol 2009
In house colorimetric reverse hybridisation assay for detection of the mutation most frequently associated with resistance to isoniazid in Mycobacterium tuberculosis. doi:10.1590/s0074-02762009000500008 Mem Inst Oswaldo Cruz 2009
Global effects of inactivation of the pyruvate kinase gene in the Mycobacterium tuberculosis complex. doi:10.1128/JB.00619-09 J Bacteriol 2009
Molecular characterization of INH-resistant Mycobacterium tuberculosis isolates by PCR-RFLP and multiplex-PCR in North India. doi:10.1016/j.meegid.2009.09.008 Infect Genet Evol 2009
Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. doi:10.3855/jidc.125 J Infect Dev Ctries 2009
Isoniazid-resistant Mycobacterium tuberculosis strains arising from mutations in two different regions of the katG gene. doi:10.1590/s1806-37132009000800009 names it J Bras Pneumol 2009
Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso. doi:10.1186/1471-2334-9-142 BMC Infect Dis 2009
Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing. doi:10.1093/jac/dkp292 J Antimicrob Chemother 2009
Comparative growth pattern of multi drug resistance versus susceptible isolates of Mycobacterium tuberculosis in mice lungs. Indian J Med Res 2009
Epidemiologic characterization of culture positive Mycobacterium tuberculosis patients by katG-gyrA principal genetic grouping. doi:10.2353/jmoldx.2009.080171 names it J Mol Diagn 2009
Comparison of performance of two DNA line probe assays for rapid detection of multidrug-resistant isolates of Mycobacterium tuberculosis. Indian J Exp Biol 2009
Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates in Guangdong, China. Jpn J Infect Dis 2009
[Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates]. Mikrobiyol Bul 2009
Rolling circle amplification and multiplex allele-specific PCR for rapid detection of katG and inhA gene mutations in Mycobacterium tuberculosis. doi:10.1016/j.ijmm.2009.05.006 names it Int J Med Microbiol 2009
Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis. doi:10.1128/IAI.00142-09 Infect Immun 2009
Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolates. doi:10.1128/AAC.00433-09 Antimicrob Agents Chemother 2009
Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance. doi:10.1093/jac/dkp237 J Antimicrob Chemother 2009
[Detection of mutations in codon 306 of the embB gene for molecular genetic characterization of clinical Mycobacterium tuberculosis strains]. Probl Tuberk Bolezn Legk 2009
Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system. Int J Tuberc Lung Dis 2009
Mutations in rpoB and katG genes in Mycobacterium isolates from the Southeast of Mexico. doi:10.1590/s0074-02762009000300012 names it Mem Inst Oswaldo Cruz 2009
Distinct role of specific tryptophans in facilitating electron transfer or as [Fe(IV)=O Trp(*)] intermediates in the peroxidase reaction of Bulkholderia pseudomallei catalase-peroxidase: a multifrequency EPR spectroscopy investigation. doi:10.1021/ja901402v J Am Chem Soc 2009
Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada. doi:10.1093/jac/dkp183 J Antimicrob Chemother 2009
Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin. doi:10.1093/jac/dkp204 J Antimicrob Chemother 2009
Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis. doi:10.1128/JCM.02499-08 J Clin Microbiol 2009
The clinical relevance of Mycobacterial pharmacogenetics. doi:10.1016/j.tube.2009.03.001 Tuberculosis (Edinb) 2009
Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG). doi:10.1074/jbc.M109.005546 names it J Biol Chem 2009
[Practical value of the TB-biochip MDR test system in the rapid identification of multidrug-resistant M. tuberculosis strains]. Klin Lab Diagn 2009
Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. doi:10.1186/1472-6890-9-2 BMC Clin Pathol 2009
In-depth molecular characterization of Mycobacterium tuberculosis from New Delhi--predominance of drug resistant isolates of the 'modern' (TbD1) type. doi:10.1371/journal.pone.0004540 PLoS One 2009
Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. doi:10.1186/1471-2180-9-39 names it BMC Microbiol 2009
Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial. doi:10.1186/1476-0711-8-4 Ann Clin Microbiol Antimicrob 2009
Identification of Mycobacterium avium KatG protein (MAV_2753) as a possible serodiagnostic marker for MAC disease. doi:10.1016/j.jinf.2008.12.002 names it J Infect 2009
Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid. Int J Tuberc Lung Dis 2009
An oxyferrous heme/protein-based radical intermediate is catalytically competent in the catalase reaction of Mycobacterium tuberculosis catalase-peroxidase (KatG). doi:10.1074/jbc.M808106200 names it J Biol Chem 2009
Role of the oxyferrous heme intermediate and distal side adduct radical in the catalase activity of Mycobacterium tuberculosis KatG revealed by the W107F mutant. doi:10.1074/jbc.M808107200 names it J Biol Chem 2009
Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis. doi:10.1016/j.ijid.2008.10.006 Int J Infect Dis 2009
Molecular detection of drug-resistant Mycobacterium tuberculosis with a scanning-frame oligonucleotide microarray. doi:10.1007/978-1-59745-207-6_26 Methods Mol Biol 2009
Elucidating isoniazid resistance using molecular modeling. doi:10.1021/ci8001342 J Chem Inf Model 2009
M. tuberculosis Central Asian Strain 1 MDR isolates have more mutations in rpoB and katG genes compared with other genotypes. doi:10.1080/00365540802570519 names it Scand J Infect Dis 2009
Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. doi:10.1093/jac/dkn433 J Antimicrob Chemother 2009
At Baltic crossroads: a molecular snapshot of Mycobacterium tuberculosis population diversity in Kaliningrad, Russia. doi:10.1111/j.1574-695X.2008.00470.x FEMS Immunol Med Microbiol 2009
Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates. doi:10.1007/s10096-008-0584-5 Eur J Clin Microbiol Infect Dis 2009
Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex. doi:10.1016/j.ijid.2008.03.025 Int J Infect Dis 2009
[Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis]. Probl Tuberk Bolezn Legk 2008
[Distribution of mutations in the rpoB, katG, inhA, ahpC gene of rifampicin and isoniazid resistant M. tuberculosis strains isolated in Kyrgyz Republic]. names it Mol Gen Mikrobiol Virusol 2008
The Metal-Dependent Regulators FurA and FurB from Mycobacterium Tuberculosis. doi:10.3390/ijms9081548 Int J Mol Sci 2008
Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran. doi:10.1089/mdr.2008.0842 Microb Drug Resist 2008
T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. doi:10.4049/jimmunol.181.12.8784 J Immunol 2008
Prevalence and dissemination of the Ser315Thr substitution within the KatG enzyme in isoniazid-resistant strains of Mycobacterium tuberculosis isolated in Uruguay. doi:10.1099/jmm.0.2008/001917-0 names it J Med Microbiol 2008
Evaluation of new GenoType MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2008
Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach. doi:10.1111/j.1747-0285.2008.00722.x Chem Biol Drug Des 2008
Impact of distal side water and residue 315 on ligand binding to ferric Mycobacterium tuberculosis catalase-peroxidase (KatG). doi:10.1021/bi801511u names it Biochemistry 2008
Spin trapping investigation of peroxide- and isoniazid-induced radicals in Mycobacterium tuberculosis catalase-peroxidase. doi:10.1021/bi800952b Biochemistry 2008
The alternative sigma factor SigF of Mycobacterium smegmatis is required for survival of heat shock, acidic pH and oxidative stress. doi:10.1099/mic.0.2008/018044-0 Microbiology (Reading) 2008
Phenotypic and genotypic characterization of drug-resistant Mycobacterium tuberculosis strains. doi:10.1016/j.diagmicrobio.2008.06.013 Diagn Microbiol Infect Dis 2008
[Utility of gene analysis for evaluation of the current status of tuberculosis developing long after primary infection]. Nihon Koshu Eisei Zasshi 2008
Molecular snapshot of drug-resistant and drug-susceptible Mycobacterium tuberculosis strains circulating in Bulgaria. doi:10.1016/j.meegid.2008.06.006 Infect Genet Evol 2008
Molecular characterization of drug-resistant mycobacterium tuberculosis isolates from Sichuan Province in china. Jpn J Infect Dis 2008
Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey. Jpn J Infect Dis 2008
The effect of oxidative stress on the mutation rate of Mycobacterium tuberculosis with impaired catalase/peroxidase function. doi:10.1093/jac/dkn259 J Antimicrob Chemother 2008
Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective. doi:10.1089/mdr.2008.0798 Microb Drug Resist 2008
[Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system]. Georgian Med News 2008
Multidrug-resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolates. doi:10.1007/s10096-008-0548-9 Eur J Clin Microbiol Infect Dis 2008
Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan. doi:10.1128/JCM.00561-08 J Clin Microbiol 2008
Detection of mutation in isoniazid-resistant Mycobacterium tuberculosis isolates from tuberculosis patients in Belarus. doi:10.4103/0255-0857.40528 Indian J Med Microbiol 2008
The katG mRNA of Mycobacterium tuberculosis and Mycobacterium smegmatis is processed at its 5' end and is stabilized by both a polypurine sequence and translation initiation. doi:10.1186/1471-2199-9-33 names it BMC Mol Biol 2008
Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR. doi:10.1089/mdr.2008.0772 Microb Drug Resist 2008
Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire). doi:10.1016/j.ijantimicag.2008.01.008 Int J Antimicrob Agents 2008
Molecular genetics of drug-resistant Mycobacterium tuberculosis isolates in Finland, 1995-2004. Int J Tuberc Lung Dis 2008
Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis. doi:10.1093/jac/dkm485 J Antimicrob Chemother 2008
Determination of global protein turnover in stressed mycobacterium cells using hybrid-linear ion trap-fourier transform mass spectrometry. doi:10.1021/ac701690d Anal Chem 2008
Development of multiplex assay for rapid characterization of Mycobacterium tuberculosis. doi:10.1128/JCM.01821-07 J Clin Microbiol 2008
Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations. doi:10.1128/AAC.01124-07 Antimicrob Agents Chemother 2008
The tuberculosis prodrug isoniazid bound to activating peroxidases. doi:10.1074/jbc.M707412200 J Biol Chem 2008
Genomic interrogation of ancestral Mycobacterium tuberculosis from south India. doi:10.1016/j.meegid.2007.09.007 Infect Genet Evol 2008
Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India. doi:10.1016/j.ijantimicag.2007.08.013 Int J Antimicrob Agents 2008
Frequency and molecular characterization of isoniazid resistance in katG region of MDR isolates from tuberculosis patients in southern endemic border of Iran. doi:10.1016/j.meegid.2007.09.002 names it Infect Genet Evol 2008
Two [Fe(IV)=O Trp*] intermediates in M. tuberculosis catalase-peroxidase discriminated by multifrequency (9-285 GHz) EPR spectroscopy: reactivity toward isoniazid. doi:10.1021/ja075108u J Am Chem Soc 2007
The mechanism of isoniazid killing: clarity through the scope of genetics. doi:10.1146/annurev.micro.61.111606.122346 Annu Rev Microbiol 2007
katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis isolates from Belarusian patients. names it Tuberk Toraks 2007
Multiple Mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells. doi:10.1111/j.1365-2249.2007.03510.x Clin Exp Immunol 2007
Drug susceptibility of Spanish Mycobacterium tuberculosis complex isolates from animals. doi:10.1016/j.tube.2007.08.004 Tuberculosis (Edinb) 2007
A novel genotypic test for rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates by a multiplex probe array. doi:10.1111/j.1365-2672.2007.03350.x J Appl Microbiol 2007
Antibiotic resistance and single-nucleotide polymorphism cluster grouping type in a multinational sample of resistant Mycobacterium tuberculosis isolates. doi:10.1128/AAC.00619-07 Antimicrob Agents Chemother 2007
Molecular investigation of recurrent tuberculosis in patients from Rwanda. Int J Tuberc Lung Dis 2007
[Analysis of mutations of multidrug-resistant M. tuberculosis strains in patients with tuberculosis in the Kyrghyz Republic]. Probl Tuberk Bolezn Legk 2007
Mass-spectrometry based minisequencing method for the rapid detection of drug resistance in Mycobacterium tuberculosis. doi:10.1016/j.mimet.2007.05.015 J Microbiol Methods 2007
M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania. doi:10.1186/1471-2180-7-51 BMC Microbiol 2007
Multiple mutations in katG and inhA identified in Thai isoniazid-resistant Mycobacterium tuberculosis isolates. names it Southeast Asian J Trop Med Public Health 2007
Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. doi:10.1128/JCM.00521-07 J Clin Microbiol 2007
Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin Med J (Engl) 2007
[Mechanism of drug resistance in M. tuberculosis and non-tuberculous acid-fast bacilli]. Nihon Rinsho 2007
Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. doi:10.1093/jac/dkm086 J Antimicrob Chemother 2007
Isoniazid induces its own resistance in nonreplicating Mycobacterium tuberculosis. doi:10.1128/AAC.00086-07 Antimicrob Agents Chemother 2007
PCR-restriction fragment length polymorphism for rapid, low-cost identification of isoniazid-resistant Mycobacterium tuberculosis. doi:10.1128/JCM.01960-06 J Clin Microbiol 2007
Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. doi:10.1111/j.1469-0691.2007.01711.x names it Clin Microbiol Infect 2007
Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. doi:10.1093/jac/dkm054 J Antimicrob Chemother 2007
Development of modern InhA inhibitors to combat drug resistant strains of Mycobacterium tuberculosis. doi:10.2174/156802607780059781 Curr Top Med Chem 2007
Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine. doi:10.1111/j.1469-0691.2006.01583.x Clin Microbiol Infect 2007
Characterization of the binding of isoniazid and analogues to Mycobacterium tuberculosis catalase-peroxidase. doi:10.1021/bi062218p Biochemistry 2007
Characterization of ndh gene of isoniazid resistant and susceptible Mycobacterium tuberculosis isolates from Brazil. doi:10.1590/s0074-02762007000100009 Mem Inst Oswaldo Cruz 2007
Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates recovered from central China. doi:10.1007/s10528-006-9074-6 Biochem Genet 2007
Autocatalytic formation of a covalent link between tryptophan 41 and the heme in ascorbate peroxidase. doi:10.1021/bi062274q Biochemistry 2007
Molecular analysis of Mycobacterium tuberculosis causing multidrug-resistant tuberculosis meningitis. Int J Tuberc Lung Dis 2007
Redox intermediates in the catalase cycle of catalase-peroxidases from Synechocystis PCC 6803, Burkholderia pseudomallei, and Mycobacterium tuberculosis. doi:10.1021/bi062266+ Biochemistry 2007
Hydrogen peroxide oxidation by catalase-peroxidase follows a non-scrambling mechanism. doi:10.1016/j.febslet.2006.12.037 FEBS Lett 2007
Radical sites in Mycobacterium tuberculosis KatG identified using electron paramagnetic resonance spectroscopy, the three-dimensional crystal structure, and electron transfer couplings. doi:10.1074/jbc.M607309200 names it J Biol Chem 2007
Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth. doi:10.1086/510247 J Infect Dis 2007
Modification of the active site of Mycobacterium tuberculosis KatG after disruption of the Met-Tyr-Trp cross-linked adduct. doi:10.1016/j.jinorgbio.2006.11.004 names it J Inorg Biochem 2007
Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: Insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates. doi:10.1128/JCM.01459-06 J Clin Microbiol 2007
Detection of multidrug resistance in Mycobacterium tuberculosis. doi:10.1128/JCM.00750-06 J Clin Microbiol 2007
Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. doi:10.1128/IAI.00732-06 names it Infect Immun 2007
[Resistance-conferring mutations of Mycobacterium tuberculosis strains with low level resistance to isoniazid]. Kekkaku 2006
High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis. doi:10.1021/cb0500042 ACS Chem Biol 2006
[Modern diagnosis of tuberculosis]. doi:10.1016/S0755-4982(06)74892-8 Presse Med 2006
Mechanisms of action of isoniazid. doi:10.1111/j.1365-2958.2006.05467.x Mol Microbiol 2006
[Mechanisms of action of and resistance to rifampicin and isoniazid in Mycobacterium tuberculosis: new information on old friends]. Rev Argent Microbiol 2006
Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. doi:10.1128/JCM.01506-06 J Clin Microbiol 2006
Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Anti-tuberculosis Drug Resistance from Venezuela. doi:10.1186/1471-2180-6-90 BMC Microbiol 2006
Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. doi:10.1099/jmm.0.46718-0 J Med Microbiol 2006
Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. doi:10.1128/JCM.01054-06 J Clin Microbiol 2006
[Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system]. Probl Tuberk Bolezn Legk 2006
[Determination of multidrug resistance of M. tuberculosis by different methods]. Probl Tuberk Bolezn Legk 2006
Application of DNA markers to estimate genetic diversity of Mycobacterium tuberculosis strains. Pol J Microbiol 2006
Molecular characterization of mutation associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis isolates. Indian J Exp Biol 2006
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. doi:10.1128/AAC.00112-06 Antimicrob Agents Chemother 2006
Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands. doi:10.1111/j.1469-0691.2006.01495.x names it Clin Microbiol Infect 2006
Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex. doi:10.2174/138161206777698927 Curr Pharm Des 2006
Rhodococcus sp. strain TM1 plays a synergistic role in the degradation of piperidine by Mycobacterium sp. strain THO100. doi:10.1007/s00203-006-0132-6 Arch Microbiol 2006
Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. doi:10.1128/JCM.00752-06 J Clin Microbiol 2006
Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. doi:10.1128/JCM.00083-06 J Clin Microbiol 2006
Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. doi:10.1128/JCM.00425-06 J Clin Microbiol 2006
Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. doi:10.1128/JCM.00330-06 J Clin Microbiol 2006
Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. doi:10.1371/journal.ppat.0020061 PLoS Pathog 2006
[Evaluation of reasons of the MDR M. tuberculosis strains dissemination by analysis of the rifampicin and/or isoniazid resistant isolates]. Mol Gen Mikrobiol Virusol 2006
Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates. doi:10.1128/JCM.44.5.1619-1624.2006 J Clin Microbiol 2006
Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid. doi:10.1038/nsmb1089 Nat Struct Mol Biol 2006
Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant. doi:10.1021/bi051967o names it Biochemistry 2006
Catalase-peroxidase of Mycobacterium bovis BCG converts isoniazid to isonicotinamide, but not to isonicotinic acid: differentiation parameter between enzymes of Mycobacterium bovis BCG and Mycobacterium tuberculosis. doi:10.1016/j.bbagen.2005.12.026 Biochim Biophys Acta 2006
Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays. doi:10.1093/jac/dkl058 J Antimicrob Chemother 2006
Detection of the mutations in katG 315 and inhA -15 of Mycobacterium tuberculosis strains isolated from Chinese patients. names it Chin Med J (Engl) 2006
Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA. doi:10.1128/AAC.50.3.1075-1078.2006 Antimicrob Agents Chemother 2006
Evaluation of the CombiChip Mycobacteria Drug-Resistance detection DNA chip for identifying mutations associated with resistance to isoniazid and rifampin in Mycobacterium tuberculosis. doi:10.1016/j.diagmicrobio.2005.09.014 Diagn Microbiol Infect Dis 2006
Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. doi:10.1128/JCM.44.2.350-352.2006 J Clin Microbiol 2006
Use of a mycobacteriophage-based assay for rapid assessment of susceptibilities of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance. doi:10.1128/JCM.44.1.201-205.2006 J Clin Microbiol 2006
Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC, SURVEYOR nuclease. doi:10.1016/j.micinf.2005.06.008 Microbes Infect 2006
The use of macroarrays for the identification of MDR Mycobacterium tuberculosis. doi:10.1016/j.mimet.2005.08.002 J Microbiol Methods 2006
[A simple enzyme test for proving the resistance to isoniazid of Mycobacterium tuberculosis strains]. Pneumologia 2005
Role of the Met-Tyr-Trp cross-link in Mycobacterium tuberculosis catalase-peroxidase (KatG) as revealed by KatG(M255I). doi:10.1021/bi051463q names it Biochemistry 2005
Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. doi:10.1128/JCM.43.11.5477-5482.2005 J Clin Microbiol 2005
Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey. Jpn J Infect Dis 2005
Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan. Int J Tuberc Lung Dis 2005
[The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays]. names it Probl Tuberk Bolezn Legk 2005
Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. doi:10.1128/AAC.49.10.4068-4074.2005 Antimicrob Agents Chemother 2005
Correlation between isoniazid resistance and superoxide reactivity in mycobacterium tuberculosis KatG. doi:10.1021/ja054366t names it J Am Chem Soc 2005
[Resistance to antituberculous drugs]. doi:10.1016/s0929-693x(05)80024-7 Arch Pediatr 2005
Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. doi:10.1128/JCM.43.8.3699-3703.2005 J Clin Microbiol 2005
[Anti-drug pattern of drug-resistant Mycobacterium tuberculosis and analysis of mutation in drug-target genes]. doi:10.11150/kansenshogakuzasshi1970.79.388 Kansenshogaku Zasshi 2005
Microarray and allele specific PCR detection of point mutations in Mycobacterium tuberculosis genes associated with drug resistance. doi:10.1016/j.mimet.2005.04.026 J Microbiol Methods 2005
Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. doi:10.1128/AAC.49.6.2218-2225.2005 Antimicrob Agents Chemother 2005
Resonance Raman spectroscopy of Compound II and its decay in Mycobacterium tuberculosis catalase-peroxidase KatG and its isoniazid resistant mutant S315T. doi:10.1016/j.jinorgbio.2005.03.016 names it J Inorg Biochem 2005
Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona. doi:10.1089/mdr.2005.11.107 Microb Drug Resist 2005
Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey. doi:10.1089/mdr.2005.11.94 Microb Drug Resist 2005
Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. doi:10.1016/j.mimet.2005.03.002 J Microbiol Methods 2005
Structure and mechanism of the alkyl hydroperoxidase AhpC, a key element of the Mycobacterium tuberculosis defense system against oxidative stress. doi:10.1074/jbc.M503076200 J Biol Chem 2005
Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes. doi:10.1093/jac/dki132 J Antimicrob Chemother 2005
[Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing]. names it Zhonghua Jie He He Hu Xi Za Zhi 2005
The Met-Tyr-Trp cross-link in Mycobacterium tuberculosis catalase-peroxidase (KatG): autocatalytic formation and effect on enzyme catalysis and spectroscopic properties. doi:10.1074/jbc.M502486200 names it J Biol Chem 2005
Genetic diversity, determined on the basis of katG463 and gyrA95 polymorphisms, Spoligotyping, and IS6110 typing, of Mycobacterium tuberculosis complex isolates from Italy. doi:10.1128/JCM.43.4.1617-1624.2005 J Clin Microbiol 2005
Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism. doi:10.1128/AAC.49.4.1455-1464.2005 Antimicrob Agents Chemother 2005
Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2005
[Mutations linked with antimicrobial resistance in Mycobacterium tuberculosis isolated from tuberculosis patients in the Samara region]. Zh Mikrobiol Epidemiol Immunobiol 2005
Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. doi:10.1084/jem.20040429 J Exp Med 2005
Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from Spain. doi:10.1128/JCM.43.3.1220-1227.2005 J Clin Microbiol 2005
Use of fluorescence resonance energy transfer for rapid detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates. Int J Tuberc Lung Dis 2005
Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany. doi:10.1128/AAC.49.3.1229-1231.2005 Antimicrob Agents Chemother 2005
Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis. doi:10.1110/ps.041163505 Protein Sci 2005
Single-nucleotide polymorphism-based differentiation and drug resistance detection in Mycobacterium tuberculosis from isolates or directly from sputum. doi:10.1111/j.1469-0691.2004.01034.x Clin Microbiol Infect 2005
Mutations responsible for Mycobacterium tuberculosis isoniazid resistance in Italy. Int J Tuberc Lung Dis 2005
Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil. names it Int J Tuberc Lung Dis 2005
Mycobacterium tuberculosis KatG(S315T) catalase-peroxidase retains all active site properties for proper catalytic function. doi:10.1021/bi048097f names it Biochemistry 2005
New multiplex PCR for rapid detection of isoniazid-resistant Mycobacterium tuberculosis clinical isolates. doi:10.1128/AAC.49.1.144-147.2005 Antimicrob Agents Chemother 2005
Genotypic diversity among isoniazid-resistant isolates of Mycobacterium tuberculosis from Rashid hospital in Dubai, United Arab Emirates. doi:10.1159/000081918 Med Princ Pract 2005
Structural characterization of the Ser324Thr variant of the catalase-peroxidase (KatG) from Burkholderia pseudomallei. doi:10.1016/j.jmb.2004.10.020 names it J Mol Biol 2005
(11)C-Labeled isoniazid. 2004
[Molecular-genetic characteristics of Mycobacterium tuberculosis strains isolated in southern region of Ukraine]. Tsitol Genet 2004
Isoniazid resistance and the future of drug-resistant tuberculosis. doi:10.1089/mdr.2004.10.280 Microb Drug Resist 2004
Three-dimensional model and molecular mechanism of Mycobacterium tuberculosis catalase-peroxidase (KatG) and isoniazid-resistant KatG mutants. doi:10.1089/mdr.2004.10.269 names it Microb Drug Resist 2004
Molecular epidemiology of drug-resistant Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Poland: a 1-year study. Int J Tuberc Lung Dis 2004
Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. doi:10.1128/JCM.42.11.5277-5285.2004 J Clin Microbiol 2004
Characterization of drug-resistant isolates of Mycobacterium tuberculosis derived from Russian inmates. Int J Tuberc Lung Dis 2004
Molecular strain identification of the Mycobacterium tuberculosis complex in archival tissue samples. doi:10.1136/jcp.2003.015719 J Clin Pathol 2004
Silent nucleotide polymorphisms and a phylogeny for Mycobacterium tuberculosis. doi:10.3201/eid1009.040046 Emerg Infect Dis 2004
PCR-RFLP analysis of a point mutation in codons 315 and 463 of the katG gene of Mycobacterium tuberculosis isolated from patients in Silesia, Poland. names it Pol J Microbiol 2004
Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation. doi:10.1128/JCM.42.10.4498-4502.2004 J Clin Microbiol 2004
Utilization of a ts-sacB selection system for the generation of a Mycobacterium avium serovar-8 specific glycopeptidolipid allelic exchange mutant. doi:10.1186/1476-0711-3-18 Ann Clin Microbiol Antimicrob 2004
Detection of Mycobacterium tuberculosis genotypic groups by a duplex real-time PCR targeting the katG and gyrA genes. doi:10.1016/j.mimet.2004.06.012 names it J Microbiol Methods 2004
[KatG Ser3 15Thr mutation as the main reason of isoniazid resistance in Mycobacterium tuberculosis isolated in the Novosibirsk and Kemerovo Regions]. names it Mol Gen Mikrobiol Virusol 2004
Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. doi:10.1128/AAC.48.9.3373-3381.2004 Antimicrob Agents Chemother 2004
[New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis]. Probl Tuberk Bolezn Legk 2004
[Molecular identification of mycobacteria and detection of antibiotic resistance]. Ann Biol Clin (Paris) 2004
Requirements for nitric oxide generation from isoniazid activation in vitro and inhibition of mycobacterial respiration in vivo. doi:10.1128/JB.186.16.5427-5431.2004 J Bacteriol 2004
Catalase-peroxidases (KatG) exhibit NADH oxidase activity. doi:10.1074/jbc.M406374200 names it J Biol Chem 2004
Nitric oxide generated from isoniazid activation by KatG: source of nitric oxide and activity against Mycobacterium tuberculosis. doi:10.1128/AAC.48.8.3006-3009.2004 names it Antimicrob Agents Chemother 2004
Purification and characterization of Mycobacterium tuberculosis KatG, KatG(S315T), and Mycobacterium bovis KatG(R463L). doi:10.1016/j.pep.2004.04.018 names it Protein Expr Purif 2004
Inhibition of Mycobacterium tuberculosis AhpD, an element of the peroxiredoxin defense against oxidative stress. doi:10.1128/AAC.48.7.2424-2430.2004 Antimicrob Agents Chemother 2004
Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis. doi:10.1086/421501 J Infect Dis 2004
Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical strains isolated in the Philippines. doi:10.1016/j.ijantimicag.2003.09.032 Int J Antimicrob Agents 2004
Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. doi:10.1128/JCM.42.6.2425-2431.2004 J Clin Microbiol 2004
Intermolecular interactions in the AhpC/AhpD antioxidant defense system of Mycobacterium tuberculosis. doi:10.1016/j.abb.2004.04.017 Arch Biochem Biophys 2004
Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. doi:10.1111/j.1365-2958.2004.04078.x names it Mol Microbiol 2004
Identification of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi, Kenya. Int J Tuberc Lung Dis 2004
[Detection of KatG 315 gene mutation associated with isoniazid resistance in Mycobacterium tuberculosis by template-directed dye-terminator incorporation with fluorescence polarization detection technology]. names it Zhonghua Jie He He Hu Xi Za Zhi 2004
Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East. doi:10.1016/j.ijantimicag.2003.10.004 names it Int J Antimicrob Agents 2004
Superoxide reactivity of KatG: insights into isoniazid resistance pathways in TB. doi:10.1021/ja031728t names it J Am Chem Soc 2004
Newer diagnostic modalities for tuberculosis. doi:10.1007/BF02724274 Indian J Pediatr 2004
Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR. doi:10.1128/JCM.42.4.1585-1589.2004 J Clin Microbiol 2004
Recovery of Mycobacterium avium subspecies paratuberculosis from the natural host for the extraction and analysis in vivo-derived RNA. doi:10.1016/j.mimet.2004.01.010 J Microbiol Methods 2004
Antimicrobial susceptibility determined by the E test, Löwenstein-Jensen proportion, and DNA sequencing methods among Mycobacterium tuberculosis isolates discrepancies, preliminary results. doi:10.1590/s0074-02762004000100019 Mem Inst Oswaldo Cruz 2004
Genetic characterization of the Guinea-Bissau family of Mycobacterium tuberculosis complex strains. doi:10.1016/j.micinf.2003.12.006 Microbes Infect 2004
[Study on isoniazid-resistant Mycobacterium tuberculosis isolates by multiple-polymerase chain reaction-single strand conformation polymorphism]. Zhonghua Jie He He Hu Xi Za Zhi 2004
Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology. Int J Tuberc Lung Dis 2004
Multiple thioredoxin-mediated routes to detoxify hydroperoxides in Mycobacterium tuberculosis. doi:10.1016/j.abb.2003.11.021 Arch Biochem Biophys 2004
An inorganic iron complex that inhibits wild-type and an isoniazid-resistant mutant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis. doi:10.1039/b313592f Chem Commun (Camb) 2004
Mycobacterium tuberculosis isolates belonging to katG gyrA group 2 are associated with clustered cases of tuberculosis in Italian patients. doi:10.1099/jmm.0.05471-0 names it J Med Microbiol 2004
Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. doi:10.1099/jmm.0.05343-0 J Med Microbiol 2004
Evidence for radical formation at Tyr-353 in Mycobacterium tuberculosis catalase-peroxidase (KatG). doi:10.1074/jbc.M311884200 names it J Biol Chem 2004
Molecular fingerprinting of multidrug-resistant Mycobacterium tuberculosis strains in Beirut reveals genetic diversity and father to daughter transmission. J Med Liban 2003
[Establishment of a method with micro-channel electrophoresis for detecting the mutations of isoniazid-resistant genes in Mycobacterium tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 2003
Typing of Mycobacterium tuberculosis strains resistant to rifampicin and isoniazid by molecular biological methods. doi:10.1023/b:bebm.0000008981.63290.ef Bull Exp Biol Med 2003
[Identification of Mycobacterium tuberculosis strains and a simultaneous identification of their drug resistance by the hybridization method on oligonucleotide microchips]. Mol Gen Mikrobiol Virusol 2003
Elevation of Mycobacterium tuberculosis subsp. caprae Aranaz et al. 1999 to species rank as Mycobacterium caprae comb. nov., sp. nov. doi:10.1099/ijs.0.02532-0 Int J Syst Evol Microbiol 2003
ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. doi:10.1128/AAC.47.12.3799-3805.2003 names it Antimicrob Agents Chemother 2003
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance. doi:10.1073/pnas.2235848100 Proc Natl Acad Sci U S A 2003
Koch's bacillus - a look at the first isolate of Mycobacterium tuberculosis from a modern perspective. doi:10.1099/mic.0.26654-0 Microbiology (Reading) 2003
Biosynthetic specificity of the rhamnosyltransferase gene of Mycobacterium avium serovar 2 as determined by allelic exchange mutagenesis. doi:10.1099/mic.0.26565-0 Microbiology (Reading) 2003
Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis 2003
Molecular analysis of isoniazid resistance in Mycobacterium tuberculosis isolates recovered from South Korea. doi:10.1016/s0732-8893(03)00132-9 Diagn Microbiol Infect Dis 2003
Detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis strains by single-strand conformation polymorphism analysis and restriction fragment length polymorphism. New Microbiol 2003
Detection of resistance to isoniazid by denaturing gradient-gel electrophoresis DNA sequencing in Mycobacterium tuberculosis clinical isolates. New Microbiol 2003
Detection of katG Ser315Thr substitution in respiratory specimens from patients with isoniazid-resistant Mycobacterium tuberculosis using PCR-RFLP. doi:10.1099/jmm.0.05223-0 names it J Med Microbiol 2003
Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3'-minor groove binder-DNA probes. doi:10.1128/JCM.41.10.4630-4635.2003 J Clin Microbiol 2003
Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis. doi:10.1128/JCM.41.9.4471-4474.2003 names it J Clin Microbiol 2003
Mycobacterium tuberculosis FurA autoregulates its own expression. doi:10.1128/JB.185.18.5357-5362.2003 J Bacteriol 2003
Rapid formation of compound II and a tyrosyl radical in the Y229F mutant of Mycobacterium tuberculosis catalase-peroxidase disrupts catalase but not peroxidase function. doi:10.1074/jbc.M304757200 J Biol Chem 2003
Characterization of the Manila family of Mycobacterium tuberculosis. doi:10.1128/JCM.41.6.2723-2726.2003 J Clin Microbiol 2003
The mechanism of Mycobacterium tuberculosis alkylhydroperoxidase AhpD as defined by mutagenesis, crystallography, and kinetics. doi:10.1074/jbc.M303747200 J Biol Chem 2003
Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. doi:10.1128/AAC.47.6.2009-2011.2003 Antimicrob Agents Chemother 2003
A novel thiocationic liposomal formulation of antisense oligonucleotides with activity against Mycobacterium tuberculosis. doi:10.1080/00365540310000102 Scand J Infect Dis 2003
1H and 13C NMR characterization of hemiamidal isoniazid-NAD(H) adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis. doi:10.1002/chem.200204637 Chemistry 2003
Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico. doi:10.1089/107662903764736328 names it Microb Drug Resist 2003
Conformational differences in Mycobacterium tuberculosis catalase-peroxidase KatG and its S315T mutant revealed by resonance Raman spectroscopy. doi:10.1021/bi026992y names it Biochemistry 2003
Improved real-time PCR for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates. doi:10.1016/s0732-8893(02)00521-7 Diagn Microbiol Infect Dis 2003
Inhibition of InhA activity, but not KasA activity, induces formation of a KasA-containing complex in mycobacteria. doi:10.1074/jbc.M302435200 J Biol Chem 2003
Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.47.4.1241-1250.2003 Antimicrob Agents Chemother 2003
Catalase-peroxidase KatG of Burkholderia pseudomallei at 1.7A resolution. doi:10.1016/s0022-2836(03)00122-0 names it J Mol Biol 2003
Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance. doi:10.1074/jbc.M300326200 names it J Biol Chem 2003
Molecular analysis of Mycobacterium tuberculosis DNA from a family of 18th century Hungarians. doi:10.1099/mic.0.25961-0 Microbiology (Reading) 2003
Isoniazid activation defects in recombinant Mycobacterium tuberculosis catalase-peroxidase (KatG) mutants evident in InhA inhibitor production. doi:10.1128/AAC.47.2.670-675.2003 names it Antimicrob Agents Chemother 2003
Deciphering an outbreak of drug-resistant Mycobacterium tuberculosis. doi:10.1128/JCM.41.1.67-72.2003 J Clin Microbiol 2003
Analysis of heme structural heterogeneity in Mycobacterium tuberculosis catalase-peroxidase (KatG). doi:10.1074/jbc.M208256200 names it J Biol Chem 2003
Exploring the structure and function of the mycobacterial KatG protein using trans-dominant mutants. doi:10.1128/AAC.47.1.188-195.2003 names it Antimicrob Agents Chemother 2003
[Study on drug-resistance of Mycobacterium tuberculosis isolated from coal workers with silico-tuberculosis]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2002
[Diagnosed tuberculosis using specific DNA probe hybridization methods]. Rinsho Byori 2002
[Rapid screening of katG gene mutation in isoniazid-resistant Mycobacterium tuberculosis]. doi:10.3785/j.issn.1008-9292.2002.03.011 names it Zhejiang Da Xue Xue Bao Yi Xue Ban 2002
Phylogenetic reconstruction within Mycobacterium tuberculosis Beijing genotype in northwestern Russia. doi:10.1016/s0923-2508(02)01374-8 Res Microbiol 2002
Molecular fingerprinting of isoniazid-resistant Mycobacterium tuberculosis isolates from chest diseases hospital in Kuwait. doi:10.1111/j.1348-0421.2002.tb02762.x Microbiol Immunol 2002
Improving bacteriological diagnosis of tuberculosis. Indian J Pediatr 2002
[Clinical application and evaluation of the detection of five drugs resistance genes in Mycobacterium tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 2002
Crystallization and preliminary X-ray analysis of the catalase-peroxidase KatG from Burkholderia pseudomallei. doi:10.1107/s0907444902017869 names it Acta Crystallogr D Biol Crystallogr 2002
Rifampin- and multidrug-resistant tuberculosis in Russian civilians and prison inmates: dominance of the beijing strain family. doi:10.3201/eid0811.020507 Emerg Infect Dis 2002
Prevalence of S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Dubai and Beirut. names it Int J Tuberc Lung Dis 2002
Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. doi:10.1128/JCM.40.10.3789-3792.2002 names it J Clin Microbiol 2002
Identification and characterization of tyrosyl radical formation in Mycobacterium tuberculosis catalase-peroxidase (KatG). doi:10.1074/jbc.M207916200 names it J Biol Chem 2002
Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. doi:10.1128/IAI.70.9.4955-4960.2002 names it Infect Immun 2002
Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.46.9.2804-2810.2002 Antimicrob Agents Chemother 2002
Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid. doi:10.1128/AAC.46.9.2765-2771.2002 Antimicrob Agents Chemother 2002
Variations in the occurrence of the S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. doi:10.1089/107662902760190644 names it Microb Drug Resist 2002
Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay targeting katG codon 315 variation. doi:10.1128/JCM.40.7.2509-2512.2002 names it J Clin Microbiol 2002
Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis. doi:10.1128/AAC.46.7.2137-2144.2002 Antimicrob Agents Chemother 2002
Temperature-mediated heteroduplex analysis performed by using denaturing high-performance liquid chromatography to identify sequence polymorphisms in Mycobacterium tuberculosis complex organisms. doi:10.1128/JCM.40.5.1610-1616.2002 J Clin Microbiol 2002
High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. doi:10.1128/AAC.46.5.1417-1424.2002 names it Antimicrob Agents Chemother 2002
Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain. Int J Tuberc Lung Dis 2002
Peptide nucleic acid probe detection of mutations in Mycobacterium tuberculosis genes associated with drug resistance. doi:10.2144/02323st01 Biotechniques 2002
The crystal structure of Mycobacterium tuberculosis alkylhydroperoxidase AhpD, a potential target for antitubercular drug design. doi:10.1074/jbc.M200864200 J Biol Chem 2002
New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. doi:10.1128/JCM.40.3.988-995.2002 J Clin Microbiol 2002
Direct voltammetry and catalysis with Mycobacterium tuberculosis catalase-peroxidase, peroxidases, and catalase in lipid films. doi:10.1021/ac010701u Anal Chem 2002
Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. doi:10.1128/AAC.46.2.443-450.2002 Antimicrob Agents Chemother 2002
Characterization of the W321F mutant of Mycobacterium tuberculosis catalase-peroxidase KatG. doi:10.1110/ps.09902 names it Protein Sci 2002
Typing of drug resistant isolates of Mycobacterium tuberculosis from India using the IS6110 element reveals substantive polymorphism. doi:10.1016/s1567-1348(01)00014-4 Infect Genet Evol 2001
[Studies on mutation of isoniazid resistant genes in M. tuberculosis]. Hunan Yi Ke Da Xue Xue Bao 2001
A fast and efficient metal-mediated oxidation of isoniazid and identification of isoniazid-NAD(H) adducts. doi:10.1002/1439-7633(20011203)2:12<877::AID-CBIC877>3.0.CO;2-V Chembiochem 2001
[Sequencing of inhA in drug-resistant Mycobacterium tuberculosis isolates]. Zhonghua Jie He He Hu Xi Za Zhi 2001
[The mechanism of action of isoniazid. A chemical model of activation]. Ann Pharm Fr 2001
Inter- and intramolecular domain interactions of the catalase-peroxidase KatG from M. tuberculosis. doi:10.1016/s0014-5793(01)03179-9 names it FEBS Lett 2001
Transcriptional regulation of furA and katG upon oxidative stress in Mycobacterium smegmatis. doi:10.1128/JB.183.23.6801-6806.2001 names it J Bacteriol 2001
Mycobacterium tuberculosis phylogeny reconstruction based on combined numerical analysis with IS1081, IS6110, VNTR, and DR-based spoligotyping suggests the existence of two new phylogeographical clades. doi:10.1007/s002390010255 J Mol Evol 2001
Evaluation of katG codon 315 mutations among isoniazid sensitive and resistant mycobacterium tuberculosis isolates from Thailand. names it J Med Assoc Thai 2001
Identification and characterization of mycobacterial proteins differentially expressed under standing and shaking culture conditions, including Rv2623 from a novel class of putative ATP-binding proteins. doi:10.1128/IAI.69.9.5777-5785.2001 Infect Immun 2001
Identification of catalase-like activity from Mycobacterium leprae and the relationship between catalase and isonicotinic acid hydrazide (INH). doi:10.1099/0022-1317-50-8-675 J Med Microbiol 2001
Secondary structure prediction and structure-specific sequence analysis of single-stranded DNA. doi:10.1093/nar/29.15.3248 Nucleic Acids Res 2001
Evidence for isoniazid-dependent free radical generation catalyzed by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T). doi:10.1021/bi002614m names it Biochemistry 2001
Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. doi:10.1007/pl00011272 names it Eur J Clin Microbiol Infect Dis 2001
Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. doi:10.1128/AAC.45.7.2157-2159.2001 Antimicrob Agents Chemother 2001
Regulation of catalase-peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis. doi:10.1046/j.1365-2958.2001.02427.x names it Mol Microbiol 2001
Carbon monoxide adducts of KatG and KatG(S315T) as probes of the heme site and isoniazid binding. doi:10.1021/bi010369g names it Biochemistry 2001
Mapping of Mycobacterium tuberculosis katG promoters and their differential expression in infected macrophages. doi:10.1128/JB.183.13.4033-4039.2001 names it J Bacteriol 2001
Characterization of IS6110 restriction fragment length polymorphism patterns and mechanisms of antimicrobial resistance for multidrug-resistant isolates of Mycobacterium tuberculosis from a major reference hospital in Assiut, Egypt. doi:10.1128/JCM.39.6.2330-2334.2001 J Clin Microbiol 2001
Molecular basis of rifampin and isoniazid resistance in Mycobacterium bovis strains isolated in Sardinia, Italy. doi:10.1128/AAC.45.6.1645-1648.2001 Antimicrob Agents Chemother 2001
Heteroresistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2001
The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg-->Leu mutation at codon 463 of katG are not associated. doi:10.1128/JCM.39.4.1591-1594.2001 names it J Clin Microbiol 2001
Active site structure of the catalase-peroxidases from Mycobacterium tuberculosis and Escherichia coli by extended X-ray absorption fine structure analysis. doi:10.1016/s0167-4838(00)00221-1 Biochim Biophys Acta 2001
The molecular peculiarities of catalase-peroxidases. doi:10.1016/s0014-5793(01)02237-2 FEBS Lett 2001
Mycobacterial FurA is a negative regulator of catalase-peroxidase gene katG. doi:10.1111/j.1365-2958.2001.02321.x names it Mol Microbiol 2001
Characterization of the Mycobacterium tuberculosis H37Rv alkyl hydroperoxidase AhpC points to the importance of ionic interactions in oligomerization and activity. doi:10.1042/0264-6021:3540209 Biochem J 2001
Transmission dynamics and molecular characterization of Mycobacterium tuberculosis isolates with low copy numbers of IS6110. doi:10.1128/JCM.39.1.217-221.2001 J Clin Microbiol 2001
Genetic diversity and evidence for acquired antimicrobial resistance in Mycobacterium tuberculosis at a large hospital in South India. doi:10.1016/s1201-9712(00)90075-4 Int J Infect Dis 2000
The DNA-binding characteristics of the Streptomyces reticuli regulator FurS depend on the redox state of its cysteine residues. doi:10.1007/s004380000328 Mol Gen Genet 2000
Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. doi:10.1086/317598 names it J Infect Dis 2000
[Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis]. doi:10.7888/juoeh.22.269 J UOEH 2000
Cloning, expression, and characterization of the katG gene, encoding catalase-peroxidase, from the polycyclic aromatic hydrocarbon-degrading bacterium Mycobacterium sp. strain PYR-1. doi:10.1128/AEM.66.10.4300-4304.2000 names it Appl Environ Microbiol 2000
Redox potential measurements of the Mycobacterium tuberculosis heme protein KatG and the isoniazid-resistant enzyme KatG(S315T): insights into isoniazid activation. doi:10.1021/bi001239v names it Biochemistry 2000
Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. doi:10.1128/JCM.38.9.3194-3199.2000 J Clin Microbiol 2000
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. doi:10.1073/pnas.97.17.9677 Proc Natl Acad Sci U S A 2000
Mycobacterium tuberculosis H37Rv comparative gene-expression analysis in synthetic medium and human macrophage. doi:10.1016/s0378-1119(00)00249-3 Gene 2000
Spectroscopic comparison of the heme active sites in WT KatG and its S315T mutant. doi:10.1021/bi0006870 names it Biochemistry 2000
Catalase-peroxidase (Mycobacterium tuberculosis KatG) catalysis and isoniazid activation. doi:10.1021/bi0005815 names it Biochemistry 2000
Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. doi:10.1054/tuld.1999.0231 names it Tuber Lung Dis 2000
The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. doi:10.1016/s1286-4579(00)00359-2 Microbes Infect 2000
Identification of drug-resistantMycobacterium tuberculosis by single strand conformation polymorphism and cleavase fragment length polymorphism. doi:10.1007/BF02883734 Indian J Clin Biochem 2000
Activation of the pro-drug ethionamide is regulated in mycobacteria. doi:10.1074/jbc.M003744200 J Biol Chem 2000
Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis. doi:10.1128/JB.182.14.4059-4067.2000 J Bacteriol 2000
Modulation of the activities of catalase-peroxidase HPI of Escherichia coli by site-directed mutagenesis. doi:10.1021/bi0000059 Biochemistry 2000
Evaluation of the invader assay, a linear signal amplification method, for identification of mutations associated with resistance to rifampin and isoniazid in Mycobacterium tuberculosis. doi:10.1128/AAC.44.5.1296-1301.2000 Antimicrob Agents Chemother 2000
[Molecular mechanisms of mycobacterium tuberculosis strains resistance to rifampicin and isoniazid]. Probl Tuberk 2000
The immunogenicity of single and combination DNA vaccines against tuberculosis. doi:10.1016/s0264-410x(99)00540-x Vaccine 2000
Characterization of Mycobacterium tuberculosis isolates from patients in Houston, Texas, by spoligotyping. doi:10.1128/JCM.38.2.669-676.2000 J Clin Microbiol 2000
Action mechanism of antitubercular isoniazid. Activation by Mycobacterium tuberculosis KatG, isolation, and characterization of inha inhibitor. doi:10.1074/jbc.275.4.2520 names it J Biol Chem 2000
Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates. Chin Med J (Engl) 1999
Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. doi:10.1054/tuld.1999.0222 Tuber Lung Dis 1999
Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain. doi:10.1054/tuld.1998.0195 Tuber Lung Dis 1999
AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis. doi:10.1002/biof.5520100219 Biofactors 1999
High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection. doi:10.1128/AAC.43.12.2922 Antimicrob Agents Chemother 1999
The Mycobacterium tuberculosis mysB gene product is a functional equivalent of the Escherichia coli sigma factor, KatF. doi:10.1016/s0378-1119(99)00430-8 Gene 1999
Molecular characterization of mycobacteria isolated from seals. doi:10.1099/00221287-145-9-2519 Microbiology (Reading) 1999
The Mycobacterium tuberculosis katG promoter region contains a novel upstream activator. doi:10.1099/00221287-145-9-2507 names it Microbiology (Reading) 1999
Involvement of the N- and C-terminal domains of Mycobacterium tuberculosis KatG in the protection of mutant Escherichia coli against DNA-damaging agents. doi:10.1099/13500872-145-8-2011 names it Microbiology (Reading) 1999
Culture-independent prediction of isoniazid resistance in Mycobacterium tuberculosis by katG gene analysis directly from sputum samples. doi:10.1016/s1084-8592(99)80038-1 names it Mol Diagn 1999
Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. doi:10.1128/IAI.67.9.4780-4786.1999 Infect Immun 1999
Mycobacterium tuberculosis subsp. caprae subsp. nov.: a taxonomic study of a new member of the Mycobacterium tuberculosis complex isolated from goats in Spain. doi:10.1099/00207713-49-3-1263 Int J Syst Bacteriol 1999
Phenotypic and genotypic characterization of Mycobacterium africanum isolates from West Africa. doi:10.1128/JCM.37.6.1921-1926.1999 J Clin Microbiol 1999
Molecular epidemiologic evaluation of transmissibility and virulence of Mycobacterium tuberculosis. doi:10.1128/JCM.37.6.1764-1770.1999 J Clin Microbiol 1999
The mycelium-associated Streptomyces reticuli catalase-peroxidase, its gene and regulation by FurS. doi:10.1099/13500872-145-3-549 Microbiology (Reading) 1999
Mycobacterium tuberculosis KatG is a peroxynitritase. doi:10.1006/bbrc.1999.0358 names it Biochem Biophys Res Commun 1999
Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997). doi:10.1128/JCM.37.4.998-1003.1999 J Clin Microbiol 1999
Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy. doi:10.1086/314677 J Infect Dis 1999
Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis. names it Biochem J 1999
Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. doi:10.1128/IAI.67.1.74-79.1999 Infect Immun 1999
Mechanisms of isoniazid resistance in Mycobacterium tuberculosis. doi:10.1016/s1368-7646(98)80028-9 Drug Resist Updat 1998
[Study on the mutations of ahpC genes in M. tuberculosis isoniazid-resistant isolates]. Zhonghua Jie He He Hu Xi Za Zhi 1998
[Molecular biology of KatG gene and isoniazid resistence in Mycobacterium tuberculosis]. names it Zhonghua Jie He He Hu Xi Za Zhi 1998
[Relationship between catalase activity, KatG gene and isoniazid-resistance in M. tuberculosis]. names it Zhonghua Jie He He Hu Xi Za Zhi 1998
Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. doi:10.1054/tuld.1998.0013 Tuber Lung Dis 1998
Protective role of the Mycobacterium smegmatis IdeR against reactive oxygen species and isoniazid toxicity. doi:10.1054/tuld.1998.0011 Tuber Lung Dis 1998
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. doi:10.1054/tuld.1998.0002 Tuber Lung Dis 1998
Comparative Evaluation of Cleavase Fragment Length Polymorphism With PCR-SSCP and PCR-RFLP to Detect Antimicrobial Agent Resistance in Mycobacterium tuberculosis. doi:10.154/MODI00300081 Mol Diagn 1998
Mechanisms for isoniazid action and resistance. doi:10.1002/0470846526.ch15 Novartis Found Symp 1998
[Mechanisms of drug-resistance in mycobacteria]. Nihon Rinsho 1998
[Multidrug-resistant tuberculosis. 2. Mechanisms of drug-resistance in Mycobacterium tuberculosis--genetic mechanisms of drug-resistance]. Kekkaku 1998
Evidence for differential binding of isoniazid by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T). doi:10.1021/bi982023k names it Biochemistry 1998
Mechanism of isoniazid uptake in Mycobacterium tuberculosis. doi:10.1099/00221287-144-9-2539 Microbiology (Reading) 1998
Site-directed mutagenesis and virulence assessment of the katG gene of Mycobacterium intracellulare. doi:10.1046/j.1365-2958.1998.00982.x names it Mol Microbiol 1998
Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis. doi:10.1007/BF01691135 Eur J Clin Microbiol Infect Dis 1998
A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. doi:10.1128/AAC.42.9.2443 names it Antimicrob Agents Chemother 1998
Oxidative stress response and characterization of the oxyR-ahpC and furA-katG loci in Mycobacterium marinum. doi:10.1128/JB.180.18.4856-4864.1998 names it J Bacteriol 1998
Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates. doi:10.1086/515362 J Infect Dis 1998
NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis. doi:10.1128/JB.180.9.2459-2467.1998 J Bacteriol 1998
Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium. doi:10.1046/j.1365-2958.1998.00774.x Mol Microbiol 1998
Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. doi:10.1086/515254 names it J Infect Dis 1998
Role of superoxide in catalase-peroxidase-mediated isoniazid action against mycobacteria. doi:10.1128/AAC.42.3.709 Antimicrob Agents Chemother 1998
The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis--a molecular story. doi:10.1099/00222615-47-3-189 J Med Microbiol 1998
[Study on the molecular mechanism of multi-drug resistance in clinical isolates of Mycobacterium tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 1997
Molecular techniques in the diagnosis of drug-resistant tuberculosis. Ann Acad Med Singap 1997
[Rapid diagnosis of tuberculosis]. Kekkaku 1997
Purification and characterization of recombinant catalase-peroxidase, which confers isoniazid sensitivity in Mycobacterium tuberculosis. doi:10.1074/jbc.272.50.31265 J Biol Chem 1997
MTC28, a novel 28-kilodalton proline-rich secreted antigen specific for the Mycobacterium tuberculosis complex. doi:10.1128/iai.65.12.4951-4957.1997 Infect Immun 1997
katGI and katGII encode two different catalases-peroxidases in Mycobacterium fortuitum. doi:10.1128/jb.179.22.6880-6886.1997 J Bacteriol 1997
Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry. doi:10.1128/iai.65.11.4515-4524.1997 Infect Immun 1997
Lack of clinical significance for the common arginine-to-leucine substitution at codon 463 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis in Singapore. doi:10.1086/517320 names it J Infect Dis 1997
Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. doi:10.1128/AAC.41.9.2057 Antimicrob Agents Chemother 1997
Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. doi:10.1086/514096 names it J Infect Dis 1997
Usefulness of Mycobacterium tuberculosis genomic mutations in the genes katG and inhA for the prediction of isoniazid resistance. names it Int J Tuberc Lung Dis 1997
Expression or possession of catalase gene does not alter the capacity of M. smegmatis to survive within human macrophages. doi:10.1080/15216549700203281 Biochem Mol Biol Int 1997
Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. doi:10.1128/AAC.41.7.1601 names it Antimicrob Agents Chemother 1997
Influence of Mycobacterium tuberculosis catalase gene (KatG) expression on nitric oxide production and the intracellular growth of transfected Mycobacterium smegmatis strains within murine macrophages. doi:10.1080/15216549700202511 names it Biochem Mol Biol Int 1997
Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. doi:10.1093/clinids/24.5.894 Clin Infect Dis 1997
Nucleotide sequence of the Mycobacterium leprae katG region. doi:10.1128/jb.179.9.3053-3057.1997 names it J Bacteriol 1997
On the catalase-peroxidase gene, katG, of Mycobacterium leprae and the implications for treatment of leprosy with isoniazid. doi:10.1111/j.1574-6968.1997.tb10340.x names it FEMS Microbiol Lett 1997
Isoniazid resistance and the point mutation of codon 463 of katG gene of Mycobacterium tuberculosis. doi:10.3346/jkms.1997.12.2.92 names it J Korean Med Sci 1997
Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. doi:10.1128/iai.65.4.1395-1401.1997 Infect Immun 1997
Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. doi:10.1128/AAC.41.3.600 Antimicrob Agents Chemother 1997
Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. doi:10.1128/jcm.35.3.719-723.1997 J Clin Microbiol 1997
Use of polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) analysis to detect a point mutation in the catalase-peroxidase gene (katG) of Mycobacterium tuberculosis. doi:10.1006/mcpr.1996.0077 names it Mol Cell Probes 1997
Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis. doi:10.1074/jbc.272.5.2834 names it J Biol Chem 1997
[Relationship between INH-resistance and katG mutation in M. tuberculosis]. names it Zhonghua Jie He He Hu Xi Za Zhi 1996
Differentiation of bacterial 16S rRNA genes and intergenic regions and Mycobacterium tuberculosis katG genes by structure-specific endonuclease cleavage. doi:10.1128/jcm.34.12.3129-3137.1996 names it J Clin Microbiol 1996
In search of tuberculosis virulence genes. doi:10.1016/0966-842x(96)10066-4 Trends Microbiol 1996
Life without KatG. doi:10.1016/0966-842x(96)30030-9 names it Trends Microbiol 1996
Presence of katG gene in resistant Mycobacterium tuberculosis. doi:10.1136/jcp.49.11.945 names it J Clin Pathol 1996
Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. doi:10.1046/j.1365-2958.1996.00133.x names it Mol Microbiol 1996
An ideR mutant of Mycobacterium smegmatis has derepressed siderophore production and an altered oxidative-stress response. doi:10.1046/j.1365-2958.1996.1461511.x Mol Microbiol 1996
Analysis of isoniazid-resistant transposon mutants of Mycobacterium smegmatis. doi:10.1111/j.1574-6968.1996.tb08507.x FEMS Microbiol Lett 1996
katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. doi:10.1128/AAC.40.9.2187 names it Antimicrob Agents Chemother 1996
Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. doi:10.1126/science.272.5268.1641 Science 1996
katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis are not infrequent. doi:10.1128/AAC.40.6.1572 names it Antimicrob Agents Chemother 1996
Overproduction of mycobacterial ribosomal protein S13 induces catalase/peroxidase activity and hypersensitivity to isoniazid in Mycobacterium smegmatis. doi:10.1016/0378-1119(95)00841-1 Gene 1996
Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996
Evaluation of inhA gene and catalase-peroxidase gene among isoniazid-sensitive and resistant Mycobacterium tuberculosis isolates. doi:10.1006/mcpr.1996.0001 Mol Cell Probes 1996
The katE gene, which encodes the catalase HPII of Mycobacterium avium. doi:10.1046/j.1365-2958.1996.352876.x Mol Microbiol 1996
Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. doi:10.1146/annurev.bi.65.070196.001243 Annu Rev Biochem 1996
Molecular biology in medicine: laboratory diagnosis of tuberculosis. Ann Acad Med Singap 1996
Host-mediated modification of PvuII restriction in Mycobacterium tuberculosis. doi:10.1128/jb.178.1.78-84.1996 J Bacteriol 1996
Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. doi:10.1093/infdis/173.1.196 names it J Infect Dis 1996
KatG sequence deletion is not the major cause of isoniazid resistance in Japanese and Yemeni Mycobacterium tuberculosis isolates. doi:10.1006/mcpr.1995.0066 names it Mol Cell Probes 1995
Comparison of isoniazid oxidation catalyzed by bacterial catalase-peroxidases and horseradish peroxidase. doi:10.1006/abbi.1995.0065 Arch Biochem Biophys 1995
Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. doi:10.1128/AAC.39.11.2472 names it Antimicrob Agents Chemother 1995
Antimicrobial agent resistance in mycobacteria: molecular genetic insights. doi:10.1128/CMR.8.4.496 Clin Microbiol Rev 1995
Mutations in katG gene sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare. doi:10.1128/AAC.39.10.2276 names it Antimicrob Agents Chemother 1995
Purification and characterization of the Mycobacterium smegmatis catalase-peroxidase involved in isoniazid activation. doi:10.1074/jbc.270.38.22290 J Biol Chem 1995
Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria. doi:10.1073/pnas.92.14.6625 Proc Natl Acad Sci U S A 1995
Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis. doi:10.1128/iai.63.4.1427-1433.1995 Infect Immun 1995
Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. doi:10.1093/infdis/171.4.954 J Infect Dis 1995
Comparison of activities of fluoroquinolones in murine macrophages infected with Mycobacterium tuberculosis. doi:10.1128/AAC.39.3.750 Antimicrob Agents Chemother 1995
Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis. doi:10.1111/j.1365-2958.1995.tb02276.x names it Mol Microbiol 1995
Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance. doi:10.1093/infdis/171.1.240 names it J Infect Dis 1995
Catalase expression, katG, and MIC of isoniazid for Mycobacterium tuberculosis isolates from São Paulo, Brazil. doi:10.1093/infdis/171.1.237 names it J Infect Dis 1995
Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. doi:10.1111/j.1365-2958.1995.tb02238.x names it Mol Microbiol 1995
PCR amplification of variable sequence upstream of katG gene to subdivide strains of Mycobacterium tuberculosis complex. doi:10.1128/jcm.32.12.3070-3071.1994 names it J Clin Microbiol 1994
Strain variation in the katG region of Mycobacterium tuberculosis. doi:10.1111/j.1365-2958.1994.tb01291.x names it Mol Microbiol 1994
Molecular genetics of drug resistance in Mycobacterium tuberculosis. doi:10.1093/jac/34.3.313 J Antimicrob Chemother 1994
Effects of peroxides on susceptibilities of Escherichia coli and Mycobacterium smegmatis to isoniazid. doi:10.1128/AAC.38.8.1829 Antimicrob Agents Chemother 1994
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. doi:10.1016/s0140-6736(94)91338-2 Lancet 1994
Mutations in the catalase-peroxidase gene from isoniazid-resistant Mycobacterium tuberculosis isolates. doi:10.1093/infdis/169.5.1162 J Infect Dis 1994
Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City. doi:10.1093/infdis/168.4.1063 J Infect Dis 1993
Susceptibilities of oxyR regulon mutants of Escherichia coli and Salmonella typhimurium to isoniazid. doi:10.1128/AAC.37.10.2251 Antimicrob Agents Chemother 1993
Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis. doi:10.1128/jb.175.13.4255-4259.1993 names it J Bacteriol 1993
Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. doi:10.1111/j.1365-2958.1993.tb01596.x names it Mol Microbiol 1993
Isolation and characterization of isoniazid-resistant mutants of Mycobacterium smegmatis and M. aurum. doi:10.1016/0923-2508(92)90067-x Res Microbiol 1992
The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. doi:10.1038/358591a0 Nature 1992

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

CRISPRi vulnerability

Vulnerability index 0.96 (95% CI -0.51 to 3.63). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Caveat on this estimate. Bosch et al. flag this gene's vulnerability estimate as NOT certain, and here that call has a mechanical cause visible in the library itself: every guide targeting this gene is >=21 nt (str_span=0.280 on a 0-1 scale, near the genome floor), and guide repression strength saturates from 21 nt on -- so the library never sampled a partial knockdown for this gene, only the near-maximal repression plateau. The dose-response fit (and this VI) is therefore essentially unconstrained by data, not merely uncertain -- a limitation of the CRISPRi library design for the non-essential class (Bosch et al. 2021), not a defect in this specific measurement. n_guides=12 is descriptive only and does not predict this. Do not cite this VI as a standalone vulnerability claim.

Legacy record & comparison (Mycobrowser)

Mycobrowser functionMultifunctional enzyme, exhibiting both a catalase, a broad-spectrum peroxidase, and a peroxynitritase activities. May play a role in the intracellular survival of mycobacteria within macrophages; protection against reactive oxygen and nitrogen intermediates produced by phagocytic cells. Seems regulated by SIGB|Rv2710 [catalytic activity: 2 H(2)O(2) = O(2) + 2 H(2)O].
Mycobrowser EC 1.11.1.6, 1.11.1.7 · superseded EC numbering; the atlas uses the current class (1.11.1.21)

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb1943c · 99.7% identity
M. marinum MMAR_2914 · 71.1% identity
M. smegmatis MSMEG_6384 · 71.5% identity
M. orygis RJtmp_001980 · 99.6% identity
M. abscessus MAB_2470c · 72.4% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WIE5 SwissProt · reviewed · Evidence at protein level
UniProt nameCatalase-peroxidase
EC (curated) EC 1.11.1.21
Curated functionBifunctional enzyme with both catalase and broad-spectrum peroxidase activity, oxidizing various electron donors including NADP(H). Protects M.tuberculosis against toxic reactive oxygen species (ROS) including hydrogen peroxide as well as organic peroxides and thus contributes to its survival within host macrophages by countering the phagocyte oxidative burst. Also displays efficient peroxynitritase activity, which may help the bacterium to persist in macrophages..; FUNCTION: Might be involved in DNA repair. Partly complements recA-deficient E.coli cells exposed to UV radiation, mitomycin C or.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category P Inorganic ion transport and metabolism
Preferred namekatG
eggNOG descriptionBifunctional enzyme with both catalase and broad- spectrum peroxidase activity
Orthologous groupCOG0376
EC number EC 1.11.1.21
KEGG orthology K03782
KEGG pathways map00360, map00380, map00940, map00983, map01100, map01110
Gene Ontology (130) GO:0000166, GO:0000302, GO:0003674, GO:0003824, GO:0004096, GO:0004601, GO:0005488, GO:0005575, GO:0005576, GO:0005618, GO:0005622, GO:0005623 +118 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.226 · purifying
Polymorphic sites (≥ 0.1% of strains) 7 synonymous, 5 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

M. canettii dN/dS (deep-divergence selection) 0.317 (low power) · 2 consensus substitution(s)
low power (2 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 52/53 (98%) · mean identity 70.0% · 4/4 closest MTBAP relatives
conserved across the genus (present in 52/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 7/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 68.6%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis)

DeJesus 2017 callNE · non-essential
What the call meansnon-essential
TA sites (Himar1) 39 in the ORF — 0 in the essential state, 0 growth-defect, 39 non-essential, 0 growth-advantage. Saturation 1.000, mean read count 119.538461538. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 39 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Mutant phenotypes (conditional Tn-seq, MtbTnDB) in-vivo phenotype

Conditionlog2FCqEffect
altered fitness under Isoniazid (drug exposure) +7.400.0 disruption advantageous
differential fitness in a comparison whose nature could not be established (upstream metadata defect, see note) (undetermined) +7.190.0 disruption advantageous
fitness after prolonged in vitro passage (in vitro passage) -4.700.0 required
Differential genetic requirements of clinical Mtb strain (ID=621) from East Asian lineage (compared to H37Rv control) (strain background) -3.540.0 required
fitness in mouse infection, day 45 (in vivo) -3.200.0 required
fitness in mouse infection (in vivo) +3.020.0 disruption advantageous
fitness in mouse infection (in vivo) +2.820.0 disruption advantageous
fitness in mouse infection (in vivo) +2.550.0 disruption advantageous
altered fitness under 6 weeks hypoxia (stress) -2.510.0 required
fitness in mouse infection (in vivo) +2.370.0 disruption advantageous
fitness in mouse infection (in vivo) +2.010.0 disruption advantageous
Differential genetic requirements of clinical Mtb strain (ID=631) from East Asian lineage (compared to H37Rv control) (strain background) -1.920.0 required

Conditional fitness of transposon-disruption mutants across 21 significant condition(s) — the table lists the 12 strongest by |log2FC|, not all 21 (|log2FC|≥1, q≤0.05), from the standardized MtbTnDB compendium. A negative log2FC means the mutant is depleted — the gene contributes to fitness in that condition. An in-vivo defect for a "hypothetical" is strong evidence it matters for infection, even without a known molecular function. Disruption (Tn insertion), not a clean deletion; genetic-interaction screens excluded.

Provenance note on a condition above. MtbTnDB labels this condition in vivo (Collaborative Cross mouse panel) and attributes it to Smith et al. 2022, eLife 74419. Both are wrong and for the same reason: its left arm, `mbio_H37Rv`, is the saturated H37Rv reference of DeJesus et al. 2017 (mBio 8(1):e02133-16, fourteen independent Tn libraries grown in standard medium), not a mouse strain, and the upstream generator read the token before `_vs_` as a mouse-strain name. The same sample is the in vitro control of six knockout screens in the same file. Measured here on rank correlation over 3971 genes: this condition tracks the other 81 first-order in vivo conditions at rho = +0.03, where those conditions track each other at +0.270 -- it does not behave like an infection measurement. What the comparison actually is could not be established, so it is reported as undetermined rather than renamed, and it is excluded from the in vivo count of this fiche.

Drug resistance (WHO catalogue) isoniazid

isoniazid597 catalogued resistance-associated variant(s)

This gene carries mutations classed Associated with resistance (WHO grade 1–2) in the consolidated catalogue (WHO 2nd ed. 2023 + tb-profiler). Only the R-associated tier is shown; "uncertain" and empirical-only signals are excluded. Test a specific strain or variant with the resistance tester. Research context, not a clinical diagnostic.

Proteomics (mass spectrometry) detected

MS detectiondetected in 16 of 16 independent MS datasets
Integrated abundance2844.0 ppm · rank 38/3519 (98.9th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length740 aa
Molecular weight80.6 kDa
Theoretical pI5.05
GRAVY-0.314 (hydrophilic)
Aliphatic index76.8
Aromaticity0.096
Instability index32.2 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
peroxidasePF00141.29 3.7e-4094–397 Peroxidase

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 8u3p (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 27 solved

PDBMethodResolutionCoverage
8u3p X-ray diffraction 1.79 Å 100%
2cca X-ray diffraction 2.0 Å 100%
8w1w X-ray diffraction 2.033 Å 100%
2ccd X-ray diffraction 2.1 Å 100%
8dwr X-ray diffraction 2.1 Å 100%
8czp X-ray diffraction 2.25 Å 100%
9sgl Electron Microscopy 2.27 Å 100%
8w1y X-ray diffraction 2.3 Å 100%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (27 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 96.1

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
8dwr-assembly2_D 1.00 1.00 0.97 1.00 100% 97% / 100% 0.0e+00 sig 8dwr-assembly2_D Crystal structure of the L333V variant of catalase-peroxidase from Mycobacterium tuberculosis
2ccd-assembly1_B 1.00 1.00 0.96 1.00 100% 97% / 100% 0.0e+00 sig 2ccd-assembly1_B Crystal structure of the catalase-peroxidase (KatG) and S315T mutant from Mycobacterium tuberculosis
4c51-assembly1_B 1.00 1.00 0.97 1.00 100% 97% / 100% 0.0e+00 sig 4c51-assembly1_B Crystal Structure of the Catalase-Peroxidase (KatG) R418L mutant from Mycobacterium Tuberculosis
4c50-assembly1_B 1.00 1.00 0.97 1.00 100% 97% / 100% 0.0e+00 sig 4c50-assembly1_B Crystal Structure of the Catalase-Peroxidase (KatG) D137S mutant from Mycobacterium Tuberculosis
8w1y-assembly1_B 1.00 1.00 0.97 1.00 100% 97% / 100% 0.0e+00 sig 8w1y-assembly1_B 2.30 angstrom resolution intermediate crystal structure of KatG from Mycobacterium tuberculosis with an MYW-OOH cofactor soaked with peroxide for 1 minute

Foldseek search of the AlphaFold DB model (mean pLDDT 96.1, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 3

Upstream (5' on genome)Rv1907c (- strand, 6 bp gap)
Downstream (3' on genome)furA (- strand, 37 bp gap)
Predicted operon Rv1907c · katG · furA

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 6: Rv1907c · katG · furA · Rv1910c · lppC · fadB5 — disagrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT1959) exponential phase: operon of 3, Rv1907c · Rv1908c · Rv1909c (coverage 437.9)
stationary phase: operon of 3, Rv1907c · Rv1908c · Rv1909c (coverage 526.58) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (4 TF) Rv0324 (activates) · Rv0767c (represses) · Rv1353c (activates) · Rv3488 (activates)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: furA (ferric uptake regulation protein FurA), high confidence (score 837, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence).

Showing the 15 strongest of this gene's 71 partners at medium confidence (31 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 71 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv1907c dark hypothetical protein 957 945 ctx neighborhood:805 coexpression:731
Rv3566c nat curated arylamine N-acetyltransferase 912 901 database:900
Rv1600 hisC1 curated histidinol-phosphate aminotransferase 910 901 database:900
Rv2231c cobC curated aminotransferase 905 900 database:900
Rv3772 hisC2 curated histidinol-phosphate aminotransferase 905 900 database:900
Rv1909c furA ferric uptake regulation protein FurA 979 837 ctx neighborhood:829 textmining:879
Rv3838c pheA curated prephenate dehydratase 801 801 database:800
Rv3846 sodA curated superoxide dismutase 973 516 database:500 textmining:948
Rv0432 sodC curated superoxide dismutase 936 503 database:500 textmining:878
Rv1910c hypothetical protein 541 471 ctx neighborhood:471
Rv1906c hypothetical protein 508 423 ctx neighborhood:415
Rv1905c aao D-amino acid oxidase 418 395
Rv3914 trxC thioredoxin TrxC 578 387
Rv1471 trxB1 thioredoxin 455 366
Rv1324 thioredoxin 415 360

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: catalase-peroxidase
  • MTBC0 PGAP product: catalase/peroxidase HPI
  • Pfam (hmmscan --cut_ga): peroxidase PF00141.29 (E=4e-40)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_216424.1)
  • Domains: Pfam-A via hmmscan --cut_ga — peroxidase (PF00141.29)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0376
  • Curated reference: UniProt P9WIE5 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 96.1)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 71 functional partner(s); context anchor furA
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Mutant phenotypes: standardized Tn-seq compendium MtbTnDB (Jinich et al. 2025, doi:10.1111/mmi.15370), aggregating many primary Tn-seq studies across conditions
  • Drug resistance: consolidated catalogue, WHO 2nd ed. 2023 (9789240082410) + tb-profiler; only the resistance-associated tier (grade 1–2) is surfaced
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_002023|Rv1908c|katG
MPEQHPPITETTTGAASNGCPVVGHMKYPVEGGGNQDWWPNRLNLKVLHQNPAVADPMGAAFDYAAEVATIDVDALTRDIEEVMTTSQPWWPADYGHYGPLFIRMAWHAAGTYRIHDGRGGAGGGMQRFAPLNSWPDNASLDKARRLLWPVKKKYGKKLSWADLIVFAGNCALESMGFKTFGFGFGRVDQWEPDEVYWGKEATWLGDERYSGKRDLENPLAAVQMGLIYVNPEGPNGNPDPMAAAVDIRETFRRMAMNDVETAALIVGGHTFGKTHGAGPADLVGPEPEAAPLEQMGLGWKSSYGTGTGKDAITSGIEVVWTNTPTKWDNSFLEILYGYEWELTKSPAGAWQYTAKDGAGAGTIPDPFGGPGRSPTMLATDLSLRVDPIYERITRRWLEHPEELADEFAKAWYKLIHRDMGPVARYLGPLVPKQTLLWQDPVPAVSHDLVGEAEIASLKSQILASGLTVSQLVSTAWAAASSFRGSDKRGGANGGRIRLQPQVGWEVNDPDGDLRKVIRTLEEIQESFNSAAPGNIKVSFADLVVLGGCAAIEKAAKAAGHNITVPFTPGRTDASQEQTDVESFAVLEPKADGFRNYLGKGNPLPAEYMLLDKANLLTLSAPEMTVLVGGLRVLGANYKRLPLGVFTEASESLTNDFFVNLLDMGITWEPSPADDGTYQGKDGSGKVKWTGSRVDLVFGSNSELRALVEVYGADDAQPKFVQDFVAAWDKVMNLDRFDVR